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SUMMARY
Herpes simplex virus (HSV) is associated with the development of 
cervical cancer. Steroid hormones play a role in the normal develop­
ment and in the pathology of the cervix. In view of the increased 
risk of developing cervical cancer in people taking the steroid - based 
contraceptive pill, possible interactions between steroid hormones and 
HSV were investigated.
The growth of HSV-2 in either primary ectocervical cells or in the 
breast cancer cell line, ZR-75-1, was shown to be independent of either 
oestradiol (E2) or progesterone (Pg), in the concentration range 10~9m  
to 10- "^ M.
The HSV IE activator sequence TAATGARAT (R = purine), which responds 
to the virion trans-inducing factor, Vmw 65, is partially homologous 
to the consensus binding site for PR found upstream of chicken egg- 
white genes. The ability of the hormones, E 2 and Pg to modulate gene 
expression via the HSV TAATGARAT element was tested. MCF-7 or 
ZR-75 -1 cells were transfected with plasmids encoding the CAT gene 
under the control of an HSV IE promoter and upstream TAATGARAT 
elements, in the presence and absence of physiological concentrations 
of E 2 or P g . No significant differences in the level of CAT activity 
with or without hormones were seen.
Vmw 65 interacts with the TAATGARAT sequence in association with 
cellular factors. Specific complexes between nuclear protein(s) 
from MCF-7 and ZR-75-1 cells and TAATGARAT DNA were detected by gel 
retardation assays. Interestingly, the two cell lines tested showed 
different binding patterns, indicating differences in the cellular 
factors which recognize TAATGARAT. E 2 treatment of cells did not 
result in any modification of the complexes formed with TAATGARAT.
No virus induced protein, specific for TAATGARAT, was observed 
under the conditions used for these experiments.
Thus no effect of E 2 or Pg on the HSV IE activator sequence, TAATGARAT, 
was seen in the gene expression and DNA-binding studies described here.
xii
Biochemical and immunological steroid receptor assays were used to 
test the levels of ER and PR in MCF-7 and ZR-75-1 cells after E 2 
treatment and/or HSV (-1 or -2) infection. E 2 treatment induced a 
4- to 7- fold stimulation of detectable PR, indicating that the cells 
were responding as expected to E a . In contrast, both E 2 and HSV 
caused the level of ER to fall to about 10% of the value measured in 
control, untreated cells. In vivo, E 2 is known to stimulate the 
level of ER. A drop in detectable receptor may be due to modification 
of the receptor which prevents ligand binding or recognition by the 
monoclonal antibody. HSV also caused the level of PR to fall, 
indicating that E 2 and HSV have different mechanisms of action.
Attempts to in vitro translate and immunoprecipitate the ER protein 
from total cytoplasmic RNA were unsuccessful, despite the 
increase in ER mRNA levels detected in these samples in response to 
E 2 treatment or HSV infection (see later). The failure to detect ER 
by in vitro translation and immunoprecipitation was probably due to 
either the low abundance of the ER mRNA population or to the inability 
of the monoclonal antibody to recognize newly synthesized ER.
The possibility that HSV could influence steroid gene expression at 
the transcriptional level was tested by Northern blot and slot-blot 
analysis of ER mRNA levels. Changes in ER mRNA levels were correlated 
with the level of actin mRNA, taken as a standard message. E 2 stimula­
tion (10~^M E 2, 24h) resulted in a 50% increase in ER mRNA levels. 
HSV-1 infection resulted in a time - dependent increase of ER mRNA, 
reaching up to 250% of the control level by 8h post-infection 
(10 pfu/cell). HSV-2 infection (10 pfu/cell, 6h) stimulated the 
ER mRNA level by only 30%. The lower stimulation by HSV-2 may reflect 
the fact that HSV-2 infection induced earlier detachment from the 
substrate than HSV-1. The combination of E 2 together with HSV gave a 
greater response than with either agent alone, showing that HSV and E 2 
stimulate the level of the ER message by different mechanisms. 
Stimulation of the ER message may be by transcriptional activation 
or by message stabilization.
ER mRNA levels were 10 - 50% lower than the control value if cells 
were treated with cycloheximide for 30 minutes prior to and 
throughout the course of infection. This result suggests the 
involvement of both viral and cellular proteins in stimulation 
of the ER mRNA level.
The mutant virus, t s K , which synthesizes only IE polypeptides at the 
non-permissive temperature (including an abnormal form of the 
regulatory protein, Vmw 175), stimulated the level of ER mRNA by 
approximately 200 - 300%. Stimulation by tsK may be mediated by an 
IE protein(s) or by the trans-inducing factor, Vmw 65, present as a 
virion component. In some experiments, stimulation of ER mRNA was 
artifactually high (up to 600%) due to a significant depression of 
the actin message against which the ER message level was calculated. 
Depression of the actin message was not seen with wild-type HSV 
infection.
HSV or tsK infection is known to induce the heat shock response. The 
possibility that the increase in ER mRNA induced by virus infection 
was related to a general stress response was tested. The ER message 
was not induced by chemical stress. In one experiment, heat - 
shocked cells showed an increase in ER mRNA but this was not a repeat- 
able result.
Three candidates for viral transcriptional activators are the IE 
proteins, Vmw 175 and Vmw 110 and the virion trans-inducing factor,
Vmw 65. The ability of each of these proteins to stimulate the level 
of ER mRNA was tested in transfection experiments. No significant 
stimulation of ER mRNA by Vmw 175 or Vmw 110 was observed, even 
although these proteins activated the expression of an HSV E gene 
(tk) in a transient CAT assay system. Transfection of plasmids 
encoding Vmw 65 resulted in a 200 - 300% increase in ER mRNA levels, 
a similar level of activation as was found with HSV-1 and tsK 
infection. Transfection of plasmids encoding mutated forms of Vmw 65, 
which were unable to trans-activate the TAATGARAT element in a
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transient CAT assay system, also resulted in a 200 - 300% increase 
in ER mRNA levels. Thus Vmw 65 functions differently in tne method 
of activation of TAATGARAT sequences and the stimulation of ER mRNA 
levels.
The ability of HSV to stimulate the level of a cellular message of 
a protein directly involved in growth control may be important in 
view of the association of HSV with cervical cancer and the 
importance of transcriptional activation as a mechanism in oncogene­
sis. It is particularly interesting that the gene transcript shown 
here to be upregulated is the ER mRNA since increased sensitivity to 
E 2 is associated with a number of reproductive epithelial cancers.
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INTRODUCTION
The introduction has been divided into three major sections:
Al. Mechanism of steroid hormone action.
Bl. Herpes simplex virus.
Cl. Role of steroid hormones and virus in the development and 
pathology of the uterine cervix.
Al MECHANISM OF STEROID HORMONE ACTION
Al.l INTERACTION OF STEROID HORMONES AND INTRACELLULAR RECEPTORS
Steroid hormones circulate in the blood bound to plasma proteins.
An equilibrium exists between the bound and free states. Free steroid 
enters the "target" cells by passive diffusion down a concentration 
gradient, but there is much current discussion on what really constitutes 
"biologically available" steroid (Moore et a l ., 1986). Target cells 
are defined by the presence of appropriate, specific, high affinity 
receptors which bind the hormone and mediate its biological effects.
Each steroid hormone has its own high affinity receptor. Various 
models have been proposed for receptor mediated steroid hormone 
action.
A l . l g1 The Classical Model
The original "two - step" model of ER action proposed by Gorski 
et a l .(1968) and Jensen et a l . (1968) was based on the distribution 
of specifically bound [3H]-E2 in the nuclear and soluble fractions 
of homogenized tissues. In this model, binding of E 2 to its "soluble" 
cytoplasmic receptor results in the formation of a hormone - receptor 
complex (step 1) which is then "translocated" to the nucleus (step 2).
Prior to translocation, the hormone - receptor complex undergoes 
a temperature - dependent activation step which results in increased 
affinity of the hormone - receptor complex for chromatin and DNA 
(Jensen et a l ., 1968, 1969). In the case of the ER complex, this 
involves the conversion of the 4S soluble receptor (8S in low ionic 
strength buffers) to the 5S form, which is the salt - extractable 
form recoverable from the nucleus (Jensen et a l ., 1969). The 5S 
form is a homodimer (Notides et a l ., 1981). In the cases of the 
GR (Vedeckis, 1983), the AR (Liao et a l ., 1973) and, in some species, 
the PR (Saffron et a l ., 1976; Chen and Leavitt, 1979), activation 
involves a decrease in sedimentation constant.
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Following activation and translocation to the nucleus, the hormone - 
receptor complex is believed to interact with ’’acceptor” sites in 
the nucleus and modulate the expression of a specific set of genes.
A l .1.2 The Equilibrium Model
Since the proposal of the ’’two - step" model for oestrogen action, 
the subcellular distribution of "empty" and "filled" receptor has 
been questioned on the grounds that homogenization of tissue in 
large volumes of buffer can lead to artifactual localization of 
the receptor in the cytosol. Sheridan’s group (Sheridan et a l .,
1979; Martin and Sheridan, 1980, 1982) has proposed that unbound 
receptor is in equilibrium, partitioned between the cytoplasm and 
nucleus according to the free water content of these intracellular 
compartments. Additionally, using the "thaw - mount" technique 
and autoradiography, Sheridan et a l .(1979) showed that even at 
0°C, extensive nuclear localization of specifically bound Ea occurred 
within 5 minutes in intact rat uteri.
A l .1.3 The Nuclear Model
Several groups have reported purely nuclear localization of steroid 
receptors. Welshons et a l . (1984, 1985) investigated the subcellular 
distribution of ER, PR and GR in rat pituitary tumour cells.
Cytoplast and nucleoplast fractions were prepared by exposing the 
cells to cytochalasin B. Incorporation of radiolabelled ligands 
into each fraction was measured. Unoccupied receptors were found 
predominantly in the nucleoplast fraction while the cytoplast fraction 
contained only minimum levels of receptors. Incubation of whole 
cells in enucleation medium (Percoll, cytochalasin B and DMSO) did 
not significantly change the number of receptors per cell or the 
distribution of receptor between the cytosol and crude nuclear pellet 
in homogenized cells. Welshons et a l . concluded that "empty" receptor 
is loosely attached to the nucleus and that tight nuclear binding 
occurs once hormone binds to the receptor.
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King and Greene (1984) utilized a number of monoclonal antibodies 
(which recognize various epitopes of the ER) in an indirect immuno- 
peroxidase technique on frozen, fixed sections of human breast 
tumours, human uterus, rabbit uterus and in MCF-7 cell cultures.
Nuclear staining was observed in all cases. The results were 
reported to be uniform under a range of fixation conditions and 
temperatures, thus the nuclear staining was unlikely to be due to 
artifactual translocation of the receptor during fixation or processing 
of tissues or cells. Short - term treatment of MCF-7 cells or immature 
rabbits with oestradiol led to no increase in nuclear staining inten­
sity. The conclusions of King and Greene were similar to those 
of Welshons et al. (1984, 1985).
As discussed by Raam (1986 ) , the anti - ER monoclonal antibodies are 
epitope specific and may cross - react with other nuclear antigens. 
Moreover, the antibodies may not be able to distinguish between the 
multiple physiological forms of the receptor (untransformed, transformed 
and "processed" receptor). The antibodies may preferentially bind 
the activated form of the receptor.
Immunofluorescence studies on frozen sections of human breast cancer 
biopsies, using polyclonal antibodies against the ER (Raam et a l .,
1982; Tamura et a l ., 1984) showed predominantly cytoplasmic fluoresc­
ence although nuclear fluorescence was also observed. Translocation 
of the receptor from the cytoplasm to the nucleus was observed after 
treatment with E 2 (Raam et a l ., 1983).
Immunohistochemical and immunocytochemical studies performed with 
monoclonal antibodies against the PR (Gasc et a l ., 1984; Perrot- 
Applanat, 1985) indicated nuclear localization of the PR. Similar 
studies on the GR did not show a purely nuclear localization 
(Govindan et a l ., 1980; Papamichail et a l ., 1980; Bernard and Joh,
1984; Fuxe et a l ., 1985; reviewed by Gustafsson et a l ., 1987).
Studies on the subcellular distribution of the rat GR after trans­
fection of cloned cDNA sequences into cultured cells (Picard and
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Yamamoto, 1987) showed cytoplasmic localization of the untransformed 
receptor in the absence of serum and phenol red, which is a weak 
oestrogen (Berthois et a l ., 1986). Artifactual nuclear localization 
of receptor was observed in the presence of serum and phenol red.
When 180 amino acids were removed from the hormone - binding carboxyl 
terminus, the receptor was localized in the cytoplasm, even in the 
presence of hormone. Two nuclear localization signals, NL1 and 
N L 2 , were identified in the amino terminus of the receptor. The 
NL1 sequence is perfectly conserved in the human (Weinberger et_ 
a l ., 1985) and the mouse (Danielson et a l ., 1986) G R ’s. Neither 
NL1 nor NL2 bound DNA in vitro (Rusconi and Yamamoto, 1987). Thus,
DNA binding activity and nuclear localization of the receptor were 
separable functions (Picard and Yamamoto, 1987).
Differences in intracellular localization of steroid receptors may 
exist but it is important to check that the methodology used to 
examine the distribution of receptors does not give artifactual 
results.
A1.2 PHOSPHORYLATION AND DEPHQSPHORYLATION OF STEROID RECEPTORS
A l .2.1 Phosphorylation of Steroid Receptors
There is some evidence that certain functions of steroid receptors 
are regulated by phosphorylation and dephosphorylation of the receptor. 
The GR is phosphorylated in glucocorticoid responsive L-cells but 
not in glucorticoid resistant L-cells (Housley and Pratt, 1983).
The chicken oviduct PR can be phosphorylated in vivo (Dougherty and 
Toft, 1982) and the rabbit uterine PR undergoes a hormone - dependent 
phosphorylation in generation of the "nuclear" DNA - binding form 
of the receptor (Logeat et a l ., 1985).
Hormone binding of purified ER from calf uterus is inactivated
by a nuclear phosphatase (Aurrichio et a l ., 1981; Migliaccio et a l .,
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1982) which removes phophate from the receptor (Aurrichio et a l . 1984). 
Hormone binding is reactivated by a calmodulin stimulated kinase 
that phosphorylates the receptor exclusively on tyrosine (Migliaccio 
et a l ., 1982, 1984). Purified ER from whole rat uterus labelled 
in vivo with [32P]-orthophosphafe is labelled on tyrosine (Migliaccio 
et al , , 1986). The ER tyrosine kinase is regulated by physiological 
concentrations of E 2 (Aurrichio et a l ., 1987). E 2 increases the 
affinity of the kinase for its substrate, dephosphorylated receptor, 
and stimulates hormone binding to its receptor. The anti - oestrogen, 
tamoxifen, inhibits tyrosine phosphorylation and binding of E 2 to 
its receptor (Aurrichio et a l ., 1987).
The complete cDNA sequence of the ER contains information for four 
tyrosyl and two seryl residues that are potential sites for phosphory­
lation (Green et a l ., 1986). Aurrichio et 3l . (1987) have suggested 
that protein tyrosine phosphorylation may be an initial event of 
oestrogen action on target tissues. Retroviral transforming proteins 
(Bishop, 1985), peptide hormones and growth factors are phosphorylated 
on tyrosine residues.
A l .2.2 Dephosphorylation of Steroid Receptors
Whereas phosphorylation is thought to play a role in hormone binding 
to the receptor, dephosphorylation may be involved in activation 
of the receptor to the DNA - binding form. Evidence for this comes 
mainly from studies with phosphatase inhibitors. Molybdate, a 
potent inhibitor of phosphatase, inhibits thermal activation of 
the GR (Leach et a l ., 1979; Barnett et a l ., 1980), the PR (Nishigori 
and Toft, 1980) and the ER (Shyamala and Leonard, 1980). These 
results are consistent with the idea that activation of the receptor 
involves dephosphorylation. However, several other phosphatase 
inhibitors (e.g. fluoride, arsenate and phosphate) do not inhibit 
activation of GR or PR (Barnett et a l ., 1980; Nishigori and Toft,
1980). Further, there are several possible ways in which molybdate 
may inhibit activation (Barnett et a l ., 1980; Nishigori and Toft,1980)
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including modification of protein activity through interaction with 
amino acid residues (e.g. thiol group of cysteine) or complexing 
of phosphate groups which may reside on the receptor or on a component 
associated with receptor activity. Molybdate may also inhibit 
serine proteases, a role for which has been suggested in activation 
of the GR (Hubbard et a l ., 1984) and ER (Puca et a l ., 1986).
Inhibitor studies by Puca et a l .(1986) have shown .that a serine protease 
within the receptor molecule itself is stimulated by hormone binding. 
They proposed that this serine protease activity is responsible 
for activation of the receptor to the DNA - binding form.
A1.3 ASSOCIATION OF HEAT SHOCK PROTEIN 90 WITH STEROID RECEPTORS
Two laboratories have reported that molybdate stabilized avian PR's 
are eluted from steroid affinity columns in association with a 
phophoprotein of mol. wt. 90 000 that does not bind progesterone 
(Dougherty and Toft, 1984; Renoir et a l ., 1984). Monoclonal antibodies 
raised against the 90K phosphoprotein also interact with molybdate 
stabilized receptors for oestrogen, androgen and glucocorticoid 
hormones (Joab et a l ., 1984; Housley et a l ., 1985; Sullivan et a l .,
1985). Immunoblotting and peptide mapping studies (Catelli et a l .,
1985; Sanchez et a l ., 1985; Schuh et a l ., 1985) have shown that 
the 90K phosphoprotein is a heat shock protein (hsp 90) similar 
to that previously shown to be induced by heat or stress (reviewed 
by Welch et a l ., 1982).
The biological significance of the association of hsp 90 with steroid 
receptors is uncertain. Activation or transformation of the receptor 
is accompanied by dissociation of hsp 90 (Mendel et a l ., 1986).
Thus hsp 90 only associates with the untransformed receptor. Based 
on the analogy of the retrovirus protein kinase association with 
hsp 90 (Brugge et a l ., 1981, 1983; Courtneidge and Bishop, 1982;
Lipsich et a l ., 1982), a number of possible functions for hsp 90 
in association with steroid receptors have been proposed (Catelli
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et a l . , 1985; Schuh et a l . , 1985; Ziemiecki, 1986). A modulatory 
role for hsp 90 would be in keeping the steroid receptor in an inactive 
state either by blocking the DNA - binding domain or by altering 
its phosphorylation state. Intracellular transport of steroid recep­
tors may be aided by hsp 90. The untransformed receptor may be 
stabilized by association with hsp 90.
Several factors argue against a specific function for hsp 90. The 
hsp 90 is an abundant cytoplasmic protein making up 1% of total 
cell protein which is about 100 times in excess of what is needed 
to account for binding to steroid receptors (Gasc et a l ., 1984). 
Moreover, hsp 90 is found in a wide variety of tissues and species 
(Riehl et a l ., 1985), not all of which are targets of hormone action.
In addition, if the true location of hsp 90, in the intact cell, 
is in the cytoplasm and the true location of steroid receptors is 
nuclear, then the association of the two proteins in broken cell 
preparations may be coincident and simply reflect the "sticky" nature 
of one and the abundance of the other.
A l .4 MODULATION OF CELLULAR ER LEVELS
The modulation of cellular ER levels by steroid has been studied 
in the immature rat uterus and in MCF-7 cells (reviewed by Kassis 
and Gorski, 1983). A single injection of Ea. in the rat leads to 
a dose dependent loss of "soluble" receptor and a simultaneous rise 
in tightly bound nuclear receptor. The soluble receptors are then 
gradually "replenished" to control levels over a period of 11 - 
16 h (Sarff and Gorski, 1971). By 32 h post-injection the receptor 
levels reach 150% of the control level, 70% of which is newly 
synthesised receptor and 80% of which is recycled receptor. 
Responsiveness of target tissues to further hormone treatment seems 
to be dependent on receptor replenishment (Anderson et a l . , 1974).
Replenishment of cytoplasmic receptor, after translocation to the
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nucleus, lags behind nuclear receptor loss and thus the total, 
detectable receptor content is decreased 2 - 6 h post-injection 
(Kassis and Gorski, 1983). This apparent loss of receptor has been 
termed "processing" and occurs both in vivo and in vitro. This 
phenomenon has been extensively studied in MCF-7 cells.
Treatment of MCF-7 cells with E 2 results in translocation of the 
ER complex to the nucleus followed by a rapid loss of competable 
nuclear receptor (70% loss within 3 - 5 h), not explained by a con­
comitant rise in cytoplasmic receptor (Horwitz and McGuire, 1978c, 
1980). This loss or "processing" of receptor is inhibited by the 
specific G-C base pair intercalators, actinomycin D and chromomycin 
A 3 but not by inhibitors of RNA, DNA or protein synthesis although 
m ainte nance of low, steady-state levels of receptor does require 
protein synthesis (Horwitz and McGuire, 1978b, 1980). This suggests 
that interaction of the receptor complex with chromatin is important 
for processing to occur.
There is some evidence to suggest that processing may be an important 
step for oestrogen action. Antioestrogens allow accumulation of 
nuclear receptor complexes but inhibit processing (Horwitz and McGuire, 
1978c). In addition, an oestrogen unresponsive variant of MCF-7 cells 
fails to show processing (Nawata et a l ., 1981). Induction of PR 
accompanies loss of ER (Horwitz and McGuire, 1978a). However, 
further investigation into the induction of PR showed no direct 
correlation with the extent of ER loss (Strobl et a l ., 1984).
Processing in MCF-7 cells involves both physical and kinetic modific­
ations to the receptor. Continued exposure of MCF-7 cells to E 2 
for 6h results in a tightly bound, less exchangeable form of the 
receptor with distinct molecular alterations ( Kas£id et a l ., 1984)
Kinetic studies show two populations; of receptor (Strobl et a l .,
1984). Generation of a rapidly dissociating population of oestradiol 
binding sites is followed by a loss of oestradiol binding capacity 
from these sites (reduced by 45% after 5h of incubation with E 2).
In the presence of actinomycin D, only a single population of slowly 
dissociating receptor is detected. Thus processing in MCF-7 cells 
seems to result from the loss of rapidly dissociating, high affinity 
binding sites for oestradiol.
An equilibrium model for oestrogen replenishment has been proposed 
by Kassis and Gorski (1983). The model describes three forms of 
the receptor:
(a) an active form with high affinity for steroid
(b) an inactive form with low affinity for steroid
(c) a transformed state with high affinity for polyanions, chromatin 
proteins and DNA.
A1.5 CHANGES IN MACRQMOLECULAR SYNTHESIS INDUCED BY OESTROGEN
A l . 5.1 Rat Model 1' '
An injection of E 2 into the rat results in a sharp rise in RNA 
polymerase H  activity within 15 min followed by a rise in polymerase 
1 activity 30 - 60 min after Ea injection (Glasser et a l ., 1972). 
Optimization of biosynthetic activity occurs through histamine release, 
eosinophil migration, increased nucleotide and amino acid uptake, 
glucose metabolism and vascular permeability (Clark and Peck, 1979). 
The stimulation of DNA synthesis is directly related to the rate 
of protein synthesis 12h after E 2 injection, the retention of nuclear 
receptors and the amount of receptor processing taking place (Stack 
and Gorski, 1985). Sustained steroid induced growth requires that 
a minimum number of available acceptor sites in the nucleus remain 
occupied for at least 6 - 12 h. Saturation of all available sites 
is not necessary (Giannopoulos and Gorski, 1971; Anderson et a l .,
1973).
PR synthesis is induced by E 2 in rat uterine tissue (Hsueh et a l .,
1975) and is dependent on RNA and protein synthesis (Leavitt et a l .,
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1979). Progesterone inhibits ER synthesis by interfering with replen­
ishment of the unfilled receptor (Hsueh et a l ., 1976).
A l .5.2 Breast Cancer Cells
E 2 induces a large number of enzymes involved in nucleic acid synthesis 
in cultured breast cancer cell lines (e.g. MCF-7, ZR-75-1), (reviewed 
by Dickson and Lippman, 1987). Stimulation of MCF-7 cells with physi­
ological concentrations of E 2 for 24h results in a 2- to 5-fold rise 
in tk activity (Bronzert et a l ., 1981). In methotrexate resistant 
MCF-7 cells, E 2 induces a 2-fold increase in dihydrofolate reductase 
(DHF) activity (Cowan et a l ., 1982). Regulation of tk and DHF 
activity by E 2 is at the mRNA level (Aitken et a l ., 1985; Kas$id 
et a l ., 1986).
A number of m R N A ’s which are regulated by oestrogen have been identi­
fied by selective screening of cDNA libraries prepared from MCF-7 
cells (Masiakowski et a l ., 1982; May and Westley, 1986) and from 
ZR-75-1 cells (Westley and May, 1987). Masiakowski et a l . (1982) 
identified a cDNA clone, pS2, corresponding to a 600 - nucleotide 
mRNA whose synthesis is induced at the transcriptional level by 
the addition of E 2 to the culture medium. Induction of pS2 mRNA by 
physiological concentrations of E 2 in MCF-7 cells (2-fold induction) 
has been confirmed by others (Aitken et a l ., 1985; Kassid et a l .,
1986). May and Westley (1986) identified four oestrogen - regulated 
m R N A ’s, pNR-i, pNR-2, pNR-3 and pNR-4, in MCF-7 cells. Two of the 
messages, pNR-3 and pNR-4, were induced at least 8-fold by E 2.
It is probable that the pS2 and pNR-2 messages are the same as both 
pS2 and pNR-2 cDNA clones hybridize to RNA of the same size (May 
and Westley, 1986).
Cathepsin D mRNA is an oestrogen - regulated message (Westley and 
May, 1987). Cathepsin D is a lysosomal aspartyl endopeptidase 
whose biological function is thought to be catabolism of cellular 
proteins. The 46K (also known as 50K or 52K) oestrogen - regulated,
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secreted protein (Westley and Rochefort, 1980) may be cathepsin D 
(Morisset et a l ., 1986).
PR synthesis is induced by E 2 in MCF-7 cells (Horwitz and McGuire, 
1978a). The presence of PR as well as ER in breast tumours is con­
sidered to be the best marker of hormone - responsive disease 
(Leake et a l . , 1981, 1987). However, the mechanisms by which
oestrogens induce PR synthesis and growth seem to be separate 
(Reiner and Katzenellenbogen, 1986) so that tumour cells may be 
able to induce PR while no longer being dependent on oestrogen for 
growth. The reverse may also be true since some breast tumours 
(about one-third) which are ER positive but PR negative respond 
to endocrine therapy (Leake e-t -a k  , 1987).
E 2 induces the synthesis of some less well characterized proteins 
in breast cancer cells: .Plasminogen activator and collagenolytic
enzymes (Butler et a l ., 1979; Huff and Lippman, 1984) are thought 
to contribute to tumour progression and growth by allowing the 
tumour to digest and traverse encapsulating basement membrane (Liotta 
et a l . , 1986). The cell surface receptor for laminin (Albini et a l .,
1986) is thought to mediate attachment of normal cells to basement 
membrane laminin (Liotta et a l ., 1986) and to contribute to cellular 
invasiveness of tumour cells in colonization of new host tissues. 
Several relatively abundant secreted proteins, whose functions are 
not clear, are also induced by E 2 (Burke et a l ., 1978; Ciocca et a l . , 
1983; Westley and Rochefort, 1980).
A1.6 MECHANISMS FOR OESTROGEN - PROMOTED GROWTH
Administration of oestrogen increases DNA synthesis and cell prolif­
eration in the rat uterus (Kaye et a l ., 1972; Stormshak et a l .,
1976). Oestrogen applied locally to the lumen of the rat uterus 
stimulates DNA synthesis but to a lesser extent than oestrogen 
administered systemically (Stack and Gorski, 1984). This suggests 
both direct and indirect mechanisms for oestrogen — promoted growth.
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The effect of oestrogen on cell proliferation in established cell 
lines derived from oestrogen - responsive tumours (e.g. MCF-7 
cells) is difficult to interpret (Sonnenschein and Soto, 1980).
These cell 1 ines require oestrogen stimulation to grow as 
tumours in vivo, yet in vitro, they often show a very poor response 
to oestrogen ( Shafie, 1980; Sonnenschein and Soto, 1980).
One possible reason for the poor response seen in vitro is the 
fact that phenol red, the pH indicator used in most cell media at 
concentrations ranging from 30 - 45 piM, is a weak oestrogen with 
a binding affinity 0 .001% that of E 2 for its receptor and capable 
of inducing cell proliferation and induction of the PR (Berthois 
et a l ., 1986; Rajendran et a l ., 1987). Rajendran et a l . (1987) 
have proposed that phenol red causes its oestrogenic effect through 
activation of unfilled receptors by interacting at a site distinct 
from the steroid binding site. These results may help to explain 
the variable degree to which MCF-7 cells are reported to be growth- 
stimulated by Ea.
The different extent of growth response to topical and systemic 
oestrogen, observed by Stack and Gorski (1984), suggests that the 
’’phenol red effect" does not fully explain the discrepancy between 
the level of response to Ea found in vivo and in vitro. This disc­
repancy has led to the proposal of indirect mechanisms for the role 
of oestrogen in inducing cell proliferation.
Sirbasku (1978) proposed that oestrogens trigger the synthesis and/or 
release of growth factors in the uterus, kidney or liver which would 
then be mitogenic for oestrogen - responsive cells. Extension of 
this model (Sirbasku, 1981; Ikeda et a l ., 1982) allows for three 
possible mechanisms (Fig. 1.1) :
(a) A growth factor may be released from a stromal cell and act 
as a mitogen on a neighbouring epithelial cell (paracrine 
mechanism).
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FIG. 1.1 PROPOSED MECHANISMS FOR INDIRECT MODELS 
OF OESTROGEN PROMOTED GROWTH
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(Reproduced from Ikeda et a l ., 1982).
(b) A growth factor may be released from the same cell for which 
it is mitogenic (autocrine mechanism).
(c) A growth factor may be released into the general circulation 
and act on a distant cell.
Evidence for the secretion of growth factors from E 2 - stimulated 
breast cancer cells has been reviewed by Dickson and Lippman (1987). 
Briefly, oestrogen regulation of MCF-7 cells is associated with 
induction of the autostimulatory transforming growth factor a(TGF-a), 
induction of insulin-like growth factor 1 (IGF-1) and repression of 
the autoinhibitory transforming growth factor @(TGF-$). In addition, 
mammary stroma appears to provide an as yet unidentified factor(s) 
required for full mitogenicity of oestrogen (McGrath, 1983).
A1.7 REGULATION OF GENE TRANSCRIPTION BY STEROID HORMONES
A l . 7 .1 Role of Specific DNA Regulatory Sequences
Al.7.1.1 MMTV Model
Regulation of gene expression by glucocorticoids in the mouse mammary
tumour virus (MMTV) has been studied as a model system for how activated 
hormone - receptor complexes interact with specific DNA regulatory 
sequences and possibly other nuclear factors to promote transcription.
Glucocorticoid hormones specifically increase the rate of synthesis 
of MMTV RNA in mouse mammary tumour cells and in MMTV - infected rat 
hepatoma cells while not appreciably affecting the overall rate of 
cellular RNA synthesis (Ringold et a l ., 1977). Hormonal regulation 
is maintained when cloned DNA fragments containing the MMTV LTR are 
transfected into cultured cells (Yamamoto et a l ., 1981; Groner et a l ., 
1982). Regulation of transcription is at the level of initiation 
(Ucker et a l ., 1983; Firzlaff and Diggelmann, 1984).
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The glucocorticoid responsive element (GRE) of the MMTV LTR can be 
distinguished and physically separated from the basal transcription 
initiation element (TIE), (Chandler et a l ., 1983). GRE activity 
persists even when its location and orientation relative to the 
TIE is changed. Transcription, in Ltk cells, of plasmids contain­
ing increasing deletions at the 5 ’-side of the LTR linked to the 
coding region of the HSV tk gene has defined a fragment of about 
200 nucleotides 5' to the transcription initiation site , as 
responsible for glucocorticoid responsiveness (Hynes et a l ., 1983; 
Buetti and Diggelmann, 1983; Majors and Varmus, 1983). Similar 
analysis of deletions progressing 3' to 5' has defined the border of 
the GRE to be between -59 and -65 of the LTR RNA initiation site 
(Ponta et a l ♦, 1985). A 184 nucleotide fragment of the LTR (-52 to 
-236) has purely regulatory properties (Ponta et a l ., 1985). This 
GRE confers inducibility to a tk gene and to an a-globin gene, 
indicating that inducibility is not promoter specific. The GRE can 
function in a distance and orientation manner thus showing typical 
properties of an enhancer element (Chandler et a l .,1983; Ponta et a l ., 
1985)
Four GR binding sites (one distal and three proximal) have been iden­
tified between -200 and -70 in the MMTV LTR by DNase 1_ footprinting 
(Scheidereit et a l ., 1983). These GR binding sites contain a common 
hexanucleotide sequence, 5'-TGTTCT-3', the guanosine residues of 
which are protected by the receptor protein from methylation by 
dimethylsulphate^ (Scheidereit and Beato, 1984), indicating that the 
TGTTCT sequence is involved in the contact between the hormone - 
receptor and the DNA double helix.
The hexanucleotide sequence is also present in the glucocorticoid 
responsive regions of the rat tyrosine aminotransferase (TAT) gene 
(Jantzen et a l ., 1987); the human metallotheionein gene LI (hMTll), 
(Karin et a l ., 1984); the 5 ’-flanking region, the first intron, the 
3'-untranslated region of the human growth hormone gene (Moore et a l ., 
1985; Slater et a l ., 1985) and the chicken lysozyme gene, inducible by
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glucocorticoid, progesterone, oestrogen and androgen hormones 
(Renkawitz et a l ., 1984). However, there is some doubt about the 
functional significance of this sequence. The hexanucleotide sequence 
can be deleted from the hMTl1 5*-flanking region without influencing 
the extent of hormonal induction (Karin et a l ., 1984) suggesting that, 
in this case, binding of GR to this sequence is not biologically 
relevant. In the case of the human growth hormone gene, only a 
region in the first intron shows the properties of a GRE and is the 
only region which gives a detectable exonuclease 111 footprint for 
GR binding (Slater et a l ., 1985). Thus the presence of the hexa­
nucleotide sequence alone is not necessarily sufficient for gluco­
corticoid inducibility. In the case of the MMTV LTR, sequences 
flanking the TGTTCT sequence are important for maximum glucocorticoid 
responsiveness (Kuhnel et a l ., 1986).
A l .7 .1.2 Recognition of the Same DNA Sequence by Different 
Steroid - Receptor Complexes
The chicken lysozyme gene contains two receptor binding sites for GR 
(Renkawitz et a l ., 1984). These sites are also recognized by PR 
(von der Ahe et a l ., 1985). The proximal binding site at -60 shows 
high affinity for GR and low affinity for PR, whereas the distal bind­
ing site at -180 has low affinity for GR and high affinity for PR. 
Deletions destroying the distal site result in parallel loss of 
inducibility by glucocorticoid and progesterone (von der Ahe et a l . ,
1985). Exonuclease 111 protection experiments have shown that the 
region covered by GR is shorter than that covered by PR at the distal 
binding site (von der Ahe et a l ., 1986). DNase footprinting and 
methylation experiments showed that the contact points between each 
receptor and the DNA double helix differ in 6 out of 7 positions 
(von der Ahe et a l ., 1986). Thus although GR and PR recognize the 
same regulatory sequences upstream of the chicken lysozyme gene, 
there are subtle differences in their recognition mechanisms.
GR and PR also recognize the same sequences within the MMTV LTR 
(von der Ahe et a l ., 1985).
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The MMTV LTR confers glucocorticoid and progesterone inducibility on 
homologous and heterologous promoters with each hormone acting through 
its own receptor (Cato et a l ., 1986). Androgen inducibility is also 
conferred by the MMTV LTR on adjacent genes provided the correct 
receptors are present in the cell (Darbre et a l . , 1986). The hormone 
responsive element (-236 to -52) within the MMTV LTR is sufficient 
to mediate progesterone and androgen induction of transcription 
Cato et a l ., 1987) although progesterone stimulates transcription to 
a greater extent than androgen. The biological significance of 
induction of MMTV gene transcription by androgens is unknown. 
Progesterone is known to play a role in the progression of mouse 
mammary tumours.
A l .7.1.3 Role of A-T Rich Sequences
Examination of sequences upstream of the egg-white genes, expressed.in 
chicken oviduct, for their ability to displace the PR complex from 
calf thymus DNA cellulose (Mulvihill et a l ., 1982) revealed the 
presence of strongly competitive fragments located 250 - 300 base pairs 
upstream of the start of transcription. The consensus sequence of
r r  a  r
these fragments, 5'-ATC^ATT^TCTG^TTGTA-3’ was A-T rich. Preferential 
binding of PR to A-T rich sequences in the 5'-flanking region of 
egg-white genes was also found by Compton et a l . (1983)using 
nitrocellulose filter binding assays with purified PR and specific 
labelled DNA fragments. The authors suggested that the receptor may 
act as a helix destabilizing protein within the A-T rich region. A 
similar model has been proposed by Sluyser (1983). Preferential 
binding of the ER complex to upstream regions of the chicken vitello­
genin gene also occurs in an A-T rich region (Jost et a l . , 1984).
A l .7.2 Role of the Hormone in Receptor Recognition of
Target DNA Sequences
Several groups (Bailly et a l ., 1986; Becker et a l . , 1986; Willmann 
and Beato, 1986) have investigated if the hormone has to be bound to
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its receptor before the receptor can bind to its target DNA sequence 
and modulate transcription. Becker et a l . (1986) carried out in vivo 
analysis of receptor - DNA interactions by the technique of genomic 
footprinting thus overcoming the problem of instability of the free 
receptor in vitro. They examined the interaction of GR with the 
upstream regulatory region of the rat TAT gene in TAT - expressing 
hepatoma cells and in rat fibroblast cells which do not express TAT. 
Dimethylsulphate reactivity patterns observed in vivo were compared 
with those obtained in vitro from methylated protein - free DNA in 
the presence and absence of dexamethasone. The in vivo analysis 
showed protection of guanosine residues in the binding site after 
treatment with dexamethasone in TAT positive but not in TAT negative 
cells, indicating that glucocorticoid increases the affinity of the 
receptor for its target sequence although this does not exclude the 
possibility that the unliganded receptor can interact with a GRE, 
albeit with lower affinity and selectivity. Many of the changes in 
dimethylsulphate reactivity observed in vivo were also found in vitro 
using cloned DNA and a partially purified GR. Local alterations in 
the structure of chromatin at the G R E ’s of the TAT gene take place 
as a consequence of hormone treatment as evidenced by the mapping of 
DNAse _1 hypersensitive sites in this region (Jantzen et a l ., 1987).
Willman and Beato (1986) performed in vitro DNA binding experiments 
with crude receptor preparations from adrenalectomized rats. Cytosol 
was either hormone - free or precharged with a synthetic glucocorti­
coid or antagonist, activated by heating at 25°C for 30 min and the 
radiolabelled DNA probe added. Receptor - DNA complexes were foot- 
printed or immunoprecipitated with mouse monoclonal antibodies against 
the receptor and the percentage DNA bound compared in control and 
steroid-treated cases. Specific binding of the receptor occurred in 
the presence and absence of hormone provided the receptor was heat - 
activated. Binding was inhibited by molybdate. The authors concluded 
that the hormone made no difference to the binding of receptor to its 
target DNA in vitro. They suggested that a possible function of the 
hormone may be to dissociate the unliganded receptor from any cellular
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factors to which it may be bound (e.g. hsp 90 - discussed in section 
A1.3). It cannot be excluded that extensive purification of the 
receptor or in vitro heat activation may mimic the action of the 
hormone in causing a conformational change in the receptor, 
converting it to the DNA - binding form.
Bailly et a l . (1986) studied the effects of ligand binding and 
receptor phosphorylation on the interaction of PR with specific DNA 
sequences in the rabbit uteroglobin gene using nitrocellulose filter 
binding and DNasel_ footprinting techniques. Binding sites were 
occupied with similar affinity by the receptor, either in its free 
state, or complexed with the hormone or an antagonist and by receptor 
that had been phosphorylated in vivo in a hormone dependent manner.
In all cases, identical footprints were observed. The authors 
concluded that the hormone dependence of receptor binding to DNA or 
chromatin observed in intact cells and in crude cellular extracts 
cannot be seen with purified receptor. They made the same suggestion 
as Willmann and Beato (1986) that in vivo, the unliganded receptor 
may interact with some stabilizing factor which keeps it in the 
inactive form. The function of the hormone in vivo would be to break 
this interaction.
The results of Groyer et a l .(1987) support the hypothesis that the 
role of the hormone in vivo is to permit transformation of the 
receptor to the DNA - binding form. The affinities of GR complexed 
with an agonist or an antagonist for DNA were compared. When the 
DNA - binding activity was measured relative to total receptor input, 
the affinity of the agonist - GR complex for DNA was greater than 
that of the antagonist - GR complex. However, when only the trans­
formed (4S) form of GR was considered, the DNA - binding affinities 
of the agonist - GR and antagonist - GR complexes were identical.
Thus it may be that the function of the hormone is to permit 
transformation of the receptor and that the antagonist acts by 
inhibiting this transformation rather than inhibiting binding of 
the hormone - receptor complex to DNA. Nuclear localization and DNA
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binding activity are separable functions in the rat GR (Picard and 
Yamamoto, 1987; section Al.l.3).
A l .7.3 Involvement of General Transcription Factors at the
Promoters of Steroid Inducible Genes
Construction of a series of clustered point mutations and small 
deletions in the MMTV LTR regulatory region and quantitative analysis 
of their effects on hormonal stimulation of transcription (Buetti and 
Kiihnel, 1986) showed regions important for maximum stimulation by 
glucocorticoid hormones. Mutations in the GR binding regions 
(section Al.7.1.1) had the greatest effect on hormone responsiveness. 
However, sequences around -70 and -30 (TATA homology required for 
efficient initiation of transcription) were required for maximum 
response but were not sufficient for hormone stimulation on their own.
The element at -70 includes all of the 5*-half of a sequence with dyad 
symmetry centred on position -70 that has been shown by Nowock et a l .
(1985) to bind a ubiquitous nuclear protein, termed "TGGCA - binding 
protein". A protein with similar properties, called "nuclear factor 1" 
(NF-1) enhances initiation of adenovirus DNA replication in vitro, 
but its function in vivo is not clear. The TGGCA consensus is also 
present in enhancers of certain papovaviruses (Nowock et a l .,1985) 
and within a tissue specific enchancer identified upstream of the 
chicken lysozyme gene (Theisen et a l ., 1986).
Miksicek et a l .(1987) tested the functional importance of the TGGCA 
sequence in a transient CAT assay system. The TGGCA sequence 
increased the level of hormone induced MMTV gene transcription but 
showed relatively stringent sequence requirements. The authors 
concluded that the TGGCA sequence constitutes an integral component 
of the MMTV core promoter and is required for efficient activity of 
the promoter and upstream regulatory region.
High resolution exonuclease 111 protection mapping of DNA - binding 
factors associated with the hormone - activated MMTV promoter in vivo
19
(Cordingley et al.., 1987) confirmed the presence of a NF-1 binding 
site. In addition, a protein (F-i), probably involved in 
initiation of transcription, bound downstream of NF-1.
Possible models for the interaction of DNA - bound receptors and 
general transcription factors have been proposed by Theveny et a 1 . 
(1987) based on electron microscopic studies of complexes formed 
between the PR and discrete regions of uteroglobin DNA (see fig. 1.2). 
Bound proteins may cooperate by transmitting a wave of conformational 
changes in the DNA or by establishing direct contact with each 
other, forming a complex which is recognized by the promoter.
A l .7.4 Role of Tissue Specific Transcription Factors
Expression of the egg-white proteins, conalbumin, ovalbumin and 
vitellogenin is differentially regulated in chicken oviduct and 
liver cells and is an excellent system for studying cell and tissue 
specific expression of genes. In chicken oviduct tubular gland cells, 
the vitellogenin 11_ gene is not expressed while transcription of 
conalbumin and ovalbumin genes is regulated by oestrogen, proges­
terone , glucocorticoid and androgen hormones (Palmiter et a l .,
1972: Lee et a l ., 1978). In chicken parenchymal liver cells, trans­
cription of the conalbumin gene is regulated by serum iron levels 
(McKnight et a l ., 1980a) and is much less sensitive to steroid 
hormones than in the oviduct (Lee et a l ., 1978; McKnight et a l ., 
1980b). The ovalbumin gene is never expressed in these liver cells 
despite the presence of functional ER molecules which allow induction 
of vitellogenin _11_ gene transcription (Deeley et a l ., 1977; Jost 
et a l . , 1978). Thus it is not just the presence or absence of 
functional steroid hormone receptors which determines how gene 
expression is controlled in specialised cells.
The ovalbumin promoter contains steroid independent elements located 
between -56 and -1 which require the presence of cell specific 
trans—acting, factors to allow expression in embryonic hepatocytes
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FIG. 1.2 POSSIBLE FUNCTION OF THE INTERACTION BETWEEN DNA -
BOUND RECEPTORS IN THE REGULATION OF GENE TRANSCRIPTION
(a) Model in which receptor oligomers (R) bind to both hormone 
regulatory elements (HRE) and associate to form a DNA loop.
A transcription factor (TF) binds to the loop.
(b) Model for receptor oligomers binding to both H R E ’s and 
forming a DNA loop. Contact between this receptor complex 
and TF enhances the binding of TF to the promoter region (P) 
or TF activity.
The direction of transcription is marked by an arrow.
(Reproduced from Theveny et a l ., 1987)
and oviduct tubular gland cells but not in adult hepatocytes or other 
cells (Dierich et a l ., 1987). A negative regulatory element(s) 
between -295 and -425 mediates the repression of the ovalbumin promoter 
region in oviduct tubular gland cells, possibly involving a specific 
"repressor" trans-acting protein (Gaub et a l ., 1987), Repression is 
relieved by steroid hormones.
The chicken lysozyme gene is also differentially expressed. In chicken 
oviduct tubular gland cells, the lysozyme gene is transcribed only when 
induced by steroid hormones ■, whereas in macrophages it is ccnstitutively 
expressed and is not dependent on steroid hormones (Hauser 
et a l . , 1981; Sippel et a l ., 1986a). Theisen e t a L . (1986) have 
identified an enhancer element 6 kb upstream of the lysozyme gene 
which is functional only in cells expressing the lysozyme gene. The 
enhancer overlaps a DNase hypersensitive site which is present only 
in chromatin of cells naturally expressing the lysozyme gene (Sippel 
et a l ., 1986a, 1986b). These results suggest that interaction of a 
cellular factor(s) with the enhancer sequence changes chromatin from 
an inactive to an active state.
A l .7.5 Role of Non-histone Chromosomal Proteins
Spelsberg's group has provided evidence for the involvement of non­
histone chromosomal proteins in the DNA/chromatin acceptor sites for 
steroid - receptor complexes (reviewed by Spelsberg et a l ., 1983). They 
have developed a cell - free nuclear binding assay in which chromatin 
is attached to an insoluble resin such as cellulose or acrylamide. 
Various protein fractions are removed, leaving residual DNA or 
DNA - protein complexes attached to the resins in an insoluble state. 
Hormone - receptor / chromatin binding studies can then be performed. 
Nuclear binding in the cell - free system is saturable and correlates 
well with that seen in vivo (Spelsberg et a l . , 1983).
Differential fractionation of chromatin proteins from avian oviduct 
and assay of PR binding to residual chromatin proteins has localized
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PR binding activity to the 10% of non-histone proteins tightly 
bound to DNA which are removed by treatment with 7M guanidinium-HCl 
(Spelsberg et a l . , 1977, 1983). This fraction, termed CP-3 has been 
used in reconstitution experiments with DNA to form acceptor sites 
for PR and ER (Ruh and Spelsberg, 1983; Spelsberg et a l ., 1984).
The reconstituted acceptor sites displayed saturable receptor 
dependent binding and patterns of binding (i.e. during the seasons 
and during oviduct development) similar to those found in vivo, 
whereas binding to pure DNA was non-saturable and did not reflect 
changes in the receptor binding pattern.
The acceptor activity of the CP-3 proteins was only seen when the bulk 
(80%) of the non-histone proteins (fraction CP-2) was removed with 4M 
guanidinium-HCl (Spelsberg et a l ., 1977, 1983). It seems therefore 
that the CP-2 proteins "mask'1 the CP-3 acceptor proteins thus prevent­
ing receptor complex interaction with DNA leading to regulation of 
gene expression. The CP-2 proteins have been further characterized 
and masking activity has been found in a fraction (CP-2b) in the 
molecular weight range 60 000 to 150 0 0 0 , which is able to "remask” 
unmasked nucleoacidic protein (Dani and Spelsberg, 1985).
A possible physiological function of masking proteins is to allow 
differential gene expression by the same hormone and receptor during 
growth and development of the animal since the degree of masking of 
acceptor sites for the avian oviduct PR varies during cytodifferentia- 
tion of the oviduct (Spelsberg et a l .(1983). It may also allow the same 
hormone and receptor to regulate different genes in different tissues 
in the same animal.
Chromatin fractions from rabbit uterus (Singh et a l ., 1984), 
calf uterus (Ruh et a l ., 1981; Ross and Ruh, 1984) and hen oviduct
(Ruh and Spelsberg, 1983) all bind homologous ER complexes with
high affinity. The tissue and species specificity of acceptor site 
non-histone proteins for ER binding has been tested by Ruh et a l .
(1986) by cross-reacting unmasked chromatin fractions and E R ’s
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derived from several different shark or mammalian tissues.
The only combination that revealed significant binding was shark 
testicular ER with shark testicular chromatin. Binding of shark 
testicular ER complex to rabbit chromatin was minimal. Similarly,
ER complex from rabbit uterus, shark oviduct or mouse testis bound 
minimally to shark testicular chromatin. These studies suggest that 
unmasked chromatin acceptor sites are tissue and species specific.
A l .7.6 Conclusions on the Factors Important for Steroid
Gene Expression
The factors involved in regulation of steroid gene expression are 
clearly complex. Specific DNA regulatory sequences and non-histone 
chromosomal proteins constitute the acceptor site for the activated 
hormone - receptor complex. Interaction of the hormone - receptor 
complex with DNA may be governed by cell and tissue specific factors. 
General and tissue specific transcription factors may cooperate with 
the activated hormone - receptor complex to induce maximum 
transcription. The role of the hormone appears to be in conversion 
of an inactive receptor to an active one capable of binding to 
chromatin/DNA.
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A 1.8 DOMAIN STRUCTURE OF STEROID HORMONE RECEPTORS IN
RELATION TO THEIR cDNA SEQUENCES
The human ER (Walter et a l . , 1985), chicken ER (Krust et a l . , 1986), 
rat ER (Koike et a l . , 1987), human GR (Hollenberg et. a l . , 1985), 
rat GR (Miesfeld et a l ., 1984), mouse GR (Danielson et a l ., 1986), 
the human mineralocorticoid receptor (hMR), (Arriza et a l ., 1987), 
rabbit PR (Misrahi et a l ., 1987) and the human PR (Conneely et a l . ,
1986, 1987; Jeltsch et a l ., 1986; Gronemeyer et a l ., 1987) cDNA's 
have all been cloned and sequenced. Comparison of the deduced amino 
acid sequences has revealed an overall domain structure for steroid 
receptors and homology to the avian erythroblastosis virus (AEV) 
p75 gag-erb-A fusion protein (Weinberger et a l ., 1985; Green et a l .,
1986), (see fig. 1.3). The v-erb A protein potentiates the action of 
v-erb B in transforming erythroblasts (Frykberg et a l ., 1983;
Yamamoto et a l ., 1983). The cellular counterpart, c-erb A, has been 
shown to be a thyroid hormone receptor (Sap et a l ., 1986; Weinberger 
et a l ., 1986). The homology between steroid receptors and v-erb A 
suggests there may be a family of potentially oncogenic hormone receptors 
(Green and Chambon, 1986). The receptors for vitamin D 3 (McDonnell e_t 
a l ., 1987) and retinoic acid (Petkovich et a l ., 1987) also show the 
same domain structure as steroid receptors and homology to v-erb A.
Al.8.1 ER cDNA
ER cDNA has been cloned from the human breast cancer cell line, MCF-7 
(Walter et a l ., 1985) and shown to hybridize to a 6.2 kb mRNA. In 
vitro translation of ER mRNA in HeLa cells produces a protein of mol. 
wt. 65 000 with binding affinity for E 2 similar to that of the 
endogenous ER of MCF-7 cells (Green et a l ., 1986). The ER mRNA is 
6322 nucleotides long with a 5 T-untranslated region of 232 nucleotides 
and a 3 ’-untranslated region of 4305 nucleotides. The major open 
reading frame, which initiates at the second ATG, is 1785 nucleotides 
long and codes for a protein of 595 amino acids of mol. wt. 66 182 
(Green et al_ 1986). The chicken ER cDNA contains a major open reading 
frame coding for a protein of 589 amino acids of mol. w t . 66 669 (Krust 
et a l ., 1986). The mRNA is 7.5 kb and has a 3 T-untranslated region.
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FIG. 1.3 DOMAIN STRUCTURE OF STEROID AND THYROID HORMONE
RECEPTOR AMINO ACID SEQUENCES
Fig. 1.3 shows a schematic alignment of steroid and thyroid hormone 
receptor sequences (reproduced from Green and Chambon, 1986). The 
amino acid sequences, deduced from their complementary DNA sequences, 
of (a) human ER, (b) chicken PR, (c) human GR and (d) both the 
chicken (1 - 408) and human (1 - 456) c-erb A proteins are aligned on 
the basis of amino acid sequence similarity. The numbers refer to 
the positions of amino acid residues.
The division of the steroid hormone receptors into 6 regions (A - F), 
based on a comparison between the chicken and human E R ’s, is shown 
at the bottom of the figure. The two highly conserved regions, 
representing the putative DNA - binding (region C) and hormone - 
binding (region E) domains, are shown as shaded blocks. Little or 
no significant homology is observed when comparing other regions of 
the receptors (solid black lines).
Comparison between the chicken and human c-erb A protein sequences 
shows 91% and 88% sequence identity in regions C and E, respectively. 
Comparison between the various receptors in regions C and E show the 
following homologies:
Region C Region E
steroid receptors/c-erb A 
human ER/chicken PR/human GR 
chicken PR/human GR
45 - 55 % 
62 % 
91 % 55 %
30 %
20 %
The rat ER cDNA has a long open reading frame coding for a protein 
of 589 amino acids of mol. w t . 67 029. The mRNA is 6 kb and contains 
a 5'-untranslated region of 210 nucleotides and a 3 -untranslated 
region of 74 nucleotides (Koike et a l ., 1987).
Comparison of the human (h), chicken (c) and rat (r) amino acid 
sequences shows extensive homology (Krust et a l ., 1986; Koike et a l .,1987) . 
Based on the cER sequence, regions termed A,C and E show 87%, 100% 
and 94% homology respectively between the cER and hER (fig. 1.3).
Overall sequence homology between rat and human ER is 88% and between 
rat and chicken ER is 77%. The N-terminal region of rER (amino acids 
1 - 32) is 100% homologous to hER and 84% homologous to c E R . Region 
C of hER and cER is 100% homologous to rER. Region E in the 
C-terminus of rER (amino acids 307 - 557) is 96% identical with 
hER and 94% with cER.
Such high conservation of sequence suggests the presence of important 
functional domains. Region A corresponds to the N-terminal end and 
may play a regulatory role in transcription. Region E is the 
C-terminal end and is strongly hydrophobic. Expression of deletion 
mutants of region E indicates that this region is indispensable 
for high affinity binding of E? and that the C-terminal half of the 
protein can bind hormone independently of the N-terminal half of the 
protein (Kumar et a l ., 1986).
Region C is hydrophilic and is rich in the basic amino acids cysteine 
lysine and arginine. This region is believed to be the DNA - binding 
domain (Green et al., Krust et a l ., 1986). Expression of deletion 
mutants in region C both in vivo and in vitro has shown that this 
region is important for tight nuclear association of the ER complex 
(Kumar et a l ., 1986). Moreover, this region contains potential DNA 
binding "fingers" in which four cysteines (or histidines) may be 
tetrahedrally coordinated with a Z n 2+ ion, allowing the intervening 
amino acids to form a finger which could make specific contact with 
the DNA (Miller et a l ., 1985; Berg et a l ., 1986 ). At least 
two highly conserved motifs of this type are contained in region C
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of the ER, GR and PR amino acid sequences (Jeltsch et a l ., 1986; 
Krust et a l ., 1986).
Replacement of two cysteines by two histidines in the first potential 
DNA - binding finger of the hER prevents it from activating gene 
transcription (Green and Chambon, 1987). A chimaeric receptor 
formed by replacing region C of hER with that of the hGR activates 
expression of a glucocorticoid inducible gene but not of an oestrogen 
inducible gene, in the presence of E 2 (Green and Chambon, 1987).
As previously discussed (sectionAl.7.1.2), the GR and PR , which are 
91% homologous within region C (Jeltsch et a l ., 1986), recognize 
common DNA - binding sites and activate a common hormone responsive 
element (von der Ahe, 1985, 1986; Cato et a l ., 1986). As the hER 
does not activate the glucocorticoid responsive MMTV-CAT reporter 
gene (Green and Chambon, 1987), it has been suggested that the 
conserved amino acids in region C provide the structural scaffolding 
of this domain, whereas the variable amino acids determine the 
specificity of the receptor - promoter interaction (Green and Chambon,
1987).
Al.8.2 GR cDNA
The complete amino acid sequence of the hGR has been deduced from cDNA 
clones (Hollenberg et a l ., 1985). Sequence analysis predicts two 
forms of the receptor, a and 3, probably generated by differential 
splicing. The sequences diverge after residue 727 with an extra 50 
amino acids in the a- sequence and 15 amino acids in the 8- sequence. 
Both cDNA's contain a long 3'-untranslated region. Northern blot 
analysis of cytoplasmic mRNA from a human fibroblast cell line shows 
multiple mRNA s of 5.6, 6.1 and 7.1 kb, apparently due to alternative 
RNA splicing and polyadenylation.
In vitro translation of GR mRNA results in a protein of mol. w t .
94 000 which is identical in size to the native receptor, reacts with
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receptor - specific antiserum and binds glucocorticoid with high 
affinity. The 3- form of the receptor does not bind steroid 
(Hollenberg et a l ., 1985).
The domain structure of the receptor has been deduced from analysis 
of the primary amino acid sequence (Weinberger et al ♦ .,1985) . The 
immunogenic domain which contains the epitope recognized by receptor - 
specific antiserum is found near the N—terminus (amino acids 145 - 278). 
The steroid - binding domain is in the extreme C-terminal end since 
a-GR binds dexamethasone but (3-GR does not. The region from amino acid 
421 - 481 is rich in the basic amino acids, cysteine, lysine and 
arginine and shows 40% homology with the putative oncogene, v-erb A.
This is considered to be the DNA - binding region.
Functional analysis of the domain structure of the hGR (Giguere et a l . , 
1986; Hollenberg et a l ., 1987 ) by the use of deletion and linker 
insertion mutants, has confirmed that the C-terminus contains the 
steroid - binding domain and the region rich in basic amino acids is 
essential for transcriptional activity. In addition, two other regions 
affect transcriptional activity; one in the major immunogenic domain 
and one in the "hinge" region between the steroid- and DNA- binding 
domains (Giguere et a l ., 1986). These regions may interact with 
general transcription factors or may have an effect on the conforma­
tion of the activated receptor.
Detailed analysis of the limits of the DNA- and hormone- binding 
domains in the 795 amino acid rat GR (rGR), (Rusconi and Yamamoto,
1987) has shown that the terminal 30% of the receptor is important 
for hormone binding, in agreement with the results of Giguere et a l .
(1986). Sequence and functional analysis of the mouse GR (Danielson 
et a l . , 1986) has shown a domain structure similar to that of the 
rGR and hGR. Comparison of mouse and human G R *s shows 89% homology 
overall (Danielson et a l ., 1986).
Deletion of the immunogenic or entire N-terminal domain of the hGR 
(Hollenberg et a l ., 1987 ) results in a constitutive receptor.
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Deletion of increasing numbers of C-terminal and N-terminal amino 
acids from the rGR (Godowski et a l ., 1987; Miesfeld et a l . , 1987) 
while keeping the DNA - binding domain intact, results in a constit- 
utively active receptor. These results imply that the DNA - binding 
domain is structurally autonomous and mediates constitutive enhance­
ment of transcription in the absence of the steroid - binding domain.
The results also suggest that the steroid — binding domain has an 
inhibitory effect on the DNA - binding domain.
Two general mechanisms by which the binding of hormone to its receptor 
results in the enhancer - activating protein have been proposed 
(Godowski et a l ., 1987):
(a) Ligand - receptor interaction triggers a conformational change 
in the protein which results in the formation of the DNA - 
binding or enhancer - activation domain.
(b) The ligand - stimulated structural transition might unmask 
(derepress) the DNA - binding or enhancer - activation domain 
already folded in the functional configuration.
The above results favour model (b).
A l .8.3 PR cDNA
Partial cDNA sequences of the chicken (c) PR cDNA have been reported 
(Conneely et a l ♦, 1986; Jeltsch et a l ., 1986). The complete cDNA 
sequence of the cPR is now known and functional domains identified 
(Conneely et a l ., 1987; Gronemeyer et a l ., 1987). The rabbit (rb)
PR has also been cloned and sequenced (Loosfelt et a l ., 1986). The 
human (h) PR amino acid sequence has been deduced from partial cDNA 
sequences but the full cDNA sequence has not yet been published.
Comparison of the cPR, hPR and rbPR amino acid sequences (Conneely 
et_al., 1987; Gronemeyer et a l ., 1987) shows 100% conservation of 
sequence in the cysteine, lysine, arginine rich region C (by analogy 
with the ER domains, Krust et a l ., 1986), spanning amino acids 
410 - 495 of the cPR. Region E from amino acid 540 to the C-terminus is
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87% conserved. Region D shows 60% homology. The N-terminal region 
A/B of these PR's diverges significantly both in sequence and length.
Functional analysis of the domain structure of the cPR (Coneely et a l ., 
1987; Gronemeyer et al., 1987) shows a similar domain structure for 
PR as for ER with region C being responsible for tight nuclear PR 
binding and region E being required to bind the hormone.
A l .8.4 v-erb A, c-erb A and Steroid Receptors
Avian erythroblastosis virus (AEV) belongs to the group of retroviruses 
capable of inducing rapid leukaemias and sarcomas in vivo. The genome 
consists of a cell - derived insert of approximately 3 kb, termed v-erb, 
flanked by remnants of the retroviral gag and env genes. Two proteins 
are generated by differential splicing of genomic RNA; a fusion protein 
of mol. w t . 75 000 (p75 gag-erb A) and a protein of mol. wt. 65 000 - 
68 000 (v-erb B ) . The v-erb B protein is homologous to a portion of 
the epidermal growth factor receptor (Downward et a l ., 1984). The 
v-erb B protein is sufficient on its own to induce transformation of 
erythroblast cells while v-erb A potentiates the action of v-erb B by 
causing early blockage of cell differentiation within the erythroid 
lineage (Frykberg et a l ., 1983; Yamamoto et a l ., 1983).
The v-erb A gene has been sequenced (Debuire et a l ., 1984) and shows 
no comparison with the amino acid sequences of other known oncogenes. 
However, the N-terminal domain of v-erb A contains elevated levels of 
basic amino acids and is highly homologous to the putative DNA - 
binding domains of steroid receptors (reviewed by Green and Chambon, 
1986; illustrated in fig. 1.3), suggesting the existence of a super­
family of potentially oncogenic steroid receptor genes.
The cellular counterpart of v-erb A, termed c-erb A has been cloned 
from a chicken embryonic cDNA library (Sap et a l ., 1986) and from 
two placenta cDNA libraries (Weinberger et a l ., 1986). In both 
cases, the protein encoded by c-erb A was shown to be a high affinity 
receptor for thyroid hormone.
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Recent studies by Glass et a l .(1987) have provided evidence that the 
transcriptional effects of triiodothyronine (T3) can be mediated by 
the product of the c-erb A gene. A 16 bp sequence, located 164 bp 
upstream of the rat pituitary growth hormone gene, is sufficient to 
confer T 3 responsiveness to the HSV tk promoter in transfected rat 
pituitary cells and specifically binds an in vitro translation 
product of the human placental c-erb A gene (Glass et a l ., 1987).
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B1 HERPES SIMPLEX VIRUS
Bl.l CLASSIFICATION
The family Herpesviridae has been divided into three subfamilies 
(Alpha-, Beta- and Gamma-) on the basis of biological properties 
such as host range, length of the reproductive cycle, cytopathic 
effect (cpe) and the ability to go latent in certain tissues 
(Matthews, 1982; Roizman, 1982).
The two serotypes of herpes simplex virus (HSV-1 and HSV-2) belong 
to the group of Alphaherpesviri dae. Characteristics of this group 
of viruses are a variable host range in vivo and in vitro, a 
short reproductive cycle in vitro (< 24h), rapid spread of infection 
in cell culture resulting in mass destruction of susceptible cells 
and an ability to become latent, most often in ganglia (Roizman,
1982). HSV-1 is generally associated with diseases above the 
waist, e.g. vesicular lesions of the mouth and lips. HSV-2 is 
associated with diseases below the waist, e.g. genital lesions.
The structure and organization of the HSV genome has recently been 
reviewed (McGeoch, 1987). Sequencing of the complete HSV-1 genome 
has been completed (McGeoch et a l ., personal communication) but the 
sequence is not yet published.
The HSV genome is a linear, double-stranded DNA molecule. The HSV-1 
genome consists of 152 260 bp with a mean G+C content of 68.3% 
(McGeoch, personal communication). Previously, the G+C content 
of HSV-1 was estimated to be 67% (Kieff et a l ., 1971) while the 
G+C content of HSV-2 was slightly higher at 69% (Goodheart et a l ., 
1968; Halliburton, 1972).
B1.2 STRUCTURE OF THE HSV GENOME
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FIG. 1.4 ORGANIZATION OF THE HSV-1 GENOME
The HSV-1 genome is shown to scale in prototype orientation.
The long unique (Up) and short unique (Ug) regions (single lines) 
are flanked by a pair of repeat sequences (boxes) in opposing 
orientation. The terminal and internal short repeats are 
designated TRg and IRg respectively. The terminal and internal 
long repeats are designated TRp and IRp respectively. A direct 
repeat sequence, known as the "a_" sequence, is present at the 
genomic termini and in inverted orientation at the L-S junction 
(a’). The sequences which bound the a_ sequence in TRp and IRp 
are termed "b" and Mb'" respectively. The sequences in TRg and 
IRg which bound the a_ sequence are termed Mc M and " c ’" respectively. 
The four possible isomers of HSV, which differ in the relative 
orientation of the two unique sequences about the joint, are shown 
by headed arrows below Up and Ug.
Below the genome are mapped (a) the IE mRNA's (spliced regions are
raised), (b) the three HSV-1 origins of DNA replication,
(c) Transcripts which specify virus encoded proteins which are 
specifically mentioned in this thesis.
A full transcript map is not shown. The hatched bar shows the limits 
for the map location of the 65Kpgp (DNA binding protein). 
Abbreviations and key references are as follows:
IE immediate-early - (IE 1, Perry et a l ., 1986; IE 2,
o n
65K
MDBP
Vmw 65
RR
Pol
tk
Whitton et a l ., 1983; IE 3, Rixon et a l ., 1982; I E ’s 4 
and 5, Rixon and Clements, 1982). 
thymidine kinase (McKnight, 1980)
major DNA binding protein (Quinn and McGeoch, 1985)
DNA polymerase (Quinn and McGeoch, 1985) 
ribonucleotide reductase (Frink et a l ., 1981 ; 
McLauchlan and Clements, 1983).
IE trans-acting factor (Dalrymple et a l ., 1985)
DNA binding protein (Marsden et a l ., 1987) 
glycoprotein D (McGeoch et a l ., 1985)
(Stow and McMonagle, 1983)
(Quinn and McGeoch, 1985)
The genomes of HSV-1 and HSV-2 are 50% homologous (Kieff et a l .,
1972) and homologous regions are essentially colinear with viral 
genes mapping at equivalent positions on both genomes (Preston 
et a l . , 1978; Davison and Wilkie, 1983).
As shown in fig. 1.4, the HSV genome consists of two covalently 
linked components, designated Long(L) and Short(S). Each 
component contains a unique sequence (U^ of 110 000 bp and Ug of 
13 000 bp) flanked by a pair of repeat sequences in opposing 
orientation. The terminal and internal long repeats are designated 
TR^ and IR^ respectively and each consist of 9200 bp. The terminal 
and internal short repeats, designated TRg and IRg each consist of 
6600 bp. The sequences of R^ and Rg are distinct.
A direct repeat sequence of 400 bp, known as the a_ sequence, is 
present at the genomic termini and in inverted orientation at the 
L-S junction(fig. 1.4). The sequences which bound the a_ sequence 
in TR^/IR^ and TRg/IRg are termed _b and c sequences respectively 
(Davison and Wilkie, 1981).
HSV virion DNA can exist in four isomeric forms which differ in the 
relative orientation of the two unique sequences about the joint.
These isomers appear to be functionally equivalent (Davison and 
Wilkie, 1983; Longnecker and Roizman, 1986). By convention, one 
isomer is regarded as the prototype (P), (fig. 1.4). The a sequence 
is thought to play a role in the inversion of the L and S components 
(Mocarski and Roizman, 1982; Chou and Roizman, 1985).
The a_ sequence also plays a role in DNA maturation and encapsidation 
following DNA replication. Concatameric DNA is processed in the cell 
nucleus by packaging into nascent nucleocapsids and cutting into 
genome unit lengths (Vlazny et a l ., 1982). Signals for cleavage 
(Varmuza and Smiley, 1985) and encapsidation (Stow et a l ., 1983) 
are contained within the a_ sequence. The order of cutting and 
packaging is unclear but these two steps are tightly coupled (Deiss and 
Frenkel, 1986; Stow et a l ., 1986).
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B1.3 STRUCTURE OF THE VIRION
The herpes virion is 120 — 200 nm in diameter and consists of four
distinct morphological elements:
(a) A central, electron - dense core containing the double-stranded 
DNA genome (Furlong et a l ., 1972) is wrapped around an electron - 
translucent proteinaceous matrix (Furlong et a l ., 1972;
Nazerian, 1974).
(b) An icosahedral capsid of 100 - 110 nm diameter consisting of 
162 capsomeres surrounds the core (Wildy et a l ., 1960).
(c) An amorphous, fibrous layer, termed the tegument, appears to be 
attached to the capsid, probably at the vertices and to the 
inner surface of the envelope (Roizman and Furlong, 1974;
Vernon et a l ., 1982). The thickness of the tegument varies 
among different herpesviruses and is genetically determined 
(McCombs et a l ., 1971).
(d) An envelope consisting of a bilayer membrane with spiked 
projections, approximately 8 nm long, surrounds the tegument 
(Wildy et a l ., 1960).
B1.4 HSV PROTEINS
The subject of the structure and function of HSV proteins is a large
one and has been extensively reviewed (Spear, 1985; Dargan, 1986;
Marsden, 1987; McGeoch, 1987). A brief summary is given here.
The HSV proteins can be divided into distinct functional groups:
(a) Structural Proteins include the proteins present in the capsid
and tegument of the virion (reviewed by Dargan, 1986) and the
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viral glycoproteins which form the spiked projections of the 
virion envelope, present on the surface of infected cells.
The viral glycoproteins are important determinants of viral 
pathogenicity. They also play a role in adsorption and 
penetration of the virus into the host cell and possibly also 
in budding and envelopment of the virus.
(Reviewed by Spear et a l ., 1985; Marsden, 1987).
(b) Proteins involved in DNA replication and nucleotide metabolism 
include thymidine kinase, ribonucleotide reductase, deoxyuridine 
triphosphatase, DNA polymerase, exonuclease, topoisomerase, an 
"orig" binding protein and the major DNA binding protein 
(reviewed by McGeoch, 1987).
(c) Proteins involved in the regulation of transcription 
(discussed in section B1.6)
(d) Other proteins include a novel virus coded protein kinase encoded 
by the U^3 gene that is not required for virus growth in cultured 
cells (Purves et a l ., 1986; Purves et a l ., 1987).
B1.5 HSV DNA REPLICATION
The mechanism by which HSV DNA is replicated is not well understood. 
Present knowledge has recently been reviewed (McGeoch, 1987).
Evidence from electron microscopic studies (Friedmann et a l ., 1977; 
Ben-Porat and Rixon, 1979) and from studies on the physical forms of 
the DNA present throughout the replicative cycle (Jacob et a l ., 1979; 
Jongeneel and Bachenheimer, 1981) suggests a rolling circle mechanism 
which yields large head-to-tail concatameric intermediates that are 
subsequently cleaved to generate unit-length molecules (Deiss and 
Frenkel, 1986).
An origin of replication, termed "ori^” , has been localized (Stow and
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McMonagle, 1983) to a 90 bp region of Rg (thus there are two copies 
of orig, one in TRg and one in IRg)- The essential features of orig 
are the presence of an imperfect palindrome with each arm consisting 
of 21 residues and a sequence, (AT)^, at the centre of the palindrome 
which is essential for ori function (Stow, 1985). Two copies of the 
orig sequence have been found within almost identical direct repeats 
of 137 bp in the Rg region of HSV-2 (Whitton and Clements, 1984).
One, but not two, of the orig sequences is dispensable for growth in 
culture (Longnecker and Roizman, 1986).
An orig binding protein has been detected in nuclear extracts of 
infected cells (Elias et a l ., 1986). The DNase 1_ footprint of this 
protein spans 18 of the 90 bp minimal orig sequence, Its potential 
function in DNA replication has not yet been determined. The orig 
sequence lies within an open reading frame with the potential of 
coding for a protein of 330 amino acids (Hubenthal-Voss et a l .,
1987). The functional significance of this is unknown.
Another origin of replication, termed "orig" , is located within a 
296 bp region near the centre of Ug (Gray and Kaerner, 1984) 
situated between two genes encoding important proteins for DNA 
replication; DNA polymerase and the major DNA binding protein 
(fig. 1.4). The orig sequence contains a long perfect palindrome 
with arms of 72 residues, showing striking homology to orin
O
(Quinn and McGeoch, 1985; Weller et a l ., 1985). Additional 
symmetry elements include short sequences forming an "inner" 
interrupted inverted repeat within each arm of the large palindrome. 
As for orig, an A+T-rich region is situated at the centre of the 
palindrome. Orig is dispensable without affecting viral growth 
(Orberg and Schaffer, 1987) or viral replication in vitro (Polvino- 
Bodnar et a l ., 1987).
Seven HSV genes necessary for transient replication of plasmids 
containing orig or ori]_ have been identified (Wu et a l ., 1988) and 
sequenced (McGeoch et a l ., 1988), two of which encode the viral DNA 
polymerase and a single-stranded DNA-binding protein.
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B1.6 HSV TRANSCRIPTION
B 1 .6.1 Temporal Regulation of Gene Expression
Infection of permissive cells with HSV results in the expression of 
three temporally regulated sets of viral genes termed immediate- 
early (IE or a), early (E or 3) and late (L or y) that are expressed 
in a coordinately regulated manner (Honess and Roizman, 1974;
Clements et a l ., 1977; Jones and Roizman, 1979). Transcription of 
HSV DNA is dependent on the host RNA polymerase 11_ (Costanzo et a l . ,
1977).
IE genes are expressed immediately after virus infection, independently 
of de novo protein synthesis (Kozak and Roizman, 1974; Clements et a l ., 
1977; Jones and Roizman, 1979). Expression of the later classes of 
genes is dependent on the prior synthesis of IE gene products (Honess 
and Roizman, 1974, 1975; Preston, 1979a; Watson and Clements, 1980).
E mRNA's are detectable by 2h post-adsorption (p.a.) and reach maxi­
mum levels by about 4 - 6 h (Wagner, 1985). The E or 3 genes can be 
divided into two subgroups, 3-^  and B2 , depending on the time of 
their expression (Mavromara-Nazos et a l ., 1986).
L genes are maximally expressed after the onset of DNA replication 
(initiated at about 2h p.a.) and reach maximum levels by 10 - 16 h 
p.a. (Holland et a l ., 1980; Wagner, 1985).
The late genes can be divided into two groups:
In the absence of DNA replication, the early-late (EL or y^) 
transcripts are detectable in the cytoplasm although DNA replication 
is required for maximum expression. Transcription of true-late 
(TL or y2 ) genes has an absolute requirement for viral DNA replication 
(Holland et a l ., 1980; Wagner, 1985).
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B1.6.2 HSV IE Gene Products
The HSV genome codes for five IE gene products which are named accord­
ing to their mobility on SDS-PAGE gels in terms of apparent mol. w t . 
(Vmw), (Preston et a l ., 1978; Watson et a l ., 1979) or by ’’infectious 
cell polypeptide" (ICP) number (Honess and Roizman, 1974; Morse et a l .,
1978).
Gene Number Apparent Mol. Wt. ICP Number
IE 1 Vmw 110 ICP 0
IE 2 Vmw 63 ICP 27
IE 3 Vmw 175 ICP 4
IE 4 Vmw 68 ICP 22
IE 5 Vmw 12 ICP 47
The IE m RNA’s have been mapped on the HSV genome (fig. 1.4),
(Clements et a l ., 1979; Watson et a l ., 1979; Anderson et a l ♦, 1980; 
Rixon and Clements, 1982; Rixon et a l ., 1982; Whitton et a l ., 1983; 
Rixon and McGeoch, 1985; Perry et a l ., 1986).
B 1 .6.3 Regulation of IE Gene Expression: Role of the Virion TIF
Regulation of IE gene expression has been extensively studied by 
biochemical and genetic methods. The biochemical approach has 
involved the use of chimaeric plasmids containing the 5 '-flanking 
sequences of an IE gene fused to the structural gene sequence of the 
E gene, thymidine kinase (tk). Several assay systems have been used 
to study the expression of the tk gene in these constructs:
(a) Recombination of the chimaeric plasmids into the virus genome 
and measurement of tk activity and RNA levels.
(b) The ability of these plasmids to convert tk~ cells to the tk+ 
phenotype.
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(c) Microinjection of Xenopus oocytes with chimaeric plasmids and 
measurement of tk activity and RNA levels.
(d) Transfection of tissue culture cells with chimaeric plasmids 
and measurement of tk activity and RNA levels.
Regulatory sequences for IE gene expression have been located in the 
5'-terminus of the IE mRNA start site. These sequences confer IE 
regulatory properties to the tk gene in that expression can occur in 
the absence of de novo protein synthesis and expression is induced in 
the presence of the HSV virion (Post et a l ., 1981; Batterson and 
Roizman, 1983). The virion component responsible for this induction, 
termed trans-inducing factor (TIF), has been identified by cotrans­
fection experiments (Campbell et a l ., 1984) as the major late phosph- 
oprotein, Vmw 65, which is assembled into the tegument region of the 
virion at approximately 400 - 600 molecules per particle (Heine et a l ., 
1974). The gene for Vmw 65 maps within the Bam HI fragment on the 
HSV-1 genome (fig. 1.5) and has been sequenced (Dalrymple et a l ., 1985; 
Pellet et a l ., 1985).
The IE gene 5 '-flanking sequences have been investigated in more 
detail by sequence analysis and by expression of chimaeric plasmids 
containing specific regions or deletions of the 5'-flanking sequences 
linked to the tk gene. From analysis of the promoter/regulatory 
regions of IE genes 1 and 2 (Mackem and Roizman, 1982b; Kristie and 
Roizman, 1984), IE gene 3 (Mackem and Roizman, 1982a; Murchie and 
McGeoch, 1982; Cordingley et a l ., 1983; Lang et a l ., 1984; Bzik and 
Preston, 1986) and IE genes 4/5 (Murchie and McGeoch, 1982; Preston 
et a l ., 1984), several cis-acting regulatory signals have been 
identified:
(a) A "TATA" homology located approximately -25 bp 5' to the start 
of IE mRNA transcription.
(b) Multiple binding sites for the general transcription factor, Spl 
(Jones and Tjian, 1985).
(c) Sequences homologous to the core (GTGG^^G) of the SV40 enhancer 
(Weiher et a l ., 1983).
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FIG. 1.5 LOCATION OF Vmw 65 CODING SEQUENCE ON THE HSV-1 GENOME
AND DESCRIPTION OF PLASMIDS USED IN TRANSFECTION EXPERIMENTS
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(Adapted from Campbell et a l ., 1984 and Dalrymple et al ♦ , 1985).
A diagrammatic representation of the HSV-1 prototype genome.
Up and Ug are the long and short unique regions of the genome.
The open boxes represent repeated sequences. Restriction endonuclease 
cleavage sites are abbreviated as follows: B, Bam HI; P, Pvu 11;
S, Sal I; X, Xho I. BamHl f is located between 0.645 and 0.695 map 
units. The coding sequence for Vmw 65 is contained entirely within 
the Sal J_ / Xho J_ restriction fragment of BamHl f (Dalrymple et a l . , 
1985). The plasmid pMCl contains the Sal J_ / Xho J_ fragment cloned 
into the vector pAT 153 (as described by Campbell et a l . , 1984).
The plasmids pBamfr:25 (pMC3), pMC7 and pMCl:ln8 contain the BanHl f 
fragment with various insertion mutations (represented as A), as 
described in section 6.8.2.
(d) Far-upstream sequences (up to -340 bp) containing at least one 
copy of the A+T-rich consensus sequence TAATGARAT (where R = 
purine), required for regulation of transcription by the 
virion TIF.
The far-upstream region shows enhancer - type properties (Lang 
et a l ., 1984; Preston and Tannahill, 1984). Expression of the tk 
gene is enhanced when the orientation of this region is reversed with 
respect to the promoter and when its distance from the promoter is 
increased by over 1000 bp. However, some positional constraints do 
operate as the element works less well when placed downstream of 
the tk promoter than when placed upstream (Lang et a l ., 1984;
Preston and Tannahill, 1984). Although the TAATGARAT element in one 
or more copies is sufficient for induction by the TIF (Gaffney et a l . , 
1985; O ’Hare and Hayward, 1987)? enhancer activity is increased by 
flanking G+C-rich sequences (consensus CCCGCCC or its complement, 
GGGCGGG) and an upstream G+A-rich element (Bzik and Preston, 1986).
The mechanism of action of the virion TIF is not yet completely 
understood. Attempts to demonstrate direct binding of the TIF to the 
promoter/regulatory domains of IE genes and specifically to the TAAT­
GARAT sequence have been unsuccessful. However, recent evidence 
(Kristie and Roizman, 1987; Preston et a l ., in press) has shown that 
cellular proteins present in both infected and uninfected cell nuclei 
recognize and complex with the the TAATGARAT sequence. This suggests 
that trans-activation by the TIF, although sequence specific, is not 
due to direct interaction of the TIF with its target sequence. Instead, 
a complex is formed with one or more cellular factors which then 
interacts with TAATGARAT DNA.
Other viral proteins may also be involved in the action of the TIF. 
McKnight et a l . (1987) have shown that two viral proteins, 
encoded by a region of the HSV-1 genome 3' to the gene encoding the 
TIF, are able to modulate the activity of the TIF in trans. Whether 
or not these proteins complex with the TIF is yet to be determined.
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B1.6.4 Regulation of Gene Expression by IE Proteins
Three of the five IE proteins (Vmw 110, Vmw 175 and Vmw 63) are 
able to regulate gene expression.
B 1 .6.4.1 Vmw 110
The product of IE gene 1, Vmw 110, is a phosphorylated polypeptide 
which is synthesized early in infection and rapidly translocated to 
the nucleus (Pereira et a l ., 1977; Ackermann et a l ., 1984). Vmw 110 is 
bound to chromatin in infected cell nuclei (Hay and Hay, 1980) but 
there is no direct evidence for binding of Vmw 110 to DNA.
Cotransfection experiments have shown that Vmw 110 is able to activate
gene expression fS^m all three major classes of HSV promoters (Everett, 
1984a, 1986; Gelman and Silverstein,’ 1985; 0'Hare and Hayward, 1985a, 
1985b; Quinlan and Knipe, 1985; Mavromara-Nazos et a l ., 1986). The 
activation of E promoters by Vmw 110 is increased in the presence of 
Vmw 175 (Everett, 1984a; 1986; 0 ’Hare and Hayward, 1985a; Quinlan and 
Knipe, 1985; Gelman and Silverstein, 1986). In the case of IE gene 
expression, repression by Vmw 175 (section Bl.6.4.3) is dominant over 
activation by Vmw 110 (0THare and Hayward, 1985b). Sequences upstream
of IE genes responding in trans to Vmw 65, Vmw 110 and Vmw 175 are
distinct (Gelman and Silverstein, 1987a; 0'Hare and Hayward, 1987).
The combination of Vmw 110 and Vmw 175 can activate plasmid borne 
cellular promoters (Everett, 1985). It has been suggested (0’Hare 
and Hayward 1985b) that Vmw 110 trans-activates genes non-specific- 
ally since it can activate each class of HSV promoter as well as 
heterologous promoters. Trans-activation may occur by recognition of, 
or interaction with, some signal which is common to many promoter/ 
regulatory regions such as the TATA homology and short G+C-rich domains
The complete DNA sequence and mapping of the RNA of IE gene 1 (Perry 
et a l ., 1986) has been used as a basis for detailed mutational analysis
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of Vmw 110 (Everett, 1987) to define functional domains of the protein. 
No mutations affected nuclear localization but at least five regions 
of Vmw 110 were important for trans-activation of gene expression.
The precise role of each of these mutation sensitive regions is not 
yet known.
The role of Vmw 110 in lytic infection is unclear. Studies with 
deletion and _ts_ mutants of IE gene 3 (DeLuca et a l ., 1985) have shown
that the presence of functional Vmw 110, in the absence of functional
Vmw 175, is not sufficient to induce expression of E and L genes.
Moreover, in cell lines carrying the anti-sense mRNA for Vmw 110
(Sandri-Goldin et a l ., 1987), E and L gene expression is not signifi­
cantly affected by the lower concentration of Vmw 110. Viruses in 
which the majority of the IE gene 1 coding region is deleted (Stow 
and Stow, 1986; Sacks and Schaffer, 1987) are able to grow in 
tissue culture but plaque relatively inefficiently. Stow and Stow 
(1986) have suggested that the mutant exhibits a defect in initiation 
of a productive infection at low multiplicity which can be overcome 
by increasing the multiplicity of infection. Thus Vmw 110 does not 
seem to be essential for productive infection in cell culture but is 
required for fully efficient viral growth.
B 1 .6.4.2 Vmw 63
The product of IE gene 2, Vmw 63, is a phosphorylated, nuclear protein 
(Wilcox et a l ., 1980). Genetic and phenotypic characteristics of 
four t_s mutants in IE gene 2 (Sacks et a l ., 1985) indicate a regula­
tory role for Vmw 63 in viral gene expression. The mutants over­
produce certain IE polypeptides at the non-permissive temperature 
(N.P.T.) and fail to produce a number of L proteins. Since a L 
function has been implicated in negative regulation of IE genes 
(DeLuca et a l ., 1984), it may be that this factor is not synthesized 
by the _ts_ mutants of Vmw 63 at the N.P.T. resulting in the observed 
overproduction of certain IE polypeptides. The _ts mutants are all 
able to synthesize E proteins and to induce significant levels of
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DNA synthesis. Therefore, Vmw 63 does not seem to be required for 
transition from IE to E gene expression or for viral DNA synthesis.
This result is supported by the inability of plasmid encoded copies of 
Vmw 63 to stimulate E gene expression in transient assays (Everett,
1984a;DeLuca and Schaffer, 1985; 0'Hare and Hayward, 1985a). Vmw 63 
may play a role in L gene expression since some of the t_s mutants in 
IE gene 2 (Sacks et a l ., 1985) failed to produce certain L proteins at 
the N.P.T. This result is supported by the ability of Vmw 63 to 
activate (in combination with Vmw 175 and Vmw 110) the late VP5 
promoter (Everett, 1986).
Bl.6.4.3 Vmw 175
Vmw 175, the product of IE gene 3, is a phosphorylated polypeptide 
which is synthesized early in infection and rapidly translocated to 
the nucleus (Pereira et a l ., 1977; Wilcox et a l ., 1980). The 
distribution of Vmw 175 within the nucleus at E and L times varies 
(Knipe et a l ., 1987) suggesting that stimulation of transcription 
by Vmw 175 may involve different molecular events or contacts during 
these two periods of the replicative cycle. When extracted with high 
salt from infected cell nuclei, the native protein is a homodimer 
(Metzler and Wilcox, 1985).
A number of _ts mutants have been described which overproduce IE m R N A ’s 
and fail to produce E and L mRNA's at the N.P.T. (Watson and Clements, 
1978, 1980; Preston, 1979a; Dixon and Schaffer, 1980). Infection by 
these _ts mutants at the permissive temperature results in a similar 
pattern of mRNA and protein synthesis as with wild-type virus. All 
of these mutants map in IE gene 3 (Dixon and Schaffer, 1980; Preston, 
1981). The mutant, tsK produces an abnormal Vmw 175 protein at the 
N.P.T. which is not properly processed to forms of lower electrophoretic 
mobility and is altered in its subcellular localization (Preston, 1979b). 
Overall, the studies with ts mutants have shown that Vmw 175 is involved 
in the transition from IE to E protein synthesis and is required 
continuously to maintain E and L protein synthesis.
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Studies with HSV-1 deletion mutants of Vmw 175 (DeLuca et a l ., 1985) 
have confirmed and extended the results obtained with ts_ mutants. In 
the absence of functional Vmw 175, significant levels of E genes are not 
expressed. The phenotypes of the deletion mutants indicate that the 
exaggerated levels of IE polypeptides induced by ts_ mutants of IE gene 
3 are due, in part, to activities associated with the _ts_ polypeptides 
themselves. Studies with HSV-2 deletion mutants of Vmw 175 (Smith and 
Schaffer, 1987a) and with intertypic recombinants of HSV-1 and HSV-2 
Vmw 175 (Smith and Schaffer, 1987b) have shown that the HSV-1 and HSV-2 
proteins are functionally interchangeable despite a number of biochem­
ical differences.
Transfection experiments (0'Hare and Hayward, 1985b, 1987; Gelman 
and Silverstein, 1987a) have shown that Vmw 175 inhibits transcription 
from its own promoter but activates transcription from E promoters. 
Inhibition of transcription from the IE promoter by Vmw 175 is 
dominant over activation by Vmw 110 or Vmw 65 and the responsive 
sequences are distinct (Gelman and Silverstein, 1987a; 0 ’Hare and 
Hayward, 1987). The inhibition of IE gene expression and activation 
of later classes of genes has been confirmed by in vitro transcription 
studies (Beard et a l ., 1986; Pizer et a l ., 1986) using cloned HSV genes 
and nuclear extracts prepared from infected and uninfected HeLa cells. 
The E protein, ICP 8, also plays a role in shutting off Vmw 175 
expression at late times post-infection (Godowski and Knipe, 1986). 
Different functions of Vmw 175 may reside on different domains of the 
protein.
Binding sites for partially purified Vmw 175 have been identified by 
DNase J_ footprinting in the HSV glycoprotein D (gD) promoter and in 
the tet^ gene of the vector pBR322 (Faber and Wilcox, 1986). The 
consensus binding site sequence is 5 ’-ATCGTCNNNNYCGRC-3' (N = any 
base, Y = pyrimidine, R = purine). Gel retardation assays, using 
HeLa nuclear cell extracts and incorporating monoclonal antibodies to 
Vmw 175, have been used to demonstrate binding of Vmw 175 to the 
promoter regions of IE genes (Kristie and Roizman, 1986a, 1986b;
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Muller, 1987). The results of Kristie and Roizman (1986b) showed 
binding of Vmw 175 within a 59 bp sequence taken from the regulatory 
region of IE gene 3. Deletions within this 59 bp sequence, including 
removal of Spl binding sites, did not affect binding. The Faber and 
Wilcox (1986) Vmw 175 consensus sequence is not present in the 59 bp 
sequence. In contrast, Muller (1987) detected binding of Vmw 175 to 
the sequence -10 to +3 of IE gene 3. This sequence contains the 
Faber and Wilcox consensus. The reason for the discrepancy between 
the results of Kristie and Roizman and those of Muller is unclear. 
However, the results of Muller support the results of transfection 
studies by 0'Hare and Hayward (1987) who found that the region from 
-108 to +30 relative to the IE gene 3 mRNA start site mediates its 
repression. It is not known if cellular proteins are involved in 
the mechanism of action of Vmw 175.
B 1 .6.5 Regulation of Early Gene Expression
As already discussed (section Bl.6.3), the regulatory cis- and trans­
acting factors involved in IE gene expression have been clearly 
defined. In contrast, the factors which distinguish E and L genes 
are less distinct. Expression of the E genes is dependent on the 
prior expression of IE proteins (Honess and Roizman, 1974; 1975; 
Preston, 1979a; Watson and Clements, 1980).
B 1 .6.5.1 Structure of the E Promoter
Functional analysis of the upstream regulatory sequences of the E 
genes, gD (Everett, 1983; 1984b) and tk (McKnight et a l ., 1981; 
McKnight and Kingsbury, 1982; McKnight et a l ., 1984; Eisenberg et a l . , 
1285, El Kareh et a l ., 1985) has shown that full trans—activation of 
these promoters by viral proteins requires 83 bp and 109 bp of
sequence 5' to the gD and tk mRNA start sites respectively. Sequence 
comparison of the E promoters gD, tk and ICP 8 (Su and Knipe, 1987) 
has identified the following common promoter elements:
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(a) "TATA" homology about -25 bp 5' to the mRNA start of trans­
cription .
(b) Distal upstream promoter region containing A+C-rich sequences 
and G+C-rich inverted repeat sequences.
(c) "CCAAT" homology positioned about -80 in the tk but not in 
the ICP 8 or gD promoters.
The distal upstream element is able to potentiate transcription, 
albeit with different efficiences, when inverted or positioned at 
variable distances relative to the TATA box (Everett, 1984b,
McKnight et a l ., 1984).
The SV40 E promoter contains six tandem G+C-rich direct repeated 
sequences, each of which bind the Spl cellular transcription factor 
resulting in activation of SV40 early RNA synthesis (Dynan and 
Tjian, 1983a; 1983b). The two distal G+C-rich hexanucleotides 
(at -100 and -50) of the tk promoter also bind Spl (Jones et a l . ,
1985; McKnight and Tjian, 1986), as do G+C-rich sequences present in 
HSV IE promoters and a variety of other eukaryotic promoters (Jones 
and Tjian, 1985; McKnight and Tjian, 1986).
Another general transcription factor, termed "CCAAT transcription 
factor" (CTF) or "CCAAT binding factor" (CBF), binds to the CCAAT 
sequence present at about -80 in the tk promoter (Jones et a l . ,
1985; Graves et a l ., 1986).
Thus no sequence elements unique to HSV E promoters have been 
identified. The general, cellular transcription factors may cooperate 
with viral proteins to form an activating complex at the promoters 
of E genes or the trans-acting factors may each function separately 
to change the chromatin to an "open" configuration to allow 
transcription to occur.
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Bl.6.6 Regulation of Late Gene Expression
Late genes have been operationally defined as those genes whose 
expression is dependent on viral DNA replication (Jones and Roizman,
1979; Holland et a l ., 1980) although some late genes (EL) are 
expressed in the absence of DNA replication (section Bl.6.1).
Expression of Vmw 175 is necessary for late gene expression (DeLuca 
and Schaffer, 1985; Godowski and Knipe, 1986). There is some evidence 
that the E protein, ICP 8, is involved in negative regulation of 
late gene expression (Godowski and Knight, 1985).
B 1 .6.6.1 Structure of the L Promoter
Experiments with chimaeric plasmids (Silver and Roizman, 1985; 
Mavromara-Nazos et a l ., 1986) containing E or L upstream sequences 
linked to the coding sequence of the HSV tk gene have shown that L 
genes are differentially regulated depending on their genomic 
environment. When integrated into the host cell genome, E and L
genes could not be distinguished. In contrast, when resident in the
viral genome, the chimaeric L-tk gene was regulated as a L gene, 
requiring DNA synthesis for expression. Similar results were 
obtained by Costa et a l .( 1985) who studied the differential 
regulation of an E and L gene in a transient assay system. Promoter 
sequence was not sufficient to distinguish between E and L genes in 
these assays (Costa et a l ., 1985).
Experiments with plasmid constructs containing the promoter of the L 
gene U^ll linked to the coding sequence of the rabbit 3-globin gene 
with or without an HSV-1 origin of replication (orip) have shown that,
in the presence of a functional origin of replication, all the DNA
sequence requirements for efficient expression of the L gene are 
contained within 31 bp of the RNA cap site (Johnson and Everett, 1986a; 
1986b). A functional origin of replication is sufficient to convert 
an E promoter into a L promoter (Johnson and Everett, 1986b). Another 
L gene (gC) has similar sequence requirements (-34 to +124) for efficient 
expression (Homa et a l ., 1986).
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B1.7 EFFECT OF HSV ON HOST MACROMOLECULAR SYNTHESIS
Bl.7.1 The "Shutoff" Effect
Infection of cultured cells with HSV-1 or HSV-2 results in rapid 
inhibition of host DNA synthesis (Roizman and Roane, 196-4), RNA 
and protein synthesis (Roizman et a l ., 1965; Sydiskis and Roizman,
1966). Host polysomes disaggregate (Sydiskis and Roizman, 1966,
1967)and new polysomes contain mainly virus encoded mRNA's (Stringer 
et a l ., 1977).
Understanding the events involved in host shutoff has been complicated 
by the variability of response seen with different virus strains and 
cell types. HSV-1 (F) infection of Friend erythroleukaemia cells 
results in a rapid shutoff of globin synthesis and mRNA production, 
(Nishioka and Silverstein, 1977, 1978) while histone mRNA is 
selectively stabilized (Mayman and Nishioka, 1985). However, 
infection of Vero cells with HSV-1 (F, KOS and 17+) or HSV-2 (G) 
results in degradation of histone M3 mRNA along with actin mRNA (Shek 
and Bachenheimer, 1985). Infection of the methotrexate resistant 
cell line KB/6b with HSV-2 (333) causes a rapid reduction in dihydro­
folate reductase synthesis and mRNA production (Bastow et a l ., 1986) 
whereas HSV-2 (HG 52) has no effect on cellular mRNA.
Studies by Nishioka and Siverstein (1977, 1978) and by Fenwick and 
Clark (1982) suggest that early shutoff of host protein synthesis 
is due to polysome disaggregation mediated by a virion component while 
delayed shutoff, involving increased catabolism of cellular mRNA, is 
dependent on viral gene expression. Studies by other groups (Inglis, 
1982; Read and Frenkel, 1983; Fenwick and McMenamin, 1984; Shek and 
Bachenheimer, 1985; Bastow et a l ., 1986) have demonstrated that 
rapid degradation of certain m RNA’s is an early event induced by a 
virion - associated factor.
A number of virion host shutoff (vhs) mutants of HSV-1 (KOS) have 
been described (Read and Frenkel, 1983) which are defective in the
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function responsible for the initial suppression of host protein 
synthesis. Further studies by Strom and Frenkel (1987) have shown 
that vhs mutants do not degrade host mRNA to the same extent as wild- 
type virus. The extent of mRNA degradation correlates well with the 
extent of inhibition of host protein synthesis, suggesting that 
inhibition of host protein synthesis and degradation of host mRNA are 
mediated by the same virion - associated function.
Preliminary characterization of the mutant, vhs-1 (Read and Frenkel,
1983) revealed a defect in post-transcriptional shutoff of HSV IE 
protein synthesis. Infection with vhs-1 results in increased stability 
of at least three different mRNA's (from IE genes -1, -2 and -3) 
compared to the instability of these IE mRNA's during wild-type 
infection (Oroskar and Read, 1987). Purified virions of the wild- 
type virus, but not of the vhs-1 mutant virus, carry a function that 
reduces the half-life of host and IE mRNA's (Kwong and Frenkel, 1987). 
Thus the wild-type virus carries a function that is able to reduce 
the half-life of both host and viral transcripts. Early translational 
shutoff may be a consequence of this function.
B 1 .7 .2 Activation of Cellular Genes
Certain cellular polypeptides are expressed at elevated levels as a 
result of HSV infection. Heat shock or stress proteins are induced 
in chicken embryo fibroblast cells by infection with tsK (section 
Bl.6.4.3) at the N.P.T. (Notarianni and Preston, 1982). In this 
case, the stress response is due to the presence of abnormal forms 
of Vmw 175 rather than the overproduction of IE genes (Russell et a l . , 
1987). Natural isolates of HSV-1 frequently possess mutations in the 
gene coding for Vmw 175 (Knipe et a l .,1981; Post et a l ., 1981). Thus 
induction of the stress response by HSV may be important during in­
fection in v i v o . Virus induction of heat shock genes occurs with 
adenovirus (Nevins, 1982; Kao and Nevins, 1983), polyoma virus and 
SV40 (Khandjian and Turler, 1983) as well as with the oncogene, c-myc 
(Kingston et a l ., 1984).
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HSV infection of rat embryo cells results in the accumulation of 
certain cellular polypeptides (including proteins of mol. w t .
90 000 and AO 000), (Macnab et a l ., 1985). These proteins are 
highly expressed in cells transformed by HSV and by other DNA or 
RNA viruses and in immortalised cell lines but not in primary cells. 
Infection of human embryo fibroblast cells with HSV-2 induces the 
synthesis of a minor cellular stress protein of mol. w t . 57 000 
which is growth regulated (La Thangue et a l ., 1984) and transcrip- 
tonally activated (Patel et a l ., 1986). Transcriptional 
activation of a cellular gene has also been shown by Kemp et a l . 
(1986).
Several herpesviruses (including HSV-1 and HSV-2) and adenovirus-2 
are able to activate plasmid borne viral and cellular promoters 
during infection (Everett and Dunlop, 1984). In addition, e- and 
3-globin promoters integrated into biochemically transformed cell 
lines are activated by HSV-1 infection and by transfection of the 
IE genes, Vmw 175 and Vmw 110 (Everett, 1985). However, the 
endogenous 3-globin gene of rabbit kidney cells is not activated by 
virus infection (Everett, 1985). The author suggests that this may 
be due to the chromatin configuration of the promoter region of the 
endogenous globin gene. Many host promoters may be in regions of 
densely packed chromatin and so would not be readily available for 
activation.
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Cl ROLE OF STEROID HORMONES AND VIRUS IN THE DEVELOPMENT
AND PATHOLOGY OF THE UTERINE CERVIX.
Cl.l ANATOMY AND PATHOLOGY OF THE CERVIX: GENERAL DESCRIPTION
C l . 1.1 Anatomy
The uterine cervix is a fibromuscular tube connecting with the 
uterine cavity at the internal os and opening out into the vagina 
at the external os (fig. 1.6). The surface of the tubular portion 
is called the endocervix and is lined by columnar epithelium.
These cells secrete mucus. The part of the cervix exposed to the 
vagina is called the ectocervix and consists of keratinising, 
stratified, squamous epithelium. There is an abrupt change at the 
external os from the columnar to the squamous type of epithelium. 
This junction can change position due to a process known as 
squamous metaplasia which occurs particularly at the time of 
menarche and also in response to oral contraception and pregnancy. 
During this process, columnar epithelium migrates, perhaps initiated 
by oestrogenic stimulation and, under the influence of the acidic 
environment of the vagina, squamous epithelium forms. Exactly 
how this happens is unknown.
The area involved in squamous metaplasia is known as the transform­
ation zone. Squamous cancer of the cervix arises almost invariably 
from the transformation zone. This zone contains numerous cells in 
premitotic or mitotic phases of the cell cycle. Such cells are 
perhaps more susceptible to cancerous transformation than quiescent 
epithelial cells. 90 - 95% of all cervical cancers arise from the 
squamous epithelium whereas 5 - 10% arise from columnar epithelium 
(adenocarcinoma). A small number of cancers are of a mixed type 
(adenosquamous carcinoma).
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FIG. 1.6 ANATOMY AND DISSECTION OF THE UTERINE CERVIX
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Cl.1.2 Definition of Cervical Intraepithelial Neoplasia
Development of cervical cancer progresses through a series of 
graded precancerous lesions. In the normal squamous epithelial 
covering of the vagina and ectocervix there is a single layer of 
basal cells, separated from the underlying stroma by the basement 
membrane. Above the basal layer there are three or four layers of 
parabasal cells which display intense mitotic activity. Dysplastic 
lesions of the parabasal layer are graded into cervical intra­
epithelial neoplasia (CIN) grade grade 1 1_ and grade 111 (which 
corresponds to carcinoma in situ or CIS, where the whole epithelium 
shows dysplasia). Invasive carcinoma is when the basement membrane 
is broken.
C l .1.3 Aetiology and Epidemiology of Cervical Cancer
Development of cervical cancer is a multifactorial process. As a 
result of investigations into various cultural, ethnic and social 
variables of women with premalignant and malignant lesions of the 
cervix, a number of high risk factors have been identified including 
multiple sexual partners and early age of first intercourse (Rotkin, 
1973; Berg and Lampe, 1981; Graham et a l ., 1982) leading to the idea 
that cervical cancer is venereally transmitted (discussed in sections 
Cl.3 and Cl.A). Other non-sexual variables include cigarette 
smoking (Wigle, 1980; Trevathan et a l ., 1983) and long-term
exposure to the contraceptive pill (Harris et a l ., 1980). Exposure 
to the non-steroidal oestrogen, diethylstilboestrol (DES) is 
associated with development of clear cell adenocarcinoma (section 
Cl.2.A).
The following sections describe the role of hormones in the normal 
growth and development of the cervix, the role of hormones and 
viruses in the development of cervical cancer and the possible 
interaction of hormones and viruses in transformation of cells.
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Cl.2 ROLE OF STEROID HORMONES IN THE NORMAL DEVELOPMENT,
FUNCTION AND PATHOLOGY OF THE CERVIX.
C l . 2 .1 Changes in Cervical Secretions During the Menstrual Cycle
The secretory activity of the cervical epithelium is governed by 
hormonal changes (reviewed by Lunenfeld and Insler, 1978). The 
daily production of mucus varies between 20 mg per day at the 
beginning of the cycle and 600 mg per day at mid-cycle. When under 
strong oestrogenic stimulation (i.e. during the ovulatory phase of 
the menstrual cycle or during oestrogen treatment), the uterine 
cervix produces abundant, watery, thin mucus due to the increased 
water and electrolyte content. Sperm permeability during this period 
is at its highest. When under the influence of both oestrogen and 
progesterone (i.e. during the luteal phase of the menstrual cycle, 
under combined contraceptive pill or in pregnancy) the cervical 
epithelium produces scant, thick mucus of great viscosity which 
forms a barrier to sperm.
Cl .2.2 Ripening of the Cervix During Pregnancy
Pregnancy induces a number of biochemical changes in cervical stroma 
(Calder, 1981). The cervix becomes increasingly softer (due to 
changes in collagen) and more vascular. The shape of the cervix 
changes due to alterations in cervival length and diameter.
Ripening of the cervix is controlled by complex endocrine mechanisms.
C l .2.3 Repair of Cervical Erosions
Hormones influence the processes of regeneration and preneoplastic 
transformation which occur during the re-epithelialization of cervical 
erosions. Oestrogens stimulate the proliferation of the stratified 
squamous epithelium of the ectocervix but not the columnar epithelium
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of the endocervix. Progesterone stimulates the columnar epithelium 
and reserve cells beneath it but not the squamous epithelium. In a 
small number of cases, re-epithelialization does not proceed smoothly 
to normal maturation of the overgrowing epithelium. Instead, pre- 
cancerous lesions of various grades may form. In such cases, the 
prolonged increase in proliferative activity may prepare the way for 
carcinogenic substances to manifest their effects.
C l .2.A Effect of In Utero Exposure to DES
The non-steroidal oestrogen, diethylstilboestrol (DES), used in the 
1950's to prevent abortion and other complications during pregnancy 
(Smith, 1948) has been reported to be responsible for the development 
of clear cell adenocarcinoma of the vagina and cervix in female 
offspring at menarche (Herbst et a l ., 1971; Noller et a l .,1972). 
Further, several non-malignant epithelial lesions have also been 
observed in the lower genital tract (Robboy et a l . , 1978 ) in females 
exposed to DES in utero. Major investigations of the frequency and 
natural history of genital tract lesions in such women (Lebarthe et_ 
al_. ,1978; Robboy et a l ., 1979; Herbst, 1981) have shown that 
vaginal epithelial changes are related to a number of variables 
including total dosage, duration of exposure and time in the menstrual 
cycle of first exposure. Risk factors such as sexual behaviour were 
difficult to account for. Almost all cases of CIS or marked grades 
of dysplasia were from the external os or around the transformation 
zone suggesting that these lesions may be coincidental rather than 
related to DES exposure. No case of invasive squamous carcinoma was 
found. However, there did appear to be a link between exposure to 
DES and the development of clear cell adenocarcinoma.
Cl .2.5 Mouse Model for the Role of Hormones in Cervical Cancer
Some studies have been done on the effect of sex steroid hormones 
on the mouse genital tract. Neonatal administration of oestrogen, 
progesterone or DES in the mouse leads to abnormalities in the vagina
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and cervix and, in some cases, the development of lesions with 
histological features resembling squamous cell carcinoma (Takasugi, 
1976; Jones and Bern, 1979; McLachlan et a l ., 1980). Transplanta­
tion of cervicovaginal tissue of mice neonatally treated with 
oestrogen and/or progesterone into syngeneic hosts resulted in six 
tumours within six months while transplantation of control cervico­
vaginal tracts did not give rise to tumours (Jones and Pacillas- 
Verjan, 1979).
Some questions have been raised as to the validity of the mouse 
model for studying cervical cancer (Munoz, 1976). Cervical cancer 
is extremely rare in untreated mice but relatively frequent in 
women. Transition from dysplasia to CIS is also rare in mice and 
more frequent in women. The cancers in both species are squamous 
cell carcinomas but cancers in mice tend to be well differentiated 
with limited infiltration and few metastases whereas in women, the 
tumours are usually undifferentiated, highly malignant and, if 
untreated, give rise to extensive distant metastases.
C l .2.6 Steroid Receptors in Cervical Tissue
Very few studies on ER and PR levels in normal cervix and cervical 
tumour tissue have been carried out. The current state of knowledge 
has recently been reviewed (Soutter and Leake, 1987). Studies by 
Sanborn et a l . (1975, 1978) have demonstrated the presence of cyto­
plasmic ER and PR in the various tissue components of the cervix. 
The level of cytoplasmic ER was uninfluenced by hormonal changes 
during the menstrual cycle although cytoplasmic PR was depressed 
during the luteal phase of the cycle. Soutter et a l .(1981, 1983) 
found both cytoplasmic and nuclear ER in all samples of normal pre­
menopausal cervical tissue assayed. The level of receptor in cervix 
is lower than in the more recognized hormone dependent tissues such 
as breast and endometrium and in some studies only a small proport­
ion of normal cervical tissue samples were ER positive (Toppila 
et a l . , 1983).
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Several studies have shown the presence of cytoplasmic E R ’s in 
squamous cervical cancer. However, estimates of the proportion of 
cervical tumours which contain ER's vary enormously (reviewed by 
Soutter and Leake, 1987). Only one group has reported on nuclear 
E R ’s (Soutter et a l ., 1981, 1983). In these studies, low concent­
rations of nuclear ER were detected in 22.4% of tumours, almost 
always in conjunction with cytoplasmic ER. However, more recent 
studies on tissue stored under better conditions shows nuclear ER 
in 45.2% of 73 squamous tumours (Soutter and Leake, 1987). The 
presence of cytoplasmic PR has also been demonstrated. Thus it 
seems that at least a proportion of squamous cervical tumours 
contain a functional ER system which could prove useful in disease 
prognosis and in treatments.
Although less data is available for adenocarcinoma of the cervix, 
there seems to be better agreement among studies with approximately 
45 - 65 % of adenocarcinomas showing the presence of functional 
receptors (Soutter and Leake, 1987).
The usefulness of receptor status in cervical cancer is uncertain 
as the receptor content of cervical tumours seems to bear no 
relationship to menopausal status or the stage of the disease or 
degree of differentiation of the tumour (Soutter and Leake, 1987).
Cl.3 ASSOCIATION OF HSV WITH CERVICAL CANCER
C l . 3 .1 Association of HSV with Human Cervical Tumours
For many years, HSV has been implicated in cervical neoplasia. 
Initial evidence came from cytopathological and histological studies 
(Stern and Longo, 1963; Naib et a l ., 1966; Naib et a l ., 1973). 
Numerous seroepidemiological studies have shown that the frequency 
and titre of antibodies to HSV types 1 and 2 are higher in sera from 
individuals with diagnosed cervical anaplasia than in the sera of
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controls (Rawls et a l ., 1969; Nahmias 6t a l . , 1970; Skinner et a l . ,
1977). Several viral antigens have been described (Royston and 
Aurelian, 1970; Aurelian et a l ., 1973; Strnad and Aurelian, 1976;
Dreesman et a l ., 1980). RNA homologous to HSV DNA in both CIN and 
CIS have been demonstrated by in situ hybridization studies 
(McDougall et a l ., 1980; 1982; Eglin et a l . , 1981).
Apart from onereport (Frenkel et a l ., 1972), early attempts to 
demonstrate the presence of HSV DNA in cervical neoplastic tissue 
failed (zur Hausen et a l ♦, 1974; Pagano, 1975). More recently, HSV-2 
DNA has been detected by Southern blotting analysis in a small 
percentage of histologically abnormal cervixes (Park et a l ., 1983; 
Manservigi et a l ., 1986; Prakash et a l ., 1985; Rotola et a l ., 1986). 
Minson (1984) did not, however, detect HSV DNA in 13 epithelial lines 
cultured from invasive carcinoma in situ tissue.
C l .3 .2 Oncogenic Potential of HSV
Inactivated HSV-1 and HSV-2 can transform rodent cells in vitro 
from a normal to a transformed phenotype and the transformed cells 
are oncogenic in newborn animals (Duff and Rapp, 1971a, 1971b, 1973; 
Macnab, 1974). Viral RNA, DNA and glycoproteins have been reported 
to be present in,HSV transformed cells (see Galloway and McDougall,
1983 and Macnab, 1987 for reviews). However, no consistent viral 
product responsible for transformation has been identified.
Moreover, viral DNA is not retained in these cells with passage 
(Frenkel et a l . , 1976; Galloway and McDougall, 1983; Cameron et a l .. 
1985),
Experiments using defined fragments of viral DNA to transform rodent 
cells in culture have led to the definition of regions in HSV-1 and 
HSV-2 responsible for morphological transformation (fig 1.7). In the 
case of HSV— 1, a iragment located uetween 0.29 and 0.45 map units (mu) is 
able to transform hamster embryo cells and BALB 3T3 cells (Camacho 
and Spear, 1978; Reyes et a l ., 1979). In the case of HSV-2, two
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different fragments have been shown to transform rodent cells in 
culture, depending on the assay used to select transformants. The 
BglTTn fragment of HSV-2, which maps between 0.58 and 0.62 mu, 
has been shown by focus formation in low serum or colony formation in 
semi-solid medium to alter the growth properties of hamster and rat
embryo cells and BALB and NIH 3T3 cells (Reyes et a l ., 1979;
Galloway and McDougall, 1981; Cameron et a l . , 1985).
A different fragment, Bglllc, which maps between 0.42 and 0.58 mu, 
has been shown by conversion to longevity, to cause transformation of 
Syrian hamster cells (Jariwalla et a l ., 1980). The Bglllc fragment 
can be subdivided into two functional domains. The region from 
0.42 to 0.53 mu is responsible for immortalisation of cells 
(Jariwalla et a l ., 1983) while the region from 0.53 to 0.58 mu is 
required for conversion of immortalised cell to a neoplastic 
phenotype (Jariwalla et a l ., 1986).
C l .3.3 Mechanisms for Transformation by HSV
C l . 3 .3.1 ’’Hit and Run1' Hypothesis
The failure to detect a consistent set of viral sequences or a specific 
protein maintained in transformed cells or in human tumours led to the 
proposal of a "hit and run" mechanism for HSV transformation (Skinner, 
1976; Galloway and McDougall, 1983). The identification of sequences 
of HSV DNA that can transform cells in tissue culture without persisting 
and without evidence of a transforming protein supports this hypothesis 
(Galloway et a l ., 1984; Cameron et a l ., 1985; Jariwalla et a l ., 1986). 
The mechanisms by which HSV may induce morphological transformation 
have recently been discussed (Macnab, 1987) and will only be briefly 
summarized here.
C l .3.3.2 Putative Transforming DNA Sequences
A small stem/loop structure in the BgllXn fragment of HSV-2 (Galloway 
et a l . > 1984) and insertion-like sequences in the Bglllc fragment of 
HSV-2 (Jones et aj_., 1986) could be involved in transposition into host 
DNA where they may activate a cellular oncogene or act as mutagens.
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However, such sequences frequently occur in other regions of HSV DNA 
as well as in randomly shuffled DNA sequences (Shillitoe et a l ., in 
press and quoted by Macnab, 1987). No evidence exists for their 
biological function.
C l .3.3.3 Ribonucleotide Reductase
HSV-1 and HSV-2 induce novel ribonucleotide reductase activities 
(Cohen et a l .,1972, 1974). There is evidence (Dutia, 1983) that the 
HSV-1 ribonucleotide reductase is virus encoded although it is not 
essential for HSV replication in exponentially growing cells in tissue 
culture (Goldstein and Weller, 1988). Ribonucleotide reductase 
consists of a large and a small subunit (Bacchetti et a l ♦, 1984, 1986; 
Frame et a l ., 1985) encoded by two transcripts whose colinear 3 T ends 
map within the Bgllln fragment of HSV-2 (McLauchlan and Clements,
1983). The small subunit is completely encoded by the Bgllln 
fragment. The large subunit is mostly encoded by Bglllc but the 
carboxyl terminus lies in Bgllln (McLauchlan and Clements, 1983),
(fig. 1-7).
It has been proposed (Huszar and Bacchetti, 1983) that ribonucleotide 
reductase could be involved in transformation. The data derived 
from transformation studies with Bgllln and Bglllc (reviewed by 
Macnab, 1987) show no clear demonstration of the requirement for 
either the large or the small subunits of ribonucleotide reductase in 
HSV transformed cells.
C l .3.3.4 Mutagenesis
Both HSV-1 (Schlehofer and zur Hausen, 1982) and HSV-2 (Pilon et a l . , 
1985) have a mutagenic effect on the hypoxanthine-guanine phospho- 
ribosyl transferase (HGPRT) gene, probably by introducing point 
mutations (Pilon et a l .,1986). Introduction of double-stranded DNA into 
NIH 313 cells mutagenizes the HGPRT gene but the HSV-2 transforming 
clone, pCB24 is more mutagenic than pBR322 (Brandt et al., 1987) 
suggesting that mutagenesis may play a role in transformation.
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Cl .3.3.5 Gene Amplification
HSV-1 can cause amplification of genes in cells in a manner similar to 
chemical carcinogens (Lavi, 1981; Schlehofer et a l . , 1983;.
Brandt et al., 1987). Amplification is dependent on the expression of 
the HSV polymerase gene (Matz et a l ., 1984; Heilbronn et a l ., 1985) 
and is involved with a cellular component being dependent on the cell 
line used (Matz et a l ., 1984; 1985; Heilbronn et a l ., 1985). Brandt 
et a l .(1986) have demonstrated a 2- to 8- fold amplification of 
HPV-18 DNA by HSV-1 and HSV-2 in HeLa cells,originally derived from 
malignant tumours of the cervix. In this case, HSV is acting at a 
late stage in carcinogenesis.
Cl .3.3.6 Activation of Cellular Genes
The activation of cellular gene expression has already been described 
(section Bl.7.2). The ability of HSV to induce expression of cellular 
genes and proteins, particularly if they are involved in mediating 
cell growth, may be an important step in transformation.
Cl.4 ROLE OF HUMAN PAPILLOMAVIRUS IN CERVICAL CANCER
Human papillomavirus (HPV), commonly known as the "wart" virus, is 
known to affect many sites in the body. There are numerous different 
types of HPV, at least eight of which (HPV 6, 11, 16, 18, 31, 33, 34 
and 35) are specific for the urogenital tract. Development of genital 
warts is associated with sexual promiscuity (Syrjanen, 1984).
Papillomavirus particles have been demonstrated within koilocytic 
cells of cervical condylomas by electron microscopy (Meisels et a l . , 
1981). Papillomavirus antigens have also been detected in the same 
cells showing HPV particles in their nuclei (Gupta et al., 1983).
DNA hybridization studies have shown that HPV types 16 and 18 are 
strongly associated with high grade CIN and invasive cancer
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(Durst et a l ., 1983; Boshart et a l ., 1984; McCance et a l ., 1985;
Prakash et a l ., 1985; Macnab et a l ., 1986). However, HPV-16 has also 
been found in a high percentage of histologically normal tissues (taken 
from an adjacent site to the tumour tissue), (Macnab et a l ., 1986) 
demonstrating that the mere presence of the HPV genome is not suffic­
ient itself to induce a cell to become tumourigenic.
The viral DNA is integrated into the host cell genome in the 
carcinomas (some of the tumours contain additional, mainly multimeric 
episomes), whereas it is present as extrachromosomal monomeric episomes 
in the precursor lesions (Durst, 1987). In cell lines established 
from cervical carcinomas e.g. HeLa, C4-1, SW 756, HPV-18 
sequences are integrated into the host cell genome by disruption of 
the papillomavirus genome within the open reading frames (ORF's) of 
the early (E) genes El and E2 (fig. 1.8), thereby joining the 5 ’-part 
of the E region (ORF E6-E7-E1 segment) to downstream host cell sequences 
(Schwartz, 1987). This integration pattern has also been observed in 
cervical carcinoma biopsies (Durst, 1987) leading to the speculation 
that in genital tract lesions, certain alterations in HPV gene 
expression, resulting from this type of integration event, are required 
for malignant conversion and/or maintenance of the malignant state.
It may also be possible that, in some genital tumours, cis-activation 
of cellular oncogenes by HPV may contribute to malignant transformation 
(Durst et a l ., 1987).
In HPV-16 and HPV-18 integrated DNA, the E6-E7 ORF's are intact and 
have the potential to code for proteins. The E7 protein has been 
detected, using E7-specific antiserum, in cell lines containing HPV-16 
or HPV-18 DNA (Smotkin and Wettstein, 1986; Seedorf et a l . , 1987).
In vitro translation of viral enriched (hybrid selected) poly (A)+
RNA from CaSki cells (contain HPV-16 DNA) and immunoprecipitation has 
shown the presence of the E6 protein. The transforming potential of 
the E6 and E7 proteins remains to be verified.
As already mentioned, HPV DNA has been found in a high percentage of
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histologically normal tissue (Macnab et a l . , 1986), suggesting that 
the presence of the HPV genome is not sufficient to induce transforma­
tion. Moreover, cell hybrids, created by fusion of HeLa cells with 
normal human fibroblast or keratinocyte cells (Stanbridge, 1976; 
Stanbridge et a l ., 1982), show tumourigenic properties in vitro 
(e.g. anchorage independence) but do not form tumours in nude mice, 
even although the parent HeLa cell line forms tumours in nude mice.
It seems therefore, that in vivo, other factors are involved in 
transformation.
There is evidence that cofactors are required to convert benign 
lesions caused by HPV to a malignant state. Rabbit papillomas induced 
by Shope papillomavirus frequently convert into squamous cell carcino­
mas. This transformation seems to be affected by the genetic 
constitution of the host and can be accelerated by carcinogens such 
as tar (Rous and Friedewald, 1944). Bovine papillomas of oesophagus 
and intestine caused by bovine papillomavirus type 4 (BPV-4) progress 
to cancer with the aid of bracken as cofactor (Jarrett et a l ., 1978). 
In the rare skin lesion, epidermodysplasia verruciforms, papillomas 
undergo malignant conversion almost exclusively in sites exposed to 
the sun (Jablonska et a l ., 1982). Possible cofactors for HPV in 
cervical cancer include smoking (Trevathan et a l ., 1983), oral 
contraceptives (Vessey et a l ., 1983) and/or HSV (zur Hausen, 1982).
It is not known how smoking acts as a cofactor. It may be due to a 
carcinogenic effect of nicotine or it may reduce the blood supply to 
tissues. Oral contraceptives contain a mixture of steroids. No one 
has linked a particular steroid to cervical cancer but steroid 
metabolism is also recognized to be altered in smokers (Editorial, 
Lancet, Dec. 1986).
It has been proposed (zur Hausen, 1982) that HSV is responsible for an 
initiation event and HPV in promotion of cervical carcinogenesis 
This would help to reconcile seroepidemiological data linking HSV to 
genital cancer with the apparent difficulties of detecting HSV DNA 
in biopsies of genital tumours.
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Cl.5 INTERACTION OF HORMONES AND VIRUSES IN CERVICAL CANCER
The association between viruses and cervical cancer and the reports 
of hormone exposed females being at higher risk of developing cervical 
cancer has stimulated a limited number of studies on the possible 
interaction of viruses and hormones in cervical cancer. Possibly 
HSV-2 acts as an initiator and hormones and/or HPV as promoting 
agents or perhaps hormones induce changes in cells so that they become 
more susceptible to viral effects.
Two lines of approach have been taken; in vivo studies on the mouse 
and in vitro studies on cultured cells. The effect of pregnancy on 
viral infection in the mouse and human has also been investigated.
C l . 5.1 In Vivo Studies
In an initial study, Munoz (1973) treated BALB/c mice with various 
combinations of hormones and HSV-2 and looked at the frequency of 
precancerous and cancerous lesions of the cervix and vagina which 
resulted. This study suggested a role for HSV-2 in cervical carcinoma 
but the role of hormones, if any, was unclear, Nishiura and Nii (1976) 
examined the effect of oestrogen and progesterone on genital HSV 
infection in mice and found that progesterone but not oestrogen 
increased the susceptibility of uterine tissue to virus infection.
There have been reports that genital infection with HSV is 2- to 3- 
fold more common during pregnancy, a period of high serum progesterone 
levels (Nahmias et a l ., 1971) and that pregnancy should be considered 
as a predisposing factor for primary HSV infection. Studies have shown 
that the pregnant mouse is more susceptible to viral infections, 
including HSV-2 (Overall et a l ., 1975) and that progesterone has a 
similar effect (Baker and Plotkin, 1978). The reason why progesterone 
should increase susceptibility to virus infection is not clear but it 
may be due to an indirect effect through lowering cell mediated 
immunity (Baker et a l ., 1980). Alternatively, progesterone may act 
directly on the vaginal mucosa to allow penetration of HSV-2.
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C1.5.2 In Vitro Studies
Several in vitro studies on the effect of hormones on virus replicat­
ion and/or transformation have been reported and have shown varying 
results. Replication of polyoma virus in mouse embryo fibroblasts 
and mouse 3T3 cells in the presence and absence of various hormones 
was studied by Morhenn et a l . (1973) using plaque assays to measure 
virus titres. Physiological concentrations (lCT^M to 10~^M) of 
dexamethasone increased plaque formation at least 10-fold. Cortisol 
had a similar effect but oestradiol and progesterone had no effect. 
Costa et a l .(1974) carried out a similar investigation with HSV-2 
with less striking results. Moreover, different virus yields were 
obtained according to the virus strain and type of cell used.
Tanaka et a l . (1984a) found that treatment of human embryonic lung 
fibroblasts with pharmacological doses of dexamethasone (10“^M to
 Q
10 °M) significantly enhanced human cytomegalovirus (HCMV) replication 
while oestrogen, progesterone and androgen had no effect. Dexametha­
sone was also able to overcome the restriction on growth of HCMV in 
a human hepatoma cell line and in primary epithelial human baby 
kidney cells (Tanaka et a l ., 1984b).
Rapp and Turner (1979) looked at the effect of DES on replication and 
transformation by herpesviruses. They found no significant enhance­
ment of plaque production by HSV-1 or HSV-2 in human embryo 
fibroblast or in primary rabbit kidney cells treated with DES.
However, the frequency of transformation of tk_ to tk+ mouse cells 
by HSV was enhanced by pretreatment of cells with DES. Gupta and 
Rapp (1977) also looked at the influence of steroids on biochemical 
transformation from tk“ to tk+ . They found that 10~6M cortisol and 
10“ 'M oestradiol inhibited HSV-2 induced transformation and that 
dexamethasone had very little effect. These experiments using such 
high concentrations of steroid are not biologically relevant since 
patients on steroid treatment are subjected to plasma concentrations 
of hormone of around 5 x 10-^M.
Thus no clear-cut pattern of the effect of hormones on virus growth 
has emerged.
63
AIM OF PROJECT
The aim of this project was to investigate the possible interaction 
of steroid hormones and HSV, with particular relevance to the 
problem of cervical cancer. HPV was not studied as there is no 
tissue culture system available for growing the virus.
The project was divided into four parts:
(a) The effect of
(b) The effect of
(c) The effect of
(d) The effect of
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MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Suppliers
Abbott Laboratories, Wokingham, U.K.
Aldrich Chemical Co., Inc., Gillingham, U.K.
Amersham International, pic, Amersham, U.K.
BCL, Lewes, U.K.
BDH Chemicals Ltd., C/o McFarlane Robson Ltd., Glasgow, U.K.
Bio-Rad Laboratories, Watford, U.K.
Boehringer Mannheim GmbH, C/o BCL, Lewes, U.K.
BRL-Gibco, Paisley, U.K.
CAMLAB, Cambridge, U.K.
Difco Laboratories, West Molesley, U.K.
Du Pont (U.K.) Ltd., Stevenage, U.K.
Falcon, C/o A & J Beveridge Ltd., Edinburgh, U.K.
Fluka-Garantie, Glossop, U.K.
Gibco, Paisley, U.K.
Koch-Light Laboratories Ltd., Haverhill, U.K.
Kodak Ltd., Manchester, U.K.
May & Baker Ltd., Dagenham, U.K.
Medicell International Ltd., London, U.K.
Miles Scientific, C/o ICN Biomedicals Ltd., High Wycombe, U.K.
Millipore (U.K.) Ltd., Harrow, U.K.
NBL Enzymes Ltd., Cramlington, U.K.
New England Biolabs, C/o CP Laboratories, Bishops Stortford, U.K.
Nunc, C/o Gibco, Paisley, U.K.
Pharmacia Ltd., Milton-Keynes, U.K.
Polaroid (U.K.) Ltd., St. Albans, U.K.
Sarstedt Ltd., Leicester, U.K.
Schleicher & Schuell, C/o Anderman & Co. Ltd., Kingston upon Thames, U.K. 
Sigma Chemical Co. Ltd., Poole, U.K.
E.R. Squibb & Sons Ltd., Hounslow, U.K.
Sterilin Ltd., Hounslow, U.K.
Whatman Ltd., C/o R & J Wood, Paisley, U.K.
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2.1.2 Continuous Cell Lines
Baby hamster kidney 21, clone 13 (BHK 21/C13) cells, established by 
Macpherson and Stoker (1962)f maintained in the Institute of Virology. 
Glasgow, were routinely used to prepare stocks of virus and to titrate 
virus.
ZR-75-1 cells, derived from the malignant ascitic effusion of a 
metastatic breast tumour (Engel et a l ., 1978) were obtained from 
two sources:
(a) Imperial Cancer Research Fund (ICRF), Lincoln Inn Fields, London.
(b) Department of Biochemistry, University of Liverpool.
MCF-7 cells, derived from the pleural effusion of a breast tumour 
(Soule et a l ., 1973) were obtained from the same sources as ZR-75-1 cells.
2.1.3 Primary Cells
Primary cervical cells were cultured from explants derived from the 
cervices of hysterectomy specimens from patients attending the Western 
Infirmary, Glasgow, with no history of, or colposcopic evidence of 
CIN or carcinoma.
2.1.4 Cell Growth Media
BHK 21 (Glasgow modification of Eagle's medium) was supplied as a 10X 
concentrate by Gibco and diluted to a final concentration of IX with 
sterile distilled water, including supplements (section 2.2.1).
Dulbecco s modification of Eagle's medium (DMEM) was supplied as a IX 
concentrate by Gibco. Biggar’s medium (without phenol red) was 
supplied as a 2X concentrate by Gibco and diluted with sterile distilled 
water to a final concentration of IX.
2.1.5 Supplements to Cell Growth Media
Sodium bicarbonate (7.5%), L-Glutamine (200 m M ) , Penicillin (10 000 U/ml)/
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Streptomycin (10 000 yg/ml), Gentamycin (50 mg/ml) and non-essential 
amino acids were obtained from Gibco.
Mycostatin sterile powder (500 000 U made up in 10 ml distilled water) 
was obtained from E.R. Squibb & Sons.
Tryptose phosphate broth (10% V /v) was obtained from Difco Laboratories.
Calf serum (CS) was prepared in the Institute of Virology from blood
at
obtained from the Abe*toir$ in Dumfries.
Foetal calf serum (FCS) was obtained from Gibco.
Human serum (HS) was prepared in the Institute of Virology from blood 
obtained from the Blood Transfusion Service, Glasgow, free of any 
pathogens.
2.1.6 Viruses
The following viruses were grown from stocks provided by Mrs. M. Murphy, 
Instit ute of Virology:
(a) HSV-1, Glasgow strain 17 syn+ (Brown et a l ., 1973)
(b) HSV-2, strain HG 52 (Timbury, 1971)
(c) HSV-1, strain 17 syn+, tsK (Crombie, 1975)
2.1.7 Bacteria
E. coli DH101 bacteria were grown from seed stocks maintained in the 
Institute of Virology.
2.1.8 Bacteria Culture Media
Bacteria were propagated in L-broth, consisting of 1% (W/v) Bacto- 
tryptone (Difco Laboratories), 0.5% (W /v) yeast extract (Difco 
Laboratories), and 0.17M NaCl with the pH adjusted to 7.5.
Agar plates were prepared from L-broth containing 1.5% (W/v) Bacto-agar 
and sterilized by autoclaving.
These media were supplemented, where appropriate, with ampicillin or 
tetracycline (100 ug/ml).
L-broth was prepared by the Media Department, Institute of Virology.
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2.1.9 Fine Chemicals
Chemicals were of 'AnalaR' grade or equivalent and were obtained from 
the following companies:
Aldrich Chemical Co. 
Amersham International 
BCL
Boehringer Mannheim 
Bio-Rad Laboratories 
Difco Laboratories 
Fluka-Guarantie 
Koch-Light Laboratories
Ltd.
May & Baker Ltd. 
Pharmacia Ltd.
DATD (N,N'-Diallyltartardiamide)
ORG 2058
DTT (Dithiothreitol)
Tris [(hydroxymethy1 )aminomethane]
Ammonium persulphate, TEMED
Agar (Noble), Bacto-agar, Yeast extract
Formaldehyde, Formamide
Acrylamide, Boric acid, Caesium chloride 
DMSO (Dimethylsulphoxide), Glycerol, Sodium 
hydroxide, Sucrose, TCA (Trichloroacetic acid) 
Acetic acid glacial, Chloroform, Hydrochloric 
acid, Methanol
Dextran T-70, Ficoll, Poly (dA-dT),
R)ly (dG-dC), Sephadex G-50
Sigma Chemical Co. Ltd. Acetyl co-enzyme A, Agarose, Bovine serum
albumin, Calf thymus DNA, Charcoal (Norit A), Chloramphenicol, 
Cholera toxin (from Vibrio cholera), Cycloheximide, Deoxy- 
ribonucleoside triphosphates, Dextran sulphate, Disulfiram, 
Epidermal growth factor, Ethidium bromide, Hydrocortisone, 
Methionine, MOPS (3-[N-Morpholino]propane-sulphonic acid), 
Oestradiol-173, PMSF (Phenylmethylsulphonyl fluoride), PVP 
(Polyvinylpyrollidone), Progesterone, Salmon sperm DNA,
Sodium arsenate, Spermidine, Triton X-100.
All other chemicals were obtained from BDH Chemicals Ltd.
2.1.10 Radi ochemicals
The following radiochemicals were obtained from Du Pont (U.K.) Ltd. 
(NEN Research Products):
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[y-32P]-adenosine triphosphates 6 000 Ci/m mol
[a-32P]-deoxynucleoside triphosphates 3 000 Ci/m mol
Chloramphenicol, D-Thero-(Dichloroacetyl-l, 2 - ^ C )  60 Ci/m mol
The following radiochemicals were obtained from Amersham International:-
[3H]-0estradiol-173 89 Ci/m mol
[3H]-0RG 2058 51 Ci/m mol
[35 s ]-methionine > 800 Ci/m mol
2.1.11 Stains and Dyes
Bromophenol blue (BFB) and Giemsa (2— [2— (4-hydroxyphenyl)-2- 
benzimidazolyl]-6-[l-methyl-4-piperazyl]benzimidazole trihydrochloride) 
were obtained from BDH Chemicals Ltd.
Hoescht 33258 and xylene cyanole were obtained from Sigma Chemical Co.Ltd.
Protein dye reagent concentrate was obtained from Bio-Rad Laboratories.
2.1 .12 Enzymes
Deoxyribonuclease 
DNA polymerase J_
Lysozyme 
Proteinase K
Restriction endonucleases 
Ribonuclease type A 
T4 polynucleotide kinase 
Trypsin
Boehringer Mannheim 
BRL-Gibco
Sigma Chemical Co. Ltd. 
Boehringer Mannheim 
BRL-Gibco or NBL Enzymes Ltd. 
Sigma Chemical Co. Ltd. 
BRL-Gibco
Difco Laboratories
2. 1.13 Photographic Material
Amf ix
Du Pont Cronex Lighting Plus 
intensifying screens 
Dx developer and X-omat S film 
667 film
May & Baker Ltd.
Du Pont (U.K.) Ltd.
Kodak Ltd.
Polaroid (U.K.) Ltd
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2.1 .14 Miscellaneous Material
ER EIA kit 
Oligolabelling kit 
Rabbit reticulocyte lysate 
RNA mol. w t . markers
Abbott Laboratories 
Pharmacia Ltd.
Sigma Chemical Co. Ltd 
BRL-Gibco
Ecoscint
EN'HANCE
University Chemistry stores 
Du Pont (U.K.) Ltd.
Chromotography paper 
Hybond-N membrane 
Nitrocellulose membrane 
Thin-layer chromatography paper 
(0.25 mm silica pre-coated plastic sheets)
Whatman Ltd.
Amersham International 
Schleicher & Schuell 
CAMLAB
Petri dishes, 35 mm Nunc
Petri dishes, 50 mm and 90 mm Sterilin
Plastic tissue culture flasks, Nunc
80 c m 2 and 175 c m 2 
Plastic tissue culture roller bottles, Falcon
850 c m 2
Eppendorf reaction vials S^arstedt Ltd.
Millex filters, 0.22 pm and 0.45 pm Millipore (U.K.) Ltd.
Plastic centrifuge tubes, 15 ml and 50 ml Falcon
Visking dialysis membrane Medicell International
2.1 .15 Standard Solutions
2.1.15.1 Buffers
Chamber
100X Denhardt's 
2X UBS
0.05M Tris, 0.05M Glycine, 0.1% (w /v) SDS 
0.02% (w/v) Ficoll, 0.02% (w/v ) PVP,
0.02% (w /v) BSA
0.28M NaCl, 1.5mM XagHPO/^, 0.05M Hopes, pH 7.2
70
HE 20 mM Hepes, 1.5 mM EDTA, pH 7.A
HED 20 mM Hepes, 1.5 mM EDTA, 0.25 mM DTT, pH 7.4
10X Kinase 1M Tris-HCl, 1M MgCl2 , 1M DTT, 0.1M Spermidine,
0.25M EDTA, pH 7.5 
10X MOPS 0.2M MOPS, 0.05M Na acetate, 0.01M EDTA, pH 7.0
Nuclear Extraction A 0.01M Hepes, 1.5mM MgCl2 , 0.01M KC1, 0.5mM DTT,
0.01M Na2S203 , 0.5 mM PMSF, pH 7.9 
B 0.02M Hepes, 25% (v/v) Glycerol, 0.42M NaCl,
1.5 mM MgCl2 , 0.2 mM EDTA, 0.5 mM DTT,
0.5 mM PMSF, 0.01M Na2S20 3 , pH 7.9 
C 0.02M Hepes, 0.02M KC1, 1 mM MgCl2 , 2 mM DTT,
17% (v/v) Glycerol, pH 7.9 
10X NTB 0.05M Tris-HCl, 5 mM MgCl2 , 1 mM DTT, pH 7.8
PBS 0.17M NaCl, 3.4 mM KC1, 1 mM Na2HP04 ,
2 mM KH2P04 , pH 7.2 
’React’ obtained as a 10X concentrate from BRL-Gibco
RNA Extraction A 0.15M NaCl, 0.01M T r i s - H C l , 1.5 mM MgCl2 ,
0.65% NP 40, pH 7.8 
B 7.0M Urea, 0.35M NaCl, 0.01M EDTA, 0.01M Tris-
HCl, 1% (w /v) SD S , pH 7.8 
Separating Gel 1.5M Tris-HCl, 0.4% (w /v) SDS, pH 8.9
Sodium Phosphate 1M NaH2P04 , 1M Na2HP04 , pH 7.0
Stacking Gel 0.5M Tris-HCl, 0.4% (w /v) SDS, pH 6.7
Sucrose-Tris 25% (w /v) Sucrose in 0.05M Tris-HCl, pH 8.0
2OX SSC 3M NaCl, 0.3M tri-Sodium Citrate, pH 7.4
2OX SSPE 3.6M NaCl, 0.2M Na2H 2P04 , 0.02M EDTA, pH 7.4
TAE 0.04M Tris-acetate, 1 mM EDTA, pH 7.8
TBE 0.089M Tris-borate, 0.089M Boric acid, 2mM EDTA
TE 0.01M Tris-HCl, 1 mM EDTA, pH 7.5 or 8.0
TEN 0.04M Tris-HCl, 0.01M EDTA, 0.12M NaCl, pH 7.8
Tris-Saline 0.14M NaCl, 0.03M KC1, 0.28 mM Na2HP04 , 1 mg/ml
dextrose, 0.25 mM Tris, 0.005% phenol red, 
pH 7.4, supplemented with 100 U/ml Penicillin 
and 100 Ug/ml Streptomycin 
Triton Lytic Mix 2 % (v/v) Triton X-100, 0.06M EDTA, 0.O5M
Tr Ls-nCl, pH 8.0
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2.1.15,2 Dyes/Stains
BFB dye 
BFB/XC dye 
Giemsa stain
Hoescht stain
10X TBE buffer, 10% (w /v) Ficoll, 0.05% (w /v) 
bromophenol blue
10% (w /v) Ficoll, 0.05% (w /v) bromophenol blue, 
0.05% (w /v) xylene cyanole in distilled water, 
1.5% (w /v) suspension of Giemsa in glycerol, 
heated at 56°C for 1.5 - 2 h and diluted with 
an equal volume of methanol.
Stock solution of Hoescht 33258, 100 pig/ml (w /v) 
in distilled water, stored at 4°C in the dark 
for a maximum of 1 month.
2.1.15.3 Steroid and Growth Factor Solutions
Cholera toxin Stock: 1.2 ml sterile, distilled water was added
to a 1 mg vial of cholera toxin to give a 10~^M 
solution and stored at 4°C.
Dilutions: 50 pil of 10~^M stock solution was
diluted in Hepes-buffered Earle’s salts + 0.1%
BSA to give a 10-^M solution which was filter 
sterilized and stored in 2 ml aliquots at -20°C.
Epidermal Growth 
Factor (EGF)
5 ml sterile, distilled water was added to a 
100 pig vial of EGF. A 1:10 dilution was made 
in sterile Hepes-buffered Earle’s salts + 0.F  
BSA and stored in 2 ml aliquots at -20°C.
Hydrocortisone 20 pig hydrocortisone was dissolved in 10 ml 
distilled water + 10 ml methanol to give a 
1 yog/ml stock which was stored at -20°C.
Oestradiol-173, Progesterone and Diethlstilboestrol were made up as
10_^M stock solutions in ethanol and stored at 
-20°C.
72
2.2 METHODS
2.2.1 Culture of Continuous Cell Lines
BHK 21/Cl3 cells were cultured in BHK 21 medium supplemented by 2mM 
glutamine, IOC U/ml penicillin, 100 pig/ml streptomycin, 0.25% (V/v) sodium 
bicarbonate, 10% (V/v) tryptose phosphate broth, 5 or 10% (V/v) 
calf serum (CS).
Stocks of cells were grown routinely in 80 oz glass bottles (washed 
and autoclaved in the Institute of Virology), seeded at a density of 
4 x 107 cells in 200 ml medium containing 10% C S . 50 mm petri dishes 
were seeded at a density of 2 x 10^ cells per dish in 4 ml medium 
containing 5% CS.
ZR-75-1 and MCF-7 cells were grown in DMEM supplemented by 2mM 
glutamine, 100 U/ml penicillin, 100 yg/ml streptomycin, 5 or 10 % 
foetal calf serum (FCS).
Stocks of cells were grown routinely in 175 c m 2 plastic tissue culture 
flasks seeded at a density of 4 x 10^ cells per flask in 50 ml DMEM +
10% FCS. For large scale experiments, 850 c m 2 plastic tissue culture 
roller bottles were seeded at a density of 2 x 107 cells per bottle in 
100 ml DMEM + 10% FCS. Most experiments were done in 80 c m 2 tissue 
culture flasks, seeded at a density of 2 x 10^ cells per flask in 
25 ml DMEM + 10% FCS.
All cells were harvested by washing once with versene (6 mM EDTA 
dissolved in PBS containing 0.0015% phenol red) and twice with trypsin- 
versene (one volume of 25% (W /v) Difco trypsin di ssolved in Tris-saline, 
plus four volumes of versene), incubating at 37°C for 5 min and resus- 
pending at the required concentration in the appropriate medium. The 
cells were seeded as described above and grown in an atmosphere of 
5% C O 2 at 37°C.
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2.2.2 Test for Mycoplasma Infection
Cells were grown on glass coverslips for 48h, washed in PBS, then 
fixed in methanol:acetone (3:1), cooled to -20°C for 4 - 5  min.
After air drying, the cells were stained with Hoescht stain (10 ul 
of stain diluted to 0.05 ug/ml) for 10 min at ambient temperature.
The coverslips were then washed in three changes of PBS and mounted 
in 20% glycerol in PBS on glass slides. The cells were examined under 
a UV-fluorescent microscope for evidence of mycoplasma infection.
2.2.3 Primary Culture of Cervical Cells
Cervical cells were cultured from explants derived from hysterectomy 
specimens of premenopausal patients with no evidence of CIN or carci­
noma. The cervix was excised from the uterus and vagina and washed 
three times in PBS to remove red blood cells. The ectocervix was 
removed by cutting 2 mm below the transformation zone (fig.1.6).
Explants were prepared by carefully removing muscle and stroma using a 
sharp, sterile scalpel until a thin epithelium of cells remained.
The epithelium was finely minced with sterile, curved scissors. The 
tissue was kept moist in PBS.
10 - 20 small explants were seeded per 35 mm plastic petri dish and 
lust covered with a small volume of FCS. The explants were incubated 
at 37°C in an atmosphere of 5% CO? in FCS for 4 - 18 h to allow them 
to attach to the surface of the dish. 2 ml of cervical medium 
(DMEM supplemented by 2 mM glutamine, 100 U/ml penicillin, 100 yg/ml 
streptomycin, 0.5 Ug/ml hydrocortisone, 10“ cholera toxin (to inhibit 
growth of fibroblast cells), 10 Ug/ml gentamycin, 100 U/ml mycostatin 
and 10% FCS) was added to the dishes and incubation continued for a 
further 2 - 3  days. Any floating explants were removed and fresh 
cervical medium containing 10 ng/ml epidermal growth factor added.
The medium was changed twice weekly. Cells formed an almost confluent 
monolayer in 2 - 3 weeks.
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2.2.4 Preparation of Frozen Cell Stocks
Frozen stocks of ZR-75-1 and MCF-7 cells were prepared as follows:
Cells were grown in 175 c m 2 flasks in DMEM + 10% FCS until they were 
approximately 80% confluent. Cells were harvested using trypsin- 
versene (section 2.2.1), pelleted by centrifugation at 1000 rpm for 
5 min at 4°C and resuspended in 6 ml DMEM + 10% FCS + 10% DMS0.
2 ml aliquots of cell suspension were transferred to small, glass 
vials. Cells were frozen in two stages; an overnight incubation at 
-70°C followed by long-term storage at -170°C under liquid nitrogen.
2.2.5 Recovery of Frozen Cells
Cells recovered from the -170°C freezer were thawed rapidly at 37°C 
and transferred to an 80 c m 2 flask containing 10 ml pre-warmed medium 
(DMEM + 10% FCS + 1% non-essential amino acids). Cells were incubated 
for 24h at 37°C in an atmosphere of 5% C O 2. The medium was then 
replaced with fresh medium to remove any dead cells and to dilute out 
the DMS0 used in the storage medium. Cells were grown as before (2.2.1).
2.2.6 Preparation of Heat-Inactivated, Charcoal-Stripped Serum
500 ml FCS was heat-inactivated at 56°C for 30 min. 1.25 g Norit A
charcoal was mixed with 0.125 g dextran T-70 in 125 ml PBS and stirred 
gently for 18h at 4°C. The dextran-coated charcoal was pelleted by 
centrifugation at 10 000 rpm for 20 min at 4°C (GSA rotor), added to 
500 ml heat-inactivated FCS and stirred gently for 18h at 4°C. The 
charcoal was pelleted by centrifugation as before.
The stripped serum passed through a series of filters including 
Whatman No. 1 paper, 0.45 pm and 0.22 urn Millex Millipore filters and 
finally through a 0.22 pirn sterile filter. The sterile, stripped 
medium was aliquoted into 10 ml amounts in glass bottles and stored at 
-20°C.
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2.2.7 Virus Infection
The medium covering cells to be infected was discarded and the approp­
riate amount of virus added in as small a volume of P5S or medium as 
was necessary to cover the cells. HSV-1 and HSV-2 were adsorbed for lh 
at 37°C. The mutant virus, tsK, was adsorbed at 38.5°C for lh. Cells 
were drained of medium containing unabsorbed virus and given fresh 
medium. Cells infected with wild-type virus were incubated at 37°C. 
Cells infected with tsK were incubated at 38.5°C.
2.2.8 Production of Virus Stocks
2.2.8.1 HSV-2
H S V - 2 stocks were prepared by infecting just subconfluent BHK 21/C13 
cells in 80 oz glass bottles at a m.o.i. of 0.003 pfu/cell. Virus was 
adsorbed for lh at 37°C and the cells overlaid with 25 ml BHK 21 medium 
containing 5% CS. Infected cells were incubated at 37°C for 2 days or 
31°C for 3 days. Cells were harvested by shaking into the medium which 
was collected and spun in 50 ml sterile, glass centrifuge bottles for 
15 min at 4°C. The majority of the supernatant was removed, leaving 
a small residue sufficient to resuspend the infected cell pellet. The 
infected cell suspension was transferred to a sterile , glass, conica1 
flask and sonicated for 15 min at 4°C in a Cole-Palmer ultrasonic 
cleaning bath. Cells were pelleted by centrifuging at 1 000 rpm {'or 
15 min at 4°C. The supernatant was removed and stored at -70°C. The 
cell pellet was resuspended in the minimum amount of medium and sonic­
ated again for 15 min at 4°C to release any remaining cell-associated 
virus. The cells were then pelleted as before. The second supernatant 
was removed and stored at -70°C.
2.2.8.2 HSV-1
HSV-1 stocks were prepared by infecting just subconfluent BHK 21/Cl3 
cells in 80 oz glass bottles at a m.o.i. of 0.002 pfu/cell. Virus was
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adsorbed, grown and harvested and centrifuged at 1 000 rpm for 15 min at
4°C, as described for HSV-2 (2.2.8.1). HSV-1 is released into the
growth medium therefore the supernatant containing HSV-1 was centrifuged 
at 12 000 rpm for 3h at 4°C or at 35 000 rpm for 45 min at 4°C to
pellet the virus. The pellet was resuspended in a minimum amount of
growth medium, sonicated and pelleted twice as for HSV-2 (2.2.8.1).
To harvest any cell-associated HSV-1, the original pellet was resus­
pended in growth medium, sonicated and pelleted once as already 
described (2.2.8.1). All virus preparations were stored at -70°C.
2.2.8.3 tsK
Preparation of tsK stocks was similar to preparation of HSV-1 stocks 
(2.2.8.2) except that adsorption and growth of virus was at 31°C, the 
permissive temperature for tsK infection.
2.2.9 Titration of Virus
2.2.9.1 HSV-1 and HSV-2
Serial 10-fold dilutions of virus were made in PBS + 2% CS. 100 ]_il 
inocula was added to almost confluent monolayers of BHK 21/Cl3 cells 
in 50 mm petri dishes. Virus was adsorbed for lh at 37°C, then 4 ml 
BHK 21 medium containing 2% HS added. Infected cells were incubated 
for a further 2 days at 37°C. The medium was discarded into flasks 
containing chloros. Monolayers were stained with Giemsa for 30 min
at ambient temperature. Excess Giemsa stain was removed by washing
in water. Plates were dried and the number of plaques counted under 
a dissecting microscope. Titres were expressed as the number of 
plaque-forming units per cell (pfu/cell).
2.2.9.2 tsK
Titration of _tsK was identical to titration of HSV-1 and HSV-2 except 
that adsorptIon and growth of virus was at 31°C. Infected cells were 
incubated for 3 days at 31°C before staining with Giemsa.
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2.2.10 Preparation of Bacteria Competent for Transformation with DNA
An isolated colony of E. coli DH101 bacteria was picked from an agar 
plate and grown in 10 ml L-broth overnight at 37°C with shaking.
100 ml L-broth was inoculated with 2 ml of the overnight bacterial 
culture and grown with vigorous shaking at 37°C to an optical density 
of 0.2 at 630 nm (3 - A h). The culture was chilled on ice for 10 min, 
then centrifuged at 6 000 rpm for 10 min at 4°C. The pellet was 
drained, resuspended in 50 ml of 10 mM ice-cold, sterile CaCl2 and 
incubated on ice for 20 min. The bacteria were centrifuged as before, 
resuspended in 50 ml of 75 mM CaCl2 and incubated on ice for 20 min.
The cells were centrifuged again as before and resuspended in 3 ml of 
75 mM CaCl2. Competent bacteria were stored at -70°C.
2.2.11 Transformation of Bacteria with DNA
0.1 - 1.0 Ug plasmid DNA in a volume of 1 pi was added to 100 - 150 yl 
competent bacteria (2.2.10), gently mixed and incubated on ice for 40 
min. The bacteria were then incubated at 37°C for 3 min and plated 
directly onto media selective for an appropriate plasmid resistance 
gene. Plates were incubated at 37°C overnight to allow colonies of 
transformed bacteria to grow. Plates were stored at 4°C.
2.2.12 Preparation of Plasmid DNA
An overnight culture of bacteria transformed with the appropriate 
plasmid was prepared from seed stocks and used to inoculate 1 litre 
of L-broth supplemented by 100 Ug/ml ampicillin (or tetracycline where 
appropriate). The bacteria were grown at 37°C with vigorous shaking 
to an optical density of 0.8 at 630 nm. Chloramphenicol was then added 
to a final concentration of 100 Ug/ml to stop the bacteria from 
multiplying while still allowing replication of plasmid DNA. Cultures 
were incubated for a further 16 - 24 h at 37°C with vigorous shaking.
The bacteria were pelleted by centrifugation at 8 QUO rpm for 15 min
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at 4°C in a Sorvall RC-5B refrigerated superspeed centrifuge using a 
GS3 rotor and resuspended in 8 ml ice-cold sucrose-tris. The bacterial 
suspension was distributed between two 50 ml SS34 centrifuge tubes on 
ice. To each tube was added 2 ml of 5 mg/ml lysozyme for 5 min at 4°C 
followed by 3 ml of 250 mil EDTA, pH 8.0 for 5 min at 4°C and finally by 
9 ml Triton lytic mix for 20 min at 4°C. Cell debris was removed by 
centrifugation at 15 000 rpm for 60 min at 4°C in a Sorvall superspeed 
centrifuge using an SS34 rotor. The lysate was incubated with 200 pig/ml 
proteinase K + 0.1% SDS at 37°C for lh, then extracted once with phenol 
(saturated with TE buffer, pH 8.0) and chloroform. The nucleic acids 
were precipitated by incubation with a half volume of isopropanol and 
0.2M sodium acetate for 30 min at ambient temperature. The precipitate 
was pelleted by centrifugation at 10 000 rpm for 30 min (Sorvall 
centrifuge, rotor, SS34), then resuspended in TE buffer, pH 8.0.
The plasmid DNA was purified by centrifugation to equilibrium in 
CsCl/EtBr gradients. Gradients were prepared to give a final density
of 1.55 g CsCl per ml and 500 yg/ml EtBr in a final volume of 20 ml.
Centrifugation was in a Sorvall 0TD 50 ultra-centrifuge using a
TV865B rotor at 40 000 rpm for a minimum of 16h at 15°C. The DNA
bands (upper = host DNA; lower = plasmid DNA) were visualized by
long-wave UV-light and the plasmid DNA collected by tube puncture.
EtBr and CsCl were removed by extracting three times with isopropanol 
saturated with CsCl followed by extensive dialysis against TE buffer, 
pH 8.0 at 4°C. The DNA was precipitated with isopropanol in the 
presence of 0.2M sodium acetate, resuspended in distilled water and 
quantitated spectrophotometrically (A = 260 n m ) . DNA was stored 
either at 4°C for immediate use or at -20°C for longer storage.
2.2.13 Quantitation of Nucleic Acids by Optical Density (0D) 
Measurement at 260 n m .
The absorption at 260 nm of various dilutions of DNA or RNA samples 
was measured using quartz microcuvettes in a Perkin Elmer double 
beam R4 spectrophotometer. The concentration was estimated assuming
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that OD = 1.0 is equivalent to 50 ug/ml double-stranded DNA, 40 ug/ml 
RNA and 20 Ug/ml oligonucleotide DNA.
2.2.14 Quantitation of Nucleic Acid by Agarose Gel Electrophoresis
Small samples (0.25 - 1.0 ug) of DNA were electrophoresed with known 
standard concentrations of A DNA on 0.6% (W /v) agarose gels in TBE 
buffer containing 0.5 ug/ml EtBr. The DNA was visualized by UV- 
illumination of the gels and the concentration of the unknown determined 
by visual comparison of the fluorescence with that of the standard A DNA. 
Gels were photographed under short-wave UV-light using Polaroid type 
667 film.
2.2.15 Transfection of Cultured Cells with Plasmid DNA
All solutions used in transfection of cells were filter sterilized 
through a 0.22 um Millipore filter before use. Pre-packed, sterile 
plastic tubes were used for the reaction. The quantities given 
below are for cells grown in 80 c m 2 flasks.
20 ug plasmid DNA in 420 ul TE buffer was added to tube 1 followed by 
60 ul 2M CaCl2 added dropwise with mixing. The contents of tube 1 
were then transferred dropwise with mixing to tube 2 containing 480 ul 
of 2X BBS, pH 7.2. Incubation was for 30 min at ambient temperature 
to allow formation of a DNA-CaPO^ precipitate. This mixture was then 
added dropwise onto the cells.
Cells were incubated at 37°C for 24h, the medium discarded and replaced 
with fresh, pre-warmed medium. Incubation was continued for a further 
24h. The medium was then discarded, the cell monolayer washed twice 
with PBS and the cells harvested by incubation in TEN buffer, pH 7.8 
for 5 min followed by cell scraping. Cells were pelleted by centrifu­
gation at 1 000 rpm for 5 min at 4°C and resuspended in 300 ul of 250 mM 
Tris, pH 7.8 on ice. Disruption of cells was by three cycLes of 
freeze/thawing. Cell debris was pelleted by centrifugation at 3 000
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rpm for 5 min. Aliquots of cell cytosol were used for protein est­
imation (2.2.14) and CAT assay (2.2.15) and the rest stored at -20°C.
2.2.16 Estimation of Protein Concentration by Bio-Rad Assay
The Bio-Rad protein assay is based on the observation that the 
absorbance maximum for an acidic solution of Coomassie brilliant blue 
G-250 shifts from 465 nm to 595 nm when binding to protein occurs.
Bio-Rad protein dye reagent was supplied as a 5-fold concentrate. For 
the standard assay procedure (2.2.16.1), the dye reagent was diluted 
5-fold in distilled water and filtered through Whatman No. 1 paper.
The diluted dye could be stored for up to two weeks in a glass 
container at ambient temperature.
2.2.16.1 Standard Assay Procedure (for measuring 20 - 140 ug protein)
A stock solution of 1 mg/ml BSA was made up in distilled water for use 
in protein standards. The stock BSA solution was stored at -20°C.
From the 1 mg/ml BSA stock solution, the following aliquots were trans­
ferred to plastic tubes-0, 100, 200, 300, 400, 500 and 600 ul - 
and the volume made up to 1 ml in each case with distilled water.
These solutions were used as "standard curve" solutions of 0 - 600 
Ug/ml BSA.
100 ul of each standard solution and 100 ul of each appropriately 
diluted sample were placed in clean, dry test tubes. 5.0 ml diluted 
dye reagent was added and the mixture vortexed gently. After a period 
of between 5 min and 60 min, the optical density at 595 nm was 
measured. A graph of versus the protein concentration of the
standards was drawn. The protein concentrations of the unknown 
samples were read from the graph.
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2.2.16.2 Microassay Procedure (to measure 1 - 20 yg protein)
BSA standards ranging from 1 to 25 fig/ml were made up in distilled 
water. 800 yl standards and appropriately diluted samples were placed 
in clean, dry test tubes. 200 ul concentrated dye reagent was added 
and the mixture vortexed gently. After a period of between 5 min and 
60 min, the optical density at 595 nm was measured. A graph of OD^c)^ 
versus the protein concentrations of the samples were read from the 
graph.
2.2. 17 Chloramphenicol Acetyl Transferase (CAT) Assay
Standard "CAT mix" consisting of 14 yl H 2O, 1 yl acetyl CoA, 0.5 yl 
14
[ C]-chloramphenicol per assay was made up as a larger stock solution 
(1 ml) and stored at 4°C. 15.5 yl CAT mix was aliquoted into eppendorf
tubes and incubated at 37°C for 5 min before addition of each 25 yl 
cell extract. Incubation at 37°C was continued for 30 min.
The reaction was stopped by the addition of 200 yl ethyl acetate with 
vigorous mixing and transfer of the tubes to ice. Organic and aqueous 
layers were separated by centrifugation in an eppendorf microfuge at 
high speed for 1.5 min. The top, organic layer was removed , transferred 
to a new eppendorf tube and dried down by lyophillization. The chloram­
phenicol products were resuspended in 25 yl ethylacetate and spotted 
onto silica thin-layer chromatography (TLC) plates. Ascending 
chromatography was in 95% chloroform and 5% methanol.
The TLC plates were autoradiographed overnight. The position of the 
spots was marked, cut out and the amount of radioactivity counted with 
"Lcoscint" on an Intertechnique SL 4000 liquid scintillation counter.
Ihe percentage1 of acetylated : non-acety lated chloramphenicol products 
was calculated. The results were expressed as n moles acetylated 
c h 1orampheni co1/mg prote i n/h.
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2.2.18 Restriction Enzyme Digestion
DNA was incubated at 37°C for at least 4h with the appropriate 
restriction enzyme (approximately 10 units of enzyme per pig DNA) 
in the presence of the appropriate "React" buffer in a total volume 
(made up with distilled water) not less than 10X the volume of the 
restriction enzyme added. For digestion with two enzymes, the 
reactions were carried out simultaneously if the enzymes operated 
under the same salt conditions. If not, then the two digestions 
were done separately. After the first digestion, the DNA was extracted 
once with phenol and chloroform and precipitated at -70°C with two 
volumes of ethanol in the presence of 0.2M sodium acetate. The DNA 
was resuspended in a small volume of distilled water and the appropriate 
enzyme and "React" buffer added. Incubation was at 37°C for at least 
Ah as before. Restriction enzyme digestion was checked on agarose 
mini-gels (2.2.19).
2.2. 19 Agarose Mini-Gel Electrophoresis
Agarose gel concentrations of 0.6% (W /v) were used routinely in mini­
gels to visualize and quantitate plasmid DNA. 1% agarose mini-gels 
were used to check the integrity of RNA samples and to check the 
result of restriction enzyme digestion of DNA.
The agarose was dissolved in TBE buffer by boiling, cooled to approx­
imately 50°C and 0.5 pig/ml EtBr added bef ore pouring. Samples were 
prepared in TBE buffer and 0.1X volume of BFB dye. Electrophoresis 
was carried out at ambient temperature at about 60V for 30 min in 
TBE buffer containing 0.5 ug/ml EtBr. Gels were photographed under 
short-wave UV-irradiation using Polaroid type 667 film.
2.2.20 Purification of DNA from Agarose Gels
Cloned 0R3 cDNA (fig. 6.1, section6.2.2) was excised from its vector 
sequences by digestion with Eco Rl. The resulting fragments were
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separated on a 1% agarose slab gel (prepared in the same way as mini 
gels, 2.2.19). Electrophoresis was carried out at 30V for 18h. The 
lower band was cut from the gel with a sharp, sterile scalpel under 
long-wave UV-light. The excised band was placed inside dialysis 
tubing along with TBE buffer. The DNA was electroeluteQ in TBE buffer 
at 100V. To release any DNA concentrated on the dialysis membrane, the 
current was reversed for a few seconds. The buffer inside the dialysis 
tubing containing the eluted DNA was transferred to a 50 ml Falcon 
centrifuge tube. The DNA was extracted once with phenol and once with 
chloroform, then precipitated twice with two volumes of ethanol in 
the presence of 0.2M sodium acetate at -20°C overnight. The DNA was 
pelleted and resuspended in distilled water and quantitated 
spectrophotometrically (A = 260 nm).
2.2.21 Purification of DNA from Low Melting Point Agarose
Cloned actin cDNA ( fig. 6.9, section 6.5.3) was excised from its 
vector sequences by digestion with Xba T. The resulting fragments 
were separated on a 1% low-melting point agarose slab gel.
The agarose was dissolved in TAE buffer by boiling, cooled to approxi­
mately 50 C and 0.5 ptg/ml EtBr added. The gel was poured and set at 
ambient temperature. The sample was prepared in TAE buffer and 0.1X 
volume BFB dye added. Electrophoresis was carried out at ambient 
temperature in TAE buffer containing 0.5 Ug/ml EtBr at 30V for 18h.
The separated bands were visualized under long-wave UV-light and the 
lower, actin band excised with a sharp, sterile scalpel. The gel slice 
was cut into smaller pieces and transferred to an eppendorf tube.
The agarose was melted at 70°C, the volume measured and the concentrat­
ion of actin DNA estimated by calculating the fraction of the total 
plasmid DNA which was actin DNA. The agarose containing actin DNA was 
stored in 50 ul aliquots in eppendorf tubes at -20°C.
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2.2.22 Nondenaturing Polyacrylamide Gel Electrophoresis
This method was used for gel retardation assays (2.2.31 )
A stock solution of 44% (W /v) acrylamide : 0.8% bisacrylamide 
(NNT-methylene-bisacrylamide) was prepared in distilled water and 
filtered through "Amberlite" monobed resin MB-1 and Whatman No. 1 
filter paper.
50 ml of an 8% polyacrylamide gel mix was prepared as follows:
Stock acrylamide 9.0 ml
20X TBE 2.5 ml
H 2O 38.5 ml
25% ammonium persulphate 0.2 ml
TEMED 15 pi
Ammonium persulphate and TEMED were added last and the gel poured 
immediately. Electrophoresis was carried out in TBE buffer at 30 mA 
for 2h. The gel was then soaked in a solution of 10% acetic acid
for 20 min and dried under vacuum at 80°C for 2h.
2.2. 23 Denaturing Polyacrylamide Gel Electrophoresis
This method was used to purify synthetic oligonucleotides after synthesis. 
A stock solution of 50% acrylamide (20:1 acrylamide : bisacrylamide) 
was made up in distilled water and filtered through "Amberlite” mono­
bed resin MB-1 and Whatman No. 1 filter paper. For purification of the 
ER oligonucleotides (section 6.2.1), a 15% acrylamide gel mix contain­
ing 7M urea was made up in TBE buffer. 400 yl ammonium persulphate and 
40 pi TEMED were added to 75 ml gel mix and the gel poured immediately.
The oligonucleotide, prepared as described in section 2.2.25, was 
loaded and electrophoresis carried out in TBE buffer at 30 mA for
3 - 4 h. The oligonucleotide band was visualized as a shadow cast under
long-wave UV-light, cut out and eluted as described in section 2.2.25.
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2.2.24 SDS Polyacrylamide Gel Electrophoresis
This method was used to separate denatured proteins on the basis of 
mol. w t .
A stock solution of 30% acrylamide : 0.75% bisacrylamide was made up in 
distilled water and filtered through "Amberlite" monobed resin MB-1 and 
Whatman No. 1 filter paper. Standard separating, stacking and chamber 
buffers used for these gels are described under section 2.1.15.1.
7% acrylamide, single concentration gels were prepared as follows:
Separating Gel
Acrylamide stock 12.0 ml
Gel Buffer (pH 8.9) 12.0 ml
H 20 24.0 ml
ammonium persulphate (10%) 0.3 ml
TEMED 40 ul
Stacking Gel
Acrylamide stock (+ 0.78% DATD) 1.0 ml
Stacking Gel Buffer (pH 6.7) 1.5 ml
H 2O 3.5 ml
ammonium persulphate (10%) 50 yl
TEMED 15 Ul
The separating gel was poured and allowed to set with a layer of 
butan-l-ol on the top to ensure a level surface. Once the separating
gel had set, the butanol was removed and the surface of the gel washed
with {- strength stacking gel buffer. The stacking gel was then poured
on top of the separating gel and allowed to set.
Protein samples were prepared in a final concentration of IX "boiling 
mix" with 0.1X volume of BPB dye and denatured by boiling for 3 min.
A 3X concentrate of boiling mix was prepared as follows:
Slacking Gel Buffer (1.0 ml), 20% SDS (1.0 ml), Glycerol (1.0 ml) and 
3-mercaptoethuno1 (0.5 ul).
86
Electrophoresis was for 3h at 40 mA in chamber buffer. The gel was
fixed in 50% methanol : 7% acetic acid for lh, washed in 5% methanol .
7% acetic acid for lh then in H 20 for 30 min. The gel was then 
soaked in "En'hance" for 30 min, washed for 2 x 15 min in H 20 and 
dried under vacuum at 80°C for 2h. The gel was autoradiographed for 
various lengths of time.
2.2.25 Synthesis and Purification of Synthetic Oligonucleotides
Oligonucleotides were synthesized on a Biosearch 8600 DMA synthesizer 
by Dr. J. McLauchlan, Institute of Virology, Glasgow.
The newly synthesized oligonucleotide (approximately 200 pig) was 
incubated at 55°C for 5 h , then split into four aliquots in eppendorf
tubes and dried down by lyophilization. Three of the tubes were stored
at -70°C until required.
The contents of the fourth tube were resuspended in 50 ul water plus 
50 ul sample buffer (0.28 ml 10X TBE, 1.7 ml H 2O, 8 ml deionized 
formamide). The mixture was vortexed, heated at 90°C for 3 min and 
immediately chilled on ice. 0.1X volume of BFB/XC dye was added to the 
sample before loading onto a denaturing polyacrylamide gel (2.2.23).
After electrophoresis, the oligonucleotide band was cut out (2.2.23), 
ground into small pieces in a 5 ml plastic tube and covered with 2 ml 
ammonium acetate elution buffer (see below). The oligonucleotide was 
eluted by shaking in this buffer for 18h at 37°C. The solution was 
then filtered through glass wool to remove the acrylamide. The 
oligonucleotide was precipitated with 2.5 volumes of ethanol at -20°C 
for 18h, pelleted by centrifugation at high speed in an eppendorf 
microfuge and resuspended in 50 ul distilled water. The DNA was 
quantitated spectrophotometrically (2.2.13). The oligonucleotide 
was stored at -20°C.
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Ammonium Acetate Elution Buffer
3M ammonium acetate 1.0 ml
0.25M EDTA (pH 7.8) 24 pi
20% SDS 30 ul
r 20 5.0 ml
2.2.26 In Vitro Labelling and Purification of cDNA Probes
2.2 .26 .1 Nick-Translation
The following ingredients were added to an eppendorf tube on ice:-
5 Ul 0.25 Ug DNA
5 Ul 1% BSA
5 Ul 10X NTB
2 Ul 2 mM dCTP
2 Ul 2 mM dGTP
5 Ul [3 2P]-dATP
5 Ul [3 2P]-dTTP
17 ul H 20
2 Ul DNA polymerase 1_ (2 units/ul)
2 Ul DNase (10~^M)
50 Ul
The reaction mix was incubated at 37°C for 2 min to start the reaction, 
then at 15°C for approximately 60 min. The reaction was stopped by 
transferring the tube to ice.
2.2.26.2 Random Priming or Oligolabel1ing
This method was used to label actin cDNA purified on low melting 
point agarose (2.2.21).
The agarose containing actin cDNA was melted at 70°C and 50 ng was 
transferred to an eppendorf tube. The total volume was made up to 31 ul
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with distilled water. The actin cDNA was denatured by heating at 90 C 
for 10 min, then transferred to a 37°C water bath for 5 min. At ambient 
temperature, the following ingredients were added
31 yl denatured DNA
10 yl reagent mix
2 yl BSA
5 yl [a-32P]-dCTP
2 yl Klenow
50 yl
'‘'Reagent mix, BSA and Klenow fragment of DNA polymerase _1_ were 
supplied in the Pharmacia oligolabelling kit. The reagent mix 
contained dATP, dGTP, dTTP, p(dN)£ and buffer.
The reaction mix was incubated at ambient temperature for 2 - 4 h.
The reaction was terminated by the addition of 20 pi "stop" buffer 
(supplied in kit) and 180 yl H 2O.
2.2.26.3 Isotope Incorporation and Specific Activity of cDNA Probes
Duplicate Whatman No. 1 filter paper discs were spotted with 1 yl of 
the nick - Lrans1 at ion or oligolabelling reaction mixtures. One disc was 
transferred directly to a scintillation vial and 2 ml Ecoscint added.
The other disc was given 3 x 5  min washes in 5% ice-cold TCA to 
precipitate the DNA and remove unincorporated nucleotide triphosphates. 
The disc was then rinsed in ethanol, dried under a lamp, transferred 
to a scintillation vial and 2 ml Ecoscint was added. The washed and 
unwashed discs were counted on an Intertechnique SL 4000 liquid 
scintillation counter. The percentage isotope incorporation was 
calculated by the percentage (bound counts/total counts). The 
specilic activity of the probe was calculated as cpm/yg DNA.
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2.2.26.4 Purification of cDNA Probes
A 1 ml sterile, plastic syringe was plugged with glass wool and filled 
with a suspension of Sephadex G-50 equilibrated in TE buffer. The 
syringe was then suspended in a 15 ml Falcon centrifuge tube containing 
a 1.5 ml eppendorf tube and centrifuged at 1 000 rpm for 1.5 min. The 
packed Sephadex volume was at least 1.8 ml. The eppendorf tube 
containing "flow-through" buffer was replaced with a fresh tube. The 
volume of the nick-translation mix was made up to 250 Ml with 200 yl 
distilled water. The volume of the oligolabelling mix was already 
250 yl due to the addition of "stop" buffer and water. The sample 
was gently layered on top of the packed Sephadex column, then 
centrifuged at 1 000 rpm for 1.5 min. Unincorporated triphosphates 
remained on the column while radiolabelled DNA passed through the 
column into the eppendorf below. Recovery of DNA was 85%.
2.2.26.5 Denaturation of cDNA Probes
Probes were denatured before use in hybridization reactions either by
(a) boiling for 5 min followed by rapid cooling on ice or
(b) incubation with NaOH at a final concentration of 0.2M for 10 min
at ambient temperature. HCi was then added to a final concentration 
of 0.2M to neutralize the NaOH.
2.2.27 In Vitro Labelling and Denaturation of Oligonucleotide Probes
2.2.27.1 Kinase Reaction
Oligonucleotide DNA was end-labelled with [y-32?]-ATP using T4 poly­
nucleotide kinase. The following reaction mixture was incubated at 
37°C for lh, then transferred to ice to stop the reaction.
Isotope incorporation and the specific activity of the probe were 
determined as described in section 2.2.26.3.
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Rpar.r.ion Mixture:
2 yl (0.2 yg) oligonucleotide DNA
3 yl 10X kinase buffer
2 yi (10 units) T4 polynucleotide
5 yi [y - 32p ]-a t p
18 yi H 20
30 yl
2.2.27.2 Denaturation of Oligonucleotide Probes
The oligonucleotide reaction mixture was made up to a total volume of 
200 yl by the addition of 170 yl formamide. This mixture was heated at 
90°C for 3 min, cooled rapidly on ice and added directly to the 
hybridization mixture. The presence of unincorporated [y-32P]-ATP 
did not affect the hybridization reaction.
2.2.28 Preparation of Cellular RNA
2 .2 .28.1 Preparation of Crude Cell Extracts
Cells grown in 50 mm petri dishes (and treated with E 2 or infected 
with virus) were washed twice in ice-cold PBS, harvested by scraping 
with a rubber policeman into 1 ml PBS and transferred to an eppendorf 
tube. Cells were pelleted by centrifugation for 30 sec at high speed 
in an eppendorf microfuge, The cells were resuspended in 45 yl TE 
buffer and 5 yl of 5/0 (v/v in TE buffer) NP 40, mixed and incubated on
ice for 5 min. A further 5 yl of 5% NP 40 was added, the samples mixed
and centrifuged at high speed in an eppendorf microfuge for 2.5 min.
50 yl supernatant was transferred to a sterile eppendorf tube 
containing 30 yl of 20X SSC + 20 yl formaldehyde, mixed and incubated 
at 60 C for 15 min. Samples were stored at —70°C.
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2.2.28.2 Extraction of Cytoplasmic Cellular RNA
Cell growth medium was removed and the monolayers washed twice in 
ice-cold PBS. Cells were harvested by scraping with a rubber police­
man and pelleted by centrifugation at 1 000 rpm for 5 min. Cells 
were resuspended and incubated in 250 pi RNA extraction buffer A for 
3 min on ice (quantities are for a confluent 80 cm flask of cells). 
Lysed cells were centrifuged at 3 000 rpm for 5 min to pellet cell 
debris and nuclei. The cytosol supernatant was removed and added to 
an equal volume of RNA extraction buffer B in an eppendorf tube. RNA 
was extracted three times with an equal volume of phenol/chloroform 
(1:1) and finally with an equal volume of chloroform alone. RNA was 
precipitated in two volumes of ethanol at -20°C overnight and pelleted 
by centrifugation in an eppendorf microfuge at high speed for 10 min. 
The pellet was resuspended in sterile, distilled water and quantitated 
spectrophotometrically (2.2.13). The integrity of the RNA was checked 
by mini-gel agarose electrophoresis (2.2.19). RNA was stored at -70°C.
2.2.29 In Vitro Translation of RNA
Rabbit reticulocyte lysate was obtained from Sigma Chemical Co. Ltd. 
and stored in 100 pi aliquots at -70°C.
12 pi lysate and 1.5 pi [ ~^S]-methionine were mixed together and 
warmed to 30°C. 1 pg total, cytoplasmic RNA was added in a volume of
1.5 pi sterile, distilled water. The mixture was vortexed and incub­
ated at 30°C for lh. 15 pi of 0.1M EDTA, 1% (w /v) methionine, 100 
Pg/ml RNase were added and the mixture incubated for a further 15 
min at 30°C to terminate the reaction. Samples were stored at -20°C 
or -70°C until a convenient time for running an SDS polyacrylamide 
gel (2.2.24).
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2.2.30 Slot-Blot Analysis of RNA
2.2.30.1 Transfer of RNA to Nitrocellulose Membrane
Various dilutions of RNA samples were made in 50% (v/v) formamide,
6% (v/v) formaldehyde, 10X SSC in a total volume of 100 til. The 
samples were denatured at 65°C for 5 min, cooled rapidly to 4°C 
and transferred to nitrocellulose membrane via a Schleicher &
Schuell slot-blot apparatus and water pressure. The membrane was 
pre-wetted in 10X SSC. After transfer of samples, the membrane 
was air-dried and baked under vacuum for 2h at 80°C.
2.2.30.2 Hybridization with ER Oligonucleotide Probes
Nitrocellulose slot-blots were prehybridized for 3h at 42°C in 50%
(v/v) formamide, 3X SSC, IX Denhardt's solution, 150 ug/ml denatured 
salmon sperm DNA in a total volume of 10 ml. Hybridization with ER 
oligonucleotide probes (-1 or -2) was in 50% formamide and 5X SSC at 
42°C for 18 - 24 h.
Blots were washed for lh at 42°C in prehybridization solution followed 
by lh at ambient temperature in 3X SSC. Blots were exposed to X-ray 
film ( flashed and "unflashed") with Du Pont intensifying screens 
at -70°C for 1 - 3  days.
2.2.30.3 Hybridization with the 0R3 cDNA Probe
The following conditions were outlined by Prof. Chambon when he sent us 
the 0R3 cDNA plasmid:
Nitrocellulose membrane was prehybridized in 50% (v/v ) formamide,
5X SSC, 5X Denhardt s solution (with no BSA), 50 mM sodium phosphate
buffer (pH 7.0), 0.1% SDS, 0.5 mg/ml denatured salmon sperm DNA, 
for 4 - 6 h at 42°C.
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Hybridization with denatured, nick-translated 0R3 cDNA was m  50% (v/v) 
formamide, 5X SSC, IX Denhardt's solution (with no BSA), 20 mM sodium 
phosphate buffer (pH 7.0), 0.1% SDS, 10% (w /v) dextran sulphate and 
0.5 mg/ml denatured salmon sperm DNA for 18 - 24 h at 42 C.
Blots were washed as follows:
(a) 2X SSC, 1% SDS for 2 x 10 min at ambient temperature
(b) IX SSC, 0.1% SDS for 30 min at 52°C
Blots were autoradiographed and if a more stringent wash was required 
then blots were washed in:
(c) 0.1X SSC, 0.1% SDS for 30 min at 52°C
2.2.31 Northern Blot Analysis of RNA
2.2.31.1 Size Fractionation of RNA by Denaturing Agarose
Gel Electrophoresis
25 pig RNA was denatured in 50% (v/v) formamide, 6% (v /v) formaldehyde 
and IX MOPS buffer in a total volume of 60 ul for 5 min at 65°C, then 
cooled rapidly to 4°C. BFB/XC dye was added (0.1X volume) and the 
samples loaded onto a denaturing 1.2% 0 v/v) agarose slab gel contain­
ing 6% (v/v) formaldehyde and IX MOPS buffer.
Ethidium bromide stainable markers, obtained from BRL, were used as 
mol. wt. size markers. 6 ug standard RNA (containing 1 ug of each 
RNA mol. wt. marker) was denatured in a similar way to the sample RNA 
and loaded on the same gel.
Electrophoresis was carried out in IX MOPS buffer at 80 - 100 V for 4 h . 
The marker track was cut off from the rest of the gel and stained 
overnight in 0.5 ug/ml ethidium bromide. The track was destained in 
distilled water for lh and then photographed under short-wave UV-light.
The position of the RNA markers was also marked on paper of the same
size as the gel so that a direct comparison could be made with the 
position of hybridized bands on Hybond membrane to which the sample 
RNA was transferred.
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2.2.31.2 RNA Transfer to Hybond-N Membrane
The gel was transferred to a sheet of Whatman 3 mm paper on a glass 
plate supported in a tray of 20X SSC. A piece of Hybond-N membrane, 
cut to the exact size of the gel, was laid directly on top of the 
gel. Six pieces of Whatman 3 mm paper, cut 2 mm smaller than the gel 
size, were laid on top of the membrane. A weighted stack of dry 
paper towels, cut to the same size as the filter paper, was placed 
on top. The blot was left for 16 - 24 h at ambient temperature to 
allow complete transfer of the RNA to the membrane. Thereafter, the 
membrane was removed, air-dried, wrapped in cling-film and placed, RNA- 
side down, on a UV short-wave transilluminator for 5 min to crosslink 
the RNA to the membrane.
2.2.31.3 Hybridization
The blot was prehybridized in 50% (v/v) formamide, 5X SSPE, 5X Denhardt's 
solution, 0.5% (w /v) SDS and 0.1 mg/ml denatured salmon sperm DNA for 
1 - A h at 42°C.
Hybridization with the appropriate radiolabelled, denatured probe 
was carried out in 50% (v/v) formamide, 5X SSPE, 5X Denhardt's 
solution, 0.5% (w /v) SDS, 10% (w/v) dextran sulphate, 0.1 mg/ml 
denatured salmon sperm DNA for 16 - 24 h at 42°C.
2.2.31.4 Washing of Blots Probed with Actin Radiolabelled cDNA
(a) 2X SSPE, 0.1% SDS for 30 min at 65°C
(b) IX SSPE, 0.1% SDS for 2 x 30 min at 65°C
(c) 0.1X SSPE, 0.1% SDS for 15 min at 65°C
Washing steps (a) and (b) resulted in a single, specific band 
corresponding to the 2 kb actin mRNA. This band remained after the 
very stringent wash (c).
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2.2.31.5 Washing of Blots Probed with Radiolabelled ER Oligonucleotide
(a) 2X SSPE, 0.1% SDS for 30 min at ambient temperature
(b) 0.1X SSPE, 0.1% SDS for 2 x 30 min at ambient temperature
These washing conditions resulted in a single, specific band corres­
ponding to the 6.2 kb ER mRNA.
2.2.31.6 Reprobing of Blots
The first probe was removed by washing the blot for 1 - 2 h at 65°C 
in 0.005M Tris-HCl, 0.002iM EDTA, 0.1X Denhardt's solution, pH 8.0. 
Removal of the probe was checked by autoradiography.
Blots were prehybridized and hybridized as before.
2.2.31.7 Storage of Blots
The damp membrane was wrapped in cling-film and silver foil on a glass 
plate and stored at A°C in the dark for short-term storage (up to 1 
month) and at -20°C or -70°C for long-term storage.
96
2.2.32 Extraction of Nuclear Protein
Cells were grown in plastic roller bottles. The cells were harvested 
after the appropriate treatment with hormones or virus infection, by 
washing twice in ice-cold PBS and scraping the cells into 25 ml PBS. 
Cells were pelleted by centrifugation at 2 500 rpm for 10 min at 4 C. 
Cells were resuspended in five packed cell volumes of ice-cold PBS 
and pelleted again. All subsequent steps were carried out at A C.
Cells were resuspended in five packed cell volumes of nuclear extrac­
tion buffer A (2.1.14), incubated for 10 min at 4°C and pelleted as 
before. Cells were resuspended in two packed cell volumes of buffer 
A and lysed by ten strokes of a Dounce B type pestle (checked 
microscopically). Nuclei and cell debris were pelleted by centrifu­
ging at 2 500 rpm for 10 min at 4°C and the supernatant discarded.
The pellet was resuspended in two packed cell volumes of buffer A 
and centrifuged for 20 min at 14 500 rpm at 4°C. The supernatant 
was discarded, the nuclear pellet resuspended in nuclear extraction 
buffer B (2.1.14), (3 ml/10^cells) and dounced with ten strokes of a 
type B pestle. The nuclear suspension was incubated in buffer B for 
30 min at 4°C with gentle stirring. The nuclei were pelleted by 
centrifugation at 14 500 rpm for 20 min at 4°C. The supernatant 
containing nuclear protein was collected. Ammonium sulphate 
(0.33 g/ml) was added with gentle stirring on ice for 15 min. The 
nuclear proteins were pelleted by centrifugation at 14 500 rpm for
20 min at 4°C, then redissolved in nuclear extraction buffer C 
iso .
(2.1.i"4), ( /12 th volume of supernatant). The protein solution was 
dialysed for 6h at 4°C against two changes of 100 volumes of buffer C. 
The insoluble proteins were removed by centrifugation at 14 500 rpm 
for 20 min at 4 C. The protein content of the supernatant was 
assayed by the Bio-Rad assay (2.2.16). The supernatant of soluble 
nuclear protein was aliquoted into 100 ul amounts, "snap-frozen" in 
dry ice/ ethanol and stored at -70°C.
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2.2.33 Gel Retardation Assay
This assay was used to test for DNA-binding proteins which interact 
with specific DNA sequences. The principle of the assay is that both 
DNA and DNA bound to protein can enter native polyacrylamide gels but 
that DNA/protein complexes migrate at a much slower rate than free 
DNA. Provided the DNA is radiolabelled, protein/DNA complexes and 
free DNA can be visualized by autoradiography.
The conditions described below for looking at proteins which 
recognize the HSV IE activatjfor sequence TAATGARAT (where R = purine) 
were optimized by Dr. R.Thompson and Dr. A. Bailey in the 
Institute of Virology, who also supplied the materials for the DNA- 
binding reaction. Preparation of protein extracts is described in 
section 2.2.3^. The sequence of the TAATGARAT oligonucleotide probe 
is given in section 4.5.2.
2.2.33.1 Protein/DNA Binding Reaction
The following components were mixed together and incubated for 20 min 
at ambient temperature
oX Binding Buffer* 5 Ul 
0.2 n g , 10 cps[Y - 32P]-labelled TAATGARAT probe
poly (dA-dI):poly(dG- dQ , (1:1) competitor 2 Ug 
0 - 30 ugprotein extract 
H^ O
Final Volume 25 ul
Binding Buffer (5X) : 125 mM Hopes 
5 mM EDTA 
25 mM DTT 
250 mM NaCl
50 % Glycerol (v/v)
All dilutions of protein extracts were in IX Binding Buffer.
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2 . 2 . 3 3 . 2  F r a c t i o n a t i o n  o f  t h e  P r o d u c t s  o f  t h e  P r o t e i n / D N A  
B i n d i n g  R e a c t i o n  a n d  A u t o r a d i o g r a p h y
BFB/XC dye (0.1X volume) was added to the protein/DNA binding reaction 
mixture before electrophoresis through an 8% nondenaturing poly­
acrylamide gel as described in section 2.2.22.
Once the gel was dried, it was autoradiographed overnight at -70 C. 
2.2.34 1~ 3H j-Steroid Solutions for ER and PR Assays
2.2.34.1 Preparation of [3H ]—E 2 Solutions
3 — 7
Stock [ H ]—E 2 was prepared from the Amersham supply at 5 x 10 M and 
stored in ethanol at -20°C. A stock solution of unlabelled DES at
1.25 x 10"AM was made up in ethanol and stored at -20°C.
Two radiolabelled assay solutions were prepared as follows:
(a) 24 yl DES was aliquoted into a glass bottle and the ethanol
evaporated under a gentle stream of N 2.
24 yl [3H]-E2 was then added and the volume of ethanol made up 
to 30 y l .
970 yl HED buffer was added, making the total volume 1 ml.
(b) 24 yl [3IIJ —E 2 was aliquoted into a glass bottle and the volume
of ethanol made up to 30 yl.
970 yl HED buffer was added making the total volume 1 ml.
Ihe final concentration of [ H ] —E 2 in the exchange assay was 30 x 10- ^ M
and DES was present in 250-fold excess.
2.2. 3a. ^  Preparation of [ Hl-ORG 2058 Solutions
Stock [ H]-0RG 2058 was prepared from the Amersham supply at 5 x 10-7M 
and stored in ethanol at -20°C. Unlabelled 0RG 2058 was made up at a 
concentration of 5 x 10~5M and stored at -20°C.
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Two radiolabelled assay solutions were made up as follows:
(a) AO pi unlabelled ORG 2058 was aliquoted into a small glass 
bottle and the ethanol evaporated under a gentle stream of Na.
40 pi of labelled ORG 2058 was then added followed by 960 yl
HED buffer containing 10% glycerol.
(b) 40 yl labelled ORG 2058 was aliquoted into a small glass bottle. 
960 yl HED buffer containing 10% glycerol was added.
Final concentration of [3H]-0RG 2058 in the exchange assay was 
50 x 10“ and unlabelled ORG 2058 was in 100-fold excess.
2.2. 35 Whole Cell [3H]-Steroid Exchange Assay for ER and PR
Growth medium was discarded and the cell monolayers washed twice in 
ice-cold PBS. Cells were scraped into PBS and pelleted by centrifug­
ation at 1 000 rpm for 5 min at 4°C. The cells were resuspended in
HED buffer containing 1.5 mM MgClg and 10% glycerol, pH 7.4.
150 yl cell suspension was incubated with 50 yl (radiolabelled ligand 
± excess unlabelled ligand), (2.2.34.1 and 2.2.34.2), for 2h at
ambient temperature. 100 yl aliquots from each tube were then added
to 5 ml aliquots of 0.9% (w /v) NaCl immediately prior to pouring
onto a pre-wetted Whatman GF/C filter disc (2.5 cm) held in a Millipore
filler apparatus. The tube which had contained the saline was washed 
out with 5 ml saline, and this was poured onto the filter also.
The chimney of the apparatus was washed with 3 x 4 ml aliquots of 
saline, then removed and the very edge of the filter washed with 3 ml 
saline. The filters were placed in scintillation vials and 4 ml 
Ecoscint added. Samples were counted in a LKB liquid scinti11ation 
counter with a counting efficiency of 35%.
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2.2.36 Cytosol Assay for ER - Dextran-Coated Charcoal Method
Growth medium was discarded and the cell monloayers washed twice in 
ice-cold PBS. The cells were scraped into PBS from the plastic 
tissue culture flask and pelleted by centrifugation at 1 000 rpm 
for 5 min at 4°C. The cells were resuspended in HED buffer, pH 7.4 
and sonicated for 3 - 5  min at 4°C in a Cole-Palmer ultrasonic 
cleaning bath (fixed, gentle setting). Cell debris was pelleted by 
centrifugation at 2 500 rpm for 5 min at 4°C. T h e 'supernatant was 
collected and tested for ER by [3H]-E2 exchange assay using dextran- 
coated charcoal to remove unbound steroid.
150 yl cell cytosol was incubated with 50 yl ( [3H]-E2 ± 250-fold 
excess DES ), (2.2. 34.1), for 18h at 4°C. 200 yl dextran -coated
charcoal solution (0.5% (w /v) Norit A charcoal, 0.005% (w /v) dextran 
T-70 in 10% (v/v) glycerol, 1.5 mM EDTA, 20 mM Hepes, pH 7.4) was 
added to each tube and the tubes mixed. Charcoal treatment was 
continued on ice for 15 min with periodic mixing. At the end of 
this time, the charcoal was pelleted by centrifugation at 2 000 rpm 
for 5 min at 4 C. Aliquots of 200 yl from each supernatant were 
transferred to scintillation vials, 4 ml of Ecoscint added and the 
vials counted in an LKB scintillation counter with a counting 
efficiency of 35%.
2.2.37 Cytosol Assay for ER - Enzyme Immunoassay Method
Cell cytosol was prepared as described in 2.2.36. Measurement of 
ER by the enzyme immunoassay (EIA) was exactly as described in the 
manual accompanying the Abbott EIA kit. The basis of the assay is 
described in section 5.2.£r3.
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RESULTS
3. EFFECT OF STEROID HORMONES ON REPLICATION OF HSV-2 IN VITRO
3.1 INTRODUCTION
A limited number of studies have been done on the effect of steroid 
hormones on virus replication in cultured cells (section Cl.5.2).
The results varied with the virus involved, the cell type used and 
the hormone given to the cells.
This section describes the replication of HSV-2 in primary cultures of 
human cervical cells and in the human breast cancer cell line, ZR-75-1 
in the presence and absence of the steroid hormones, oestradiol (E2) 
and progesterone (Pg).
3.2 GROWTH AND CHARACTERIZATION OF ECTOCERVICAL CELLS
Primary ectocervical cells were cultured from explants of normal 
cervical tissue as described in section 2.2.3.
Fig. 3.1 shows ectocervical cells which have grown out from an explant 
of normal cervical tissue. The cells are epithelial as evidenced by 
the presence of desmosomes and tonofilaments (fig. 3.2).
3.3 INFECTION OF ECTOCERVICAL CELLS WITH HSV-2
3.3.1 Method
The cells were grown in cervical growth medium (section 2.2.3) for 
2 - 3  weeks. The medium was changed to DMEM + 2% HIDCC-FCS for 2 
days to reduce endogenous steroid hormone levels to a minimum.
The appropriate hormone was given to the cells 24h prior to virus 
infection and was present throughout the course of infection. As it 
was difficult to obtain confluent monolayers of cells, the number of 
cells per plate was estimated using a standard grid method previously 
developed by Dr. S. Walkenshaw and Dr. J. Macnab. Cells were infected
1H2
FIG. 3.1 GROWTH OF PRIMARY ECTOCERVICAL CELLS
Two photographs of a 10 day old culture of ectocervical cells. 
Magnification X80.

FIG. 3.2 ELECTRON MICROSCOPY OF ECTOCERVICAL CELLS
Electron micrograph of ectocervical cells showing the presence of 
desmosomes (D) and tonofilaments (T).
Magnification X45 000
The electron microscopy was kindly carried out by Jim Aitken 
(Institute of Virology).

with HSV-2 at a m.o.i. of 1 pfu/cell for 48h resulting in extensive 
c.p.e. (fig. 3.3).
Cells were harvested by scraping into the cell medium. Virus was 
extracted by sonicating the cells in a Cole-Palmer ultrasonic cleaning 
bath for 5 min at 4°C. Cells were pelleted by centrifugation at 
1 000 rpm for 5 min. The supernatant was stored at -70°C until a 
suitable time for titration. Virus was titrated as described in 
section 2.2.9.
3.3.2 Results
Table 3.1 shows the virus yields from cells treated with hormones 
compared to untreated cells. In all cases, productive infection 
yielded a burst size of 10 pfu/cell. Neither physiological (10-<^ M,
10“®M) nor pharmacological (10~^M, 10-^M) doses of E 2 or Pg (tables 
3.1A and 3.IB) significantly altered the virus titre. The combination 
of E 2 and Pg together did not alter the virus titre (table 3.1C).
Thus, under these conditions, neither E 2 nor Pg seemed to have any 
effect on the growth of HSV-2 in ectocervical cells.
3.3.3 Problems Involved in Culturing Primary Cervical Cells
A number of difficulties were encountered when culturing primary 
cervical cells. Only a limited number of suitable hysterectomy samples 
were available. These were collected from the theatre and taken to the 
Pathology Department of the Western Infirmary. The pathologists 
examined the tissue (under non-sterile conditions) for any sign of 
abnormal tissue and cut off a small piece of normal cervical tissue 
which was transferred to a sterile container with sterile PBS on ice 
and taken back to the laboratory. A maximum of a dozen 35 mm petri 
dishes of explants were seeded from each piece of cervix. A separate 
batch of cells was used for each experiment although within experiments, 
each treatment was performed in triplicate. Cells were not able to be 
passaged. Explants from some cervix samples grew better than others.
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TABLE 3.1
Effect of E. and/or Pg on the Replication of HSV-2 In 
Primary Cervical Cells
Primary ectocervical cells were grown and maintained in 3d mm 
petri dishes as described in section 3.3.1 prior to the start 
of the experiment. The number of cells per dish was estimated 
by a standard grid method. Triplicate dishes of celis were 
treated ± a range of concentrations (see table) of:
A. oestradiol-173 (Ea)
B. progesterone (Pg)
C. Ea + Pg (lCT^M only)
for 24h prior to infection with HSV-2. Cells were infected with 
HSV-2 at low multiplicity (1 pfu/cell) for 48h in the continued 
presence of the same hormones. Cells were harvested, virus 
extracted and titrated as described in section 3.3.1. The 
results are expressed as total pfu/cell ± standard deviation (S.D.) 
and divided by the control value (i.e. HSV—2 alone) to give 
relative titre values.
TABLE 3.1
EFFECT OF E 2 AND/OR Pg ON THE REPLICATION OF
HSV-2 in primary cervical cells
A. Effect of a range of concentration of E 2
Treatment Total pfu/cell 
x ± S.D.
No. of plates 
per condition
pfu/cell (treated) 
pfu/cell (control)
HSV-2 alone 10.0 ± 0.5 3 1.0
HSV-2 + 10-9M e 2 10.5 ± 0.4 3 1.0
O
HSV-2 + 10 M e 2 9.3 ± 1.2 3 0.9
HSV-2 + 10“7M e 2 10.0 ± 0 3 1.0
HSV-2 + 10_6M e 2 10.0 ± 0 3 1.0
B. Effect of a range of concentrations of Pg
Treatment Total pfu/cell No. of plates pfu/cell (treated)
x ± S.D. per condition pfu/cell (control)
HSV-2 alone 9.5 ± 1.0 3 1.0
HSV-2 + 10_9M Pg 12.0 ± 1.0 3 1.3
HSV-2 + 10_7M Pg 11.0 ± 0.7 3 1.2
C. Effect of the combination of E 2 and Pg
Treatment Total pfu/cell No. of plates pfu/cell (treated)
x ± S.D. per condition pfu/fell (control)
HSV-2 alone 10.5 ± 1.9 3 1.0
HSV-2 + 10“9M E 2 14.0 ± 0.5 3 1.3
HSV-2 + 10-9M Pg 9.0 ± 0.9 3 0.9
HSV-2 + 10_9M 9.5 ± 1.4 3 0.9
(E2 + Pg)
TABLE 3.2
Replication of HSV-2 in ZR-75-1 cells
Effect of E 2 and Pg
Total pfu/cell No. plates pfu/cell (treated)
x ± S.D. per condition pfu/cell (control)
HSV-2 alone 23 ± 4.0 3 1.0
-9
HSV-2 + 10 M E 2 30 ± 6.0 3 1.3
HSV-2 + 10_8M E 2 28 ± 2.0 3 1.2
HSV-2 + 10-?M E 2 25 ± 4.0 3 1.1
-9
HSV-2 + 10 M Pg 17 ± 0.5 3 0.7
HSV-2 + 10_8M Pg 23 ± 2.0 3 1.0
HSV-2 + 10"7M Pg 18 ± 0.5 3 0.8
ZR-75-1 cells were grown and maintained in 50 mm petri dishes as 
described in section 3.4.2 prior to the start of the experiment. 
Cells were treated ± a range of concentrations (see table) of E 2 
or Pg for 48h prior to infection with HSV-2. Triplicate dishes of 
cells were infected with HSV-2 at low multiplicity (1 pfu/cell) for 
18h in the continued presence of the same hormones. Cells were 
harvested, virus extracted and titrated as described for infected 
primary cervical cells in section 3.3.1. The results are expressed 
as total pfu/cell ± standard deviation (S.D.) and divided by the 
control value (i.e. HSV-2 alone) to give relative titre values.
Often the cells were contaminated with fungus, probably resulting from 
initial exposure to non-sterile conditions at the Pathology Department. 
This problem was largely overcome with the help of Dr. H. Kitchener 
who agreed to cut off a piece of cervix from the hysterectomy sample 
before it was sent to the Pathology Department.
3.4 STUDIES IN ZR-75-1 CELLS
3.4.1 Introduction
In light of the difficulties involved in culturing primary cervical 
cells, it was decided to use an established cell line in which the 
presence of steroid receptors was well characterized. Since no such 
cervical cell line was available, the breast cancer cell line, ZR-75-1 
(Engel et a l ♦, 1978) was chosen to study the interaction of steroid 
hormones and HSV-2.
3.4.2 Method
ZR-75-1 cells were seeded in 50 mm petri dishes at a density of 10^ cells
per dish in DMEM + 10% FCS and allowed to plate down for 18h. The
medium was then changed to DMEM + 2% HIDCC-FCS for 2 days prior to 
hormone treatment. Various concentrations of E 2 or Pg (table 3.2) 
were given 48h prior to infection and were present throughout the course 
of infection. The cells were infected at a m.o.i. of 1 pfu/cell for 
18h by which time the cells showed characteristic HSV c.p.e. Cells 
were harvested, virus extracted and titrated as described for primary 
cervical cells (3.3.1).
3.4.3 Results
ZR-75-1 cells were productively infected (table 3.2) yielding a burst 
size of 20 pfu/cell. There was no significant difference in virus 
titre between control and hormone-treated cells.
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3.5 CONCLUSIONS
Neither physiological (10 % ,  10 8M). nor pharmacological (10_7M, 10-6>1) 
concentrations of E 2 or Pg have a significant effect on the growth of 
HSV-2 in primary cultures of cervical cells or in the breast cancer 
cell line, ZR-75-1 at low multiplicity of HSV-2 infection.
3.6 DISCUSSION
As already described in secion Cl.5, a limited number of studies have 
been carried out on the effect of steroid hormones on virus growth 
both in vivo and in vitro. The in vitro studies often used pharmaca- 
logical doses of hormones and a wide variety of cell types. For 
example, Gupta and Rapp (1977) reported an inhibition of HSV-2 induced 
transformation of tk_ mouse cells to the tk+ phenotype in the presence 
of 10~8M E 2. Higher concentrations of E 2 had no effect. Concentrations 
of 10-8M are extremely unlikely to occur in vivo. Normal plasma levels 
of E 2 are around 10- -^8M. Plasma levels of E 2 can be up to 5 x 10-7M 
if E 2 is being taken in the form of drugs. Rapp and Turner (1979) 
reported no significant enhancement of plaque production by HSV-1 
or HSV-2 in human embryo fibroblast cells or in primary rabbit 
kidnev cells treated with DES but an increased frequency of tk trans­
formation by HSV-1 and HSV-2 in cells pretreated with DES at concent­
rations of 10“ J to 10“8>1.
No studies on the effect of hormones on the growth of HSV in cervical 
cells have been reported. In view of the association of HSV-2 with 
CIN (section Cl.3), the influence of hormones in the normal growth and 
development of cervical tissue (section Cl.2) and the increased risk of 
developing CIN if using the contraceptive pill (a mixture of E 2 and Pg), 
(section Cl.1.3), it is important to establish whether the growth of 
HSV in cervical cells is affected by hormones.
The results of the studies presented here show that concentrations of 
E 2 or Pg in the range 10-8 to 10_C)M do not significantly affect the
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growth of HSV-2 either in primary cultures of cervical cells or in the 
breast cancer cell line, ZR-75-1. Significant differences are generally 
considered to be of an order of magnitude between "control” and "treated" 
cells. Such changes were not seen in the studies described here.
Although culturing primary cells is the closest in vitro system available 
for studying an analogous system in vivo, many other factors may influence 
the state of the cells in which the virus replicates. For example, 
it has been shown that stromal cells adjacent to breast epithelial 
cells secrete growth factors which then act on the neighbouring 
epithelial cells (Schor et a l . , 1987.). The same may be true of the 
cervix. Any interaction of stromal and epithelial cells in the cervix 
is not reproduced in primary culture of cervical explants as described 
here although it may be possible to develop a feeder-layer culture 
system to look at this question.
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4. EFFECT OF HORMONES ON HSV GENE EXPRESSION
4.1 INTRODUCTION
Activation of HSV IE gene expression occurs by interaction of the 
trans-inducing virion component, Vmw 65 with the "TAATGARAT" sequence 
found upstream of all HSV IE genes (Campbell et a l ., 1984). Vmw 65 
acts in association with cellular factors (Preston et a l ., in press). 
(Section Bl.6.3 describes the role of Vmw 65 in activation of HSV IE 
gene expression in more detail).
The HSV IE activator sequence shows some homology to the consensus 
sequence for PR binding (Mulvihill et a l ., 1982) in the 5'-flanking 
region of hormone responsive chicken oviduct genes:
Consensus Sequence
HSV IE activator TAATGARAT (R = purine)
PR binding site in 5'-flanking
A A A A
region of hormone responsive TACAA^CAGA^AAT^GAT (inverted
chicken oviduct genes orientation)
In view of this homology, it was decided to investigate if hormones 
could influence viral gene expression via the TAATGARAT activator 
sequence.
4.2 METHODS
4.2.1 Plasmi ds
Three plasmids, pLU'2, pLU4 and pLU'5 (Gaiiney et al . , 1985) were used 
in transfection experiments. These plasmids were constructed by Lindsay 
Whit ton in the Institute of Virology and were kindly donated by Dr. D.
Gaffney.
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FIG. 4.1 pLW PLASMID CONSTRUCTS
The description of the plasmids is given in the text (section 4.2.1).
pUC9
pLW2
CAT
pLW4
CAT
pLW5
CAT
Fig. 4.1 shows the plasmid constructs. The control plasmid is pLW2 
consisting of a pUC 9 backbone and the coding sequence of the 
chloramphenicol ac^etyl transferase (CAT) gene flanked on the 5'-side 
by a Sma J_/Sau 3A1 fragment of 210 bp from the promoter/leader region 
of HSV-2 IE mRNA -4/5 and on the 3'-side by a Sma _1/Xba J_ fragment of 
100 bp from the terminating sequence of HSV-2 IE mRNA -5. The plasmids 
pLW4 and pLW5 contain, in addition, a 179 bp Bgl 1/Ava J_l_ sequence 
from the intergenic region between IE mRNA's -3 and -4/5 containing 
three copies of TAATGARAT. The orientation of the central TAATGARAT 
element in pLW5 is inverted relative to the orientation in pLW4.
4.2.2 Cells
These experiments were done in the E R , PR positive breast cancer cell 
lines ZR-75-1 and MCF-7. Cells were seeded in 80 c m 2 flasks in DMEM 
+ 10% FCS and allowed to plate down overnight. The medium was changed 
to DMEM + 2% HIDCC-FCS for 2 days to reduce the level of endogenous 
steroids to a minimum. Cells were then maintained as controls in 
DMEM + 2% HIDCC-FCS or as hormone stimulated cells in DMEM + 2% HIDCC- 
FCS supplemented by the appropriate hormone.
4.2.3 Transfection of Cells and CAT Assay
Modulation of gene expression via the TAATGARAT sequence was assayed by 
measuring the level of expression of the reporter CAT gene after 
transfection of pLW2, pLW4 or pLW5 as described in sections 2.2.15 and 
2.2.17).
Fig. 4.2 shows the structure of [^CJ-chloramphenicol. Acetylation 
can occur at Cl or at C3 or on both Cl and C 3 . Chloramphenicol is 
acetylated to different extents depending on the CAT activity of the
cell extracts. Results are expressed as n moles acetylated chlorain-
phenicol/yg protein/h and divided by the control value (i.e. CAT 
expression in the absence oi hormones) to allow the relative values 
to be compared.
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4.3 ACTIVATION OF TAATGARAT BY SUPERINFECTION WITH UV-tsK
4.3.1 Method
The ability of the HSV virion component, Vmw 65, to modulate gene 
expression via the TAATGARAT sequence in ZR-75-1 cells was tested.
Cells were transfected with 20 pig pLW2 or pLW4 or pLW5. After 36h, 
the cells were exposed to the trans-inducing virion component by 
superinfecting the cells with UV-irradiated tsK, which does not 
transcribe viral genes. (tsK virus was UV-irradiated with an Englehard 
Hanovia lamp - model 16, operated at 15 watts and 30 mA at a height of
27.5 cm above the sample for 30 min). Cytosol extracts were made and 
assayed for CAT activity as previously described (sect ions 2.2.15, 2.2.17).
4.3.2 Results
The results are shown in fig. 4.3 and table 4.1.
Super infection by UV-tsK of cells transfected with pLW4 or pLW5 
resulted in approximately 3-fold stimulation of CAT activity compared 
with non-infected cells. Superinfection of cells transfected with the 
control plasmid, pLW2, did not stimulate the basal level of CAT activity.
4.3.3 Cone!usi on
Plasmid directed CAT expression in ZR-75-1 cells is activated 3-fold by 
the HSV virion when the TAATGARAT sequence is present in either orientation.
4.3.4 Dlscussi on
The levels of CAT activity expressed in pLW4- and pEW5- transformed 
ZR-75-1 cells were stimulated 3-fold in the presence of thr' HSV virion 
supplied by UV-tsK (fig. 4.3 and table 4.1). The virus was UV- 
irradiated to inactivate transcription. Thus any effect of t sK was 
due only to the presence of the virion. The plasmids, pEV4 and pLW5 
contain TAATGARAT elements in inverse orientation. Thus tsK was able1
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FIG. 4.3 CAT ASSAY SHOWING ACTIVATION OF TAATGARAT BY n v - ^  
IN ZR-75-1 CELLS
The experiment was carried out as described in the legend to 
table 4.1.
The samples were spotted onto TLC paper at the origin (ori),
The positions of unconverted chloramphenicol (CAP), chloramphenicol 
acetylated at Cl (1-ac) and C3 (3-ac) after ascending chromatographv 
and autoradiography are shown.
<------- 1 s K ------- )
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TABLE 4.1
Activation of TAATGARAT by UV-tsK in ZR-75-1 cells
Treatment % [14C]-CM
acetylated/
assay
(Protein]
Ug/assay
Acetylated
[U C]-CM
nmoles/pig/h
Fold
Stimulation 
by UV-tsK
PLW2 48 3.90 1.00 1.0
PLW4 32 3.75 0.70 1.0
PLW5 18 3.63 0.41 1.0
PLW2 + UV-tsK 40 4.55 0.72 0.7
PLW4 + UV-tsK 99 4.40 1.85 2.6
PLW5 + UV-tsK 71 4.35 1.34 3.3
ZR-75-1 cells were grown and maintained in 80 c m 2 flasks as described 
in section 4.2.2. Duplicate flasks of cells were transfected with 
20 ug pLW2, pLW4 or pLW5 as described in section 2.2.15. Plasmids 
are described in section 4.2.1 and illustrated in fig. 4.1.
Cells were incubated at 37°C for 3 6 h , then transferred to 38.5°C.
One set of flasks was superinfected with UV-tsK (10 pfu/cell) for 12h.
The other set of flasks were maintained at 38.5°C. Cells were harvested, 
cytosol extracts made and assayed for protein concentration and CAT 
activity as described in sections 2.2.15 - 2.2.17. Results are 
expressed as n moles acetylated [14C]-chloramphenicol (CM)/ug protein/h. 
The "fold" stimulation induced by UV-tsK was calculated relative to 
the CAT specific activity of the cell extracts not superinfected.
to activate the TAATGARAT element in both orientations. These results 
agree with those of Gaffney et a l . (1985) who found that pLW4- and pLW5- 
transformed HeLa cells were stimulated 4-fold by superinfection with 
tsK whereas pLW2- transformed HeLa cells were not stimulated by tsK 
superinfection.
A.4 EFFECT OF E 2 AND PROGESTERONE (Pg) ON THE EXPRESSION OF
pLW2, pLW4 AND pLW5 IN ZR-75-1 AND MCF-7 CELLS
4.4.1 Method
Cells were grown and maintained as described in section 4.2.2 prior to 
the start of the experiments. Cells were then treated as shown below:
Treatment Days 1 and 2 Days 3 and 4 Days 5 and 6
Control - - -
E 2 - 1CT8M e 2 1CT8M E 2
Pg 10_8M E 2 10“8M Pg 1CT8M Pg
Cells were transfected with 20 yg pLW2, pLW4 or pLW5 on day 5 and 
harvested on day 7.
4.4.2 ResuIts
The results are shown in table 4.2. The majority of experiments were 
done in ZR-75-1 cells but some experiments were also done in MCF-7 cells. 
A typical example of a CAT assay result is shown in fig. 4.4.
No consistent modulation of CAT expression by E 2 or Pg was observed.
The results varied among experiments as is indicated by some high 
standard deviations (table 4.2). In some cases, transfection of the 
pLW plasmids in the presence of hormones led to a small stimulation of 
CAT expression. However, such increases occurred with pLW2, which 
does not contain the TAATGARAT element (table 4.2), as well as with
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TABLE 4.2
Comparison of the Levels of Expression of pLW2, pLW4 and pL\o
in the Presence and Absence of Hormones
ZR-75-1 cells (table A) and MCF-7 cells (table B) were grown 
and maintained in 80 c m 2 flasks as described in section 4.2.2. 
Cells were treated as described in section 4.4.1. Cytosol 
extracts were prepared and assayed for protein concentration 
and CAT activity as described in sections 2.2.15 - 2.2.17.
The activity of each cell extract was expressed as n moles 
acetylated chloramphenicol/tig protein/h. The activities of the 
hormone treated extracts were expressed relative to the activi­
ties of the extracts not treated with hormones (given a value 
of 1.0). The results in the table show the mean values and 
standard deviations of several experiments. The number of 
experiments is shown in brackets.
TABLE 4.2
Comparison of the Levels of Expression of pLW2, pLV/4 and pLW5
in the Presence and Absence of Kcrcones
A. ZR-75-1 cells
pLW2 pLW2 + E 2 pLW2 + Pg
1.0 1.6 ± 1.3 (5) 2.2 ± 2.0 (5)
pLW4 pLW4 + E 2 pLW4 + Pg
1.0 i.l ± 0.4 (5) 1.0 ± 0.6 (5)
pLW5 pLW5 + E 2 pLW5 + Pg
1.0 0.8 ± 0.3 (5) 0.7 ± 0.4 (5)
B. MCF-7 cells
pLW2 pLW2 + E 2
1.0 1.6 ± 1 (3)
pLW4 pLW4 + E 2 pLW4 + Pg
1.0 1.4 ± 0.4 (3) 2.1 *
pLW5 pLW5 + E 2 pLW5 + Pg
1.0 1.0 ± 0.2 (3) 1.0 *
mean of 2 experiments
FIG. 4.4 CAT ASSAY OF CYTOSOL EXTRACTS FROM ZR-75-1 CELLS
TRANSFECTED WITH pLW2, pLW4 OR pLW5 IN THE PRESENCE 
AND ABSENCE OF E? OR Pg
The experiment was carried out as described in the legend to 
table 4.2.
The samples were spotted onto TLC paper at the origin (ori).
The positions of unconverted chloramphenicol (CAP), chloramphenicol 
acetylated at Cl (1-ac) and C3 (3-ac) after ascending chromatography 
and autoradiography are shown.

pLW4, which does contain the TAATGARAT sequence (e.g. fig. 4.4, track 5). 
Thus any specific effects of the hormones on CAT expression could not 
be linked to the presence of the HSV activator sequence, TAATGARAT.
4.4.3 Conclusion
In the system described here, there is no evidence for a consistent 
modulation of gene expression by hormones in the presence of the HSV 
IE activator sequence, TAATGARAT.
4.4.4 Discussion
The results of section 4.4. show no consistent modulation of CAT 
activity by E 2 or Pg in the presence of the TAATGARAT element. E 2 
induces synthesis of the PR in vivo (Hsueh et a l ., 1975) and in vitro 
(Horwitz and McGuire, 1978a). Therefore, cells to be treated with Pg 
were prestimulated with E 2 to increase the level of PR in the cell.
PR, in the presence or absence of its ligand, was not able to activate 
the TAATGARAT element.
These experiments were dependent on high levels of PR being induced by 
E 2, efficient transfection of pLW plasmids and the ability of the PR to 
recognize the TAATGARAT element in the environment of flanking HSV 
sequences. In the context of the HSV genome, the activity of the 
TAATGARAT element is modulated by flanking sequences (Bzik and Preston, 
1986). It is perhaps not surprising that the TAATGARAT element, which 
is only partially homologous to the consensus sequence for the PR 
binding site in the 5 '-flanking region of chicken oviduct genes (section 
4.1) is either insufficient by itself or is not flanked by the correct 
sequences to be recognized by the PR. It may also be that there are 
different sequence requirements or cellular factors involved in PR 
recognition of its target sequence in chicken and human cells. It may 
be that the chromatin configuration of the plasmid sequence is not the 
same as that required in vivo.
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The problem of inducing reproducibly high levels of PR by E a could be 
overcome by cotransfecting an expression vector containing the coding 
sequence of the PR under the control of a strong promoter along with 
the pLW plasmids. Such expression vectors have been described for the 
chicken PR (Conneely et a l ., 1987; Gronemeyer et a l ., 1987).
4.5 BINDING OF NUCLEAR PROTEINS IN ZR-75-1 AND MCF-7 CELLS
TO TAATGARAT DN A .
4.5.1 Introduction
Vmw 65 interacts indirectly with the TAATGARAT sequence via a cellular 
protein(s), (Kristie and Roizman, 1987; Preston et a l ., in press), 
present in HeLa cells. Since the transfection experiments described in 
section 4.4 were done in ZR-75-1 and MCF-7 cells, it was decided to 
investigate if the cellular factor(s) required to form the TAATGARAT/
Vmw 65/ cellular protein(s) complex was present in these cells. It 
was also of interest to know if the presence of E? influenced the 
formation of a TAATGARAT/protein complex. For example, E? may increase 
the level of a cellular factor involved in the interaction with 
TAATGARAT.
4.5.2 Method
Cells were grown in 850 c m 2 plastic roller bottles in DMEM + 10% FCS.
When the cells were approximately 70% confluent, the medium was changed 
to DMEM + 2% HIDCC-FCS for 2 days. Cells were then maintained as 
controls, treated with lCT^M E j for 48h or infected with HSV-2 for 8h 
at 37°C. Nuclear extracts were prepared as described in section 2.2.12.
Gel retardation assays (section 2.2.33) were used to look at complex 
formation between nuclear protein from ZR-75-1 and MCF-7 cells and the 
[y-32P]-labelled oligonucleotide (19 bp, double-stranded) containing 
one copy of the TAATGARAT element, as shown below:
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5'- TTCGTGGTAATGAGATGCC -3' 
AAGCACCATTACTCTACGG
Binding reactions were done in the presence of 50 mM NaCl and excess 
non-specific competitor poly dA.dT/poly dG.dC DNA (section 2.2.33.1). 
DNA/protein complexes were separated from unbound DNA on an 85 
polyacrylamide gel (section 2.2.22).
A .5.3 Results
A .5.3.1 Titration of Nuclear Proteins from ZR-75-1 Cells that 
Complex with TAATGARAT DNA
The results of titrating increasing amounts of nuclear protein from 
ZR-75-1 control, Ei-stimulated and HSV-2 infected cells are shown in 
fig. A.5. In each case, as more protein is added, more complex is 
formed as is shown by the increasing intensity of the upper protein/DNA 
bands on the autoradiograph. Two major bands are seen running close 
together near the top of the gel and are likely to represent the major 
cellular protein complex(es) formed with TAATGARAT DNA. Two lower, 
fainter bands may represent non-specific binding of cellular proteins 
to TAATGARAT. Alternatively, the presence of minor bands may represent 
oligomeric complexes or different cellular factors bound to TAATGARAT. 
No obvious differences in binding pattern were seen in control and E 2- 
stimulated cells. An extra band running below the two major bands was 
seen in the HSV-2 infected track, suggesting the presence of an HSV 
specific protein in a TAATGARAT/protein complex.
A .5.3.2 Titration of Nuclear Proteins from MCF-7 Galls that 
Complex with TAATGARAT DNA
The results of titrating increasing amounts of nuclear protein from 
MCF-7 control and Ea-stimulated cells are shown in fig. A.A. In each 
case, as more protein is added, more complex is formed as is shown by 
the increasing intensity of the protein/DNA band on the autoradiograph.
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FIG. 4.5 TITRATION OF NUCLEAR EXTRACTS FROM ZR-75-1 CELLS
(± E 2 OR HSV-2) WITH TAATGARAT DNA 
The experiment was carried out as described in section 4.5.2.
Z R - 7 5 - 1
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FIG. 4.6 TITRATION OF NUCLEAR EXTRACTS FROM MCF-7 CELLS (± EO
WITH TAATGARAT DNA 
The experiment was carried out as described in section 4.5.2.
Only one strong band is seen representing the interaction of TAATGARAT 
DNA with cellular protein(s). No obvious differences were seen in the 
binding pattern in control and E 2-stimulated cell extracts.
4.5.4 Specificity of the TAATGARAT Binding Reaction
4.5.4.1 Method
The ability of excess unlabelled TAATGARAT DNA to compete with radio­
labelled TAATGARAT probe for binding to cellular proteins was tested.
20 pg protein extract was incubated with 0.2 ng radiolabelled probe 
and 0-, 150- or 300- fold excess of unlabelled probe in the DNA 
binding reaction described in section 2.2.33.1.
4.5.4.2 Results
The results are shown in fig. 4.7. Exact resolution of the major band 
was not accomplished in this gel. However, on the basis of the previous 
results (figs. 4.5 and 4.6), it is probable that the ZR-75-1 major 
band is in fact a doublet and the MCF-7 band is a single band. The 
MCF-7 band appears in the same position on the gel as the top band in 
the ZR-75-1 extracts (fig. 4.7).
The presence of unlabelled probe greatly reduced the intensity of the 
top band in MCF-7 and ZR-75-1 extracts (fig. 4.7) indicating that these 
complexes contain at least some specific protein(s) binding to 
TAATGARAT. If a second, lower band was present in the ZR-75-1 major 
complex in the uncompeted tracks, it was completely abolished in the 
presence of excess unlabelled TAATGARAT DNA, indicating complete 
specificity for TAATGARAT DNA. The minor faint bands present in each 
of the ZR-75-1 cell extracts were unaffected by excess unlabelled 
competing TAATGARAT DNA as was the extra band in HSV-2 infected cell 
extracts, suggesting that these bands represent non-specific binding.
FIG. 4.7 COMPETITION OF TAATGARAT / PROTEIN BINDING IN ZR-75-1 
AND MCF-7 NUCLEAR EXTRACTS (± E. OR HSV-2)
The experiment was carried out as described in section 4.5.4.1
The 'fold' excess competitor unlabelled TAATGARAT DNA is shown at 
the bottom of the figure.
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4.5.5 Conclusions
1. Both ZR-75-1 and MCF-7 cells contain a cellular factor(s) which 
forms a specific complex with TAATGARAT DNA.
2. The cellular factor(s) involved in binding TAATGARAT DNA is not 
induced by E 2 or HSV-2.
3. An extra complex forms with HSV infected ZR-75-1 cell extracts 
compared with control cell extracts but this band is not specific 
for TAATGARAT DNA.
4. The pattern of protein/DNA complexes formed with ZR-75-1 and 
MCF-7 extracts are different although both types of cell form 
a similar major complex with TAATGARAT DNA. More bands are 
present in ZR-75-1 gels than in MCF-7 gels, indicating the 
presence of different cellular factors.
4.5.6 Discussion
The results of section 4.5 show competable binding of host cell factors 
in ZR-75-1 and MCF-7 cells to TAATGARAT DNA. A major, slow-migrating, 
protein concentration dependent band is seen in gel retardation assays 
of protein/DNA complexes formed from MCF-7 cell extracts. This band 
appears as a doublet in ZR-75-1 cell extracts in the gels shown here.
A lower percentage polyacrylamide gel would be required to resolve 
these bands further.
The top band in the ZR-75-1 cell extracts has the same mobility as the 
major band in the MCF-7 cell extracts. In both cases, this band is 
competed, although not abolished, by the presence of unlabelled 
TAATGARAT DNA. The second band in the ZR-75-1 doublet is completely 
abolished by excess competitor TAATGARAT DNA indicating that this band 
is totally specific for TAATGARAT DNA. The biological significance of 
an extra, TAATGARAT specific factor in ZR-75-1 cells compared to MCF-7 
cells is unknown. Minor bands present in ZR-75-1 cell extracts are not
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com peted by excess competitor TAATGARAT DNA and probably represent non­
specific binding. MCF-7 cell extracts do not show these minor complexes. 
This may be due to the presence of different cellular factors in the 
two cell lines.
The host cell factor(s) which complex with TAATGARAT DNA in ZR-75-1 
and MCF-7 cells is not induced by Ea. HSV-2 infected ZR-75-1 cell 
extracts form an extra complex not present in control or E 2 treated 
cell extracts. This complex runs as a band just below the major 
TAATGARAT bands. However, the band induced in HSV infected extracts 
is not competed by excess competitor TAATGARAT DNA, indicating that 
this band does not represent a specific complex with TAATGARAT DNA.
Instead, it probably represents binding between some abundant,
unidentified viral protein and TAATGARAT DNA.
These results are in agreement with those of Kristie and Roizman (1987)
who showed binding of host cell factors to TAATGARAT DNA in uninfected 
and HSV-1 infected HeLa cell extracts. No specific virus induced 
complex was observed. In contrast, Preston et a l .(in press) have 
recently identified a novel, virus induced complex consisting of HeLa 
cell factors, the HSV virion component Vmw 65 and TAATGARAT DNA. This 
is a large, slow-migrating complex, possibly containing several 
cellular proteins, which is only seen in low percentage (<■ 3.5%) 
polyacrylamide gels. This may explain why such a complex was not seen 
in the system described here using 8% polyacrylamide gels.
The results of TAATGARAT binding studies with E 2 stimulated cell 
extracts show no effect of E 2 on protein binding to TAATGARAT DNA. It 
is unlikely therefore that E 2 induces the PR or some other cellular 
protein to interact with the TAATGARAT sequence. Complex formation in 
the presence of Pg was not tested. It is possible that although E 2 
can induce the PR, the "empty" receptor does not recognize the TAATGARAT 
sequence but requires the presence of its ligand. However, it seems 
more likely that the PR simply does not recognize the TAATGARAT sequence 
since there is only a partial homology between the TAATGARAT sequence 
and the sequence for binding PR in chicken oviduct r °sponsive genes
116
(section 4.1) and as both are consensus sequences.
As already discussed (section 4.4.4), the core and/or flanking DNA 
sequences required for recognition and binding of the human and 
chicken PR's may be different. Moreover, different cellular factors 
may be present in the chicken oviduct than in human cells, affecting 
binding of PR to its target sequence. There may also be a problem of
inducing high enough levels of receptor for these binding studies.
An expression vector for PR (as previously discussed in section 4.4.4)
may help to overcome this problem.
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5. EFFECT OF E2 AND HSV ON STEROID RECEPTOR LEVELS
5.1 INTRODUCTION
Modulation of cellular ER and PR levels in response to E 2 stimulation
and the importance of such changes in the physiological action of 
oestrogen have been extensively studied in the immature rat uterus and 
in MCF-7 cells (reviewed by Kassis and Gorski, 1983; see also sections 
A1.4 and A1.5). Changes in ER and PR levels, induced by E 2, involve 
recycling, synthesis and/or processing of the ER. E 2 also induces
synthesis of the PR in the rat uterus (Hsueh et a l ., 1975) and in 
MCF-7 cells (Horwitz and McGuire, 1978a).
HSV selectively stimulates the expression of certain cellular 
polypeptides, notably the heat shock proteins (Notarianni and Preston,
1982; LaThangue et a l ., 1984) as well as other cellular polypeptides 
whose precise functions have not yet been identified but which may be 
linked to the process of transformation (Macnab et a l ., 1985).
Receptors play a central role in steroid hormone action. The ability 
of HSV to directly modulate the sensitivity of the host cell for E 2 
by affecting ER and PR levels was tested in MCF-7 and ZR-75-1 cells.
5.2 METHOD
5.2.1 Treatment of Cells
Cells were grown in 175 c m 2 flasks in DMEM + 10% FCS until about 50% 
confluent. The cells were maintained in serum-free medium for 2 days 
and thereafter in DMEM + 2% HIDCC-FCS. Cells were then treated as follows:
Control Maintained in DMEM + 2% HIDCC-FCS
Maintained in DMEM + 2% HIDCC-FCS supplemented by 
10~8M E 2 for 4 8 h .
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HSV Maintained in DMEM + 2% HIDCC-FCS for a total of 
48h, including the time of virus infection (1 pfu/ 
cell for 16h or 10 pfu/cell for 4 -  6 h).
HSV + E 2 Maintained in DMEM + 2% HIDCC-FCS supplemented by
10-®M Ea for a total of 48h, including the time of 
virus infection (1 pfu/cell for 16h or 10 pfu/cell 
for 4 - 6 h ) .
Cells were harvested and assayed for ER and/or PR as described in 
sections 2.2.34 - 2.2.37 -and outlined briefly below:
5.2.2 "Whole Cell” [3H]-Steroid Exchange Assay
Details of this method are given in section 2.2.35.
Whole cell suspensions were prepared in HED buffer containing 1.5 mM 
MgCl2 to help maintain the cell integrity. For PR assays, 10% 
glycerol was added to the buffer to help stabilize the PR. "Two-point" 
[3H]-steroid exchange assays were carried out as full Scatchard analysis 
required too many cells and was difficult to handle for the number of 
conditions tested. Steroid bound to receptor was separated from free 
steroid by Millipore filtration through nitrocellulose filters in the 
presence of 0.9M N aCl. The specific counts incorporated into [3H]- 
steroid receptor complexes were determined by scintillation counting.
The protein content of the cellular suspension was determined by 
Bio-Rad assay (section 2.2.16). Receptor results were calculated as 
fmol/mg protein and expressed as a percentage relative to control values.
j •2.3 Cytosol [3Hl~Steroid Exchange Assay
Cells were harvested and resuspended in HED buffer. Cells were disrupted 
by sonication and cell debris and nuclei pelleted by centrifugation
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(section 2.2.36). A "two-point” [3H]-steroid exchange assay was set 
up as described above using cytosol rather than a whole cell suspension. 
Steroid bound to receptor was separated from unbound steroid by 
incubation with dextran-coated charcoal which absorbs the free steroid. 
Results were calculated in a manner similar to that described for the 
whole cell assay (5.2.2.1).
5.2.4 Abbott ER EIA (Enzyme Immunoassay)
The EIA assays were kindly done by Sheila Cowan or Jackie Courtney in 
Lab C6, Department of Biochemistry. Details of the procedure are given 
in the manual accompanying the EIA kit. The anti-ER antibodies are 
described by Greene et a l . (1984). The kit is a "sandwich" assay 
involving incubation of cell cytosol with beads coated with the ER 
monoclonal antibody, D 5 4 7 , followed by washing and the addition of a 
second, different anti-ER antibody (H222 - recognizes an epitope in 
the steroid - binding domain) to which is attached the peroxidase 
enzyme for colour development. Samples of cell cytosol were prepared 
at the same time and in the same way as for the [3H]-steroid exchange 
DCC assay. Sonication of cells allowed exposure of the ER antigenic 
sites for detection by the anti-ER antibody.
5.3 RESULTS
5.3.1 Assay of Total ER and PR Levels in ZR-75-1 Cells
Treated with Ea and/or HSV-2
Results from two separate experiments (out of a total of four independ­
ent experiments) on ZR-75-1 cells are shown in tables 5.1 and 5.2.
Cells were treated with lCT^M E? for 48h and/or infected with HSV-2 
for 16h (time used for replication experiments in section 3) at low 
multiplicity (1 pfu/cell). Whole cell [3H]-steroid exchange assays 
were used to measure the relative levels of ER and PR.
The results in table 5.1 show a significant drop in ER level to
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TABLE 5.1
Effect of E 2 and/or HSV-2 on Total ER and PR Levels in ZR-75-1 
Cells: Example 1
Growth and pretreatment of cells is described in section 5.2.1. 
Cells were treated as follows (as described in section 5.2.1):
Control maintained as controls
E 2 treated with 10“^M E 2 alone for 48h
HSV-2 maintained as controls for 32h, then infected with
HSV-2 (1 pfu/cell) for 16h
HSV-2 treated with lCP^M e 2 for 32h, then infected with
+ HSV-2 (1 pfu/cell) for 16h in the continued
presence of 1 0 ~ %  E 2
Cells were harvested and assayed for ER and PR by a "whole cell" 
[3H]-steroid exchange assay (section 2.2.35). The protein 
concentrations of the extracts were estimated by Bio-Rad assay 
(section 2.2.16). Receptor concentrations were calculated in 
f mol/mg protein and expressed as percentages of the control 
value (taken as 100%).
The ER results are shown in table A.
The PR results are shown in table B.
TABLE 5.1
Effect of E2 and/or HSV-2 on total ER and PR levels in ZR-75-1 cells:
Example 1
A. ER Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER] 
fmol/mg
[ER] as 
% of control
Control 195 0.50 390 100
E, 18 0.69 26 7
HSV-2 32 0.77 42 11
HSV-2 + E 2 51 1.60 32 8
B. PR Results
Treatment [PR]
fmol/ml
[protein ] 
mg/ml
r do ]Li iv J
fmol/mg
[PR] as 
% of control
Control 106 0 .5 0 212 100
e 2 577 0 .6 9 836 394
HSV-2 39 0 .7 7 51 24
HSV-2 + E2 358 1 .6 0 224 106
TABLE 5.2
Effect of E 2 and/or HSV-2 on total ER and PR levels in ZR-75-1 cells: 
Example 2
A. ER Results
Treatment [ER]
fmol/ml
[ protein ] 
mg/ml
[ER]
fmol/mg
JER] as 
% of control
Control 135 0.50 270 100
E2 36 1.04 35 13
HSV-2 22 0.52 42 16
HSV-2 + E 2 23 1.43 16 6
B. PR Results
Treatment [PR]
fmol/ml
[protein] 
mg/ml
[PR]
fmol/mg
[PR] as 
% of control
Control 47 0.50
•
94 100
e 2 680 1.04 654 696
HSV-2 33 0.52 63 67
HSV-2 + S 2 495 1.43 346 368
Cells were treated and results calculated exactly as described in 
the legend to table 5.1.
approximately 10% of the control value in the presence of E 2 or HSV-2 
alone or in combination. The level of PR in the same cells is increased 
to approximately 400% of the control level by E 2 but is reduced to 20% 
of the control level by HSV-2 infection. When both E 2 and HSV-2 are 
present, the level of PR is the same as in the control value. Thus 
the expected stimulation of PR by E 2 is observed, confirming that the 
cells are behaving as predicted from previous studies. Yet, PR synthe­
sis is inhibited by HSV-2.
In the second experiment, the same general pattern of response to E 2 
and HSV-2 in ZR-75-1 cells is seen (table 5.2). E 2 and HSV-2 alone 
reduced the level of ER to 13% and 16% respectively. In combination.
Es and HSV-2 reduced the level of ER further to 6% of the control value.
E2 stimulated the level of PR (700% of control). HSV-2 reduced the 
level of PR (70% of control) and reduced the increase of PR induced by 
E2 (370% of control) when present together with E 2.
5.3.2 Comparison of the Effects of E 2 and HSV-2 on Total ER 
Levels in ZR-75-1 and MCF-7 Cells
The results of treating ZR-75-1 and MCF-7 cells with 10“®M E? for 48h 
and/or infection with HSV-2 at 10 pfu/cell for 4h are shown in table 5.3.
As found previously (tables 5.1 and 5.2), treatment of ZR-75-1 cells 
with E 2 alone or in combination with HSV-2 caused a drop in ER levels 
to 10% of the control value (table 5.3A). In this particular experiment, 
HSV-2 alone only reduced the ER level to 70% of the control value rather 
than the 10% value found previously (table 5.1).
The results in MCF-7 cells (table 5.3B) show a similar pattern of 
response to E 2 and HSV-2 as for ZR-75-1 cells (tables 5.1 to 5.3A).
H2 alone caused the level of ER to fall to 10% of the control value.
HSV—2 alone resulted in a 50% drop in ER level. The combination of 
E* and HSV-2 reduced the ER level to 20% of the control value.
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TABLE 5.3
Comparison of the effects of E 2 and HSV-2 on 
total ER levels in ZR-75-1 and MCF-7 cells
Growth and pretreatment of ZR-75-1 cells (table A) and MCF-7 
cells (table B) is described in section 5.2.1. Cells were 
treated as follows (as described in section 5.2.1):
Control maintained as controls in DMEM + 2% HIDCC-FCS
E 2 treated with 10-8M Ea alone for 48h
HSV-2 maintained as controls for 44h, then infected with
HSV-2 (10 pfu/cell) for 4h
HSV-2 treated with 10-8M E 2 for 44h, then infected with
+ E 2 HSV-2 (10 pfu/cell) for 4h in the continued presence
of 10-8M E 2
Cells were harvested and assayed for ER by the "whole cell"
[ H]-steroid exchange assay (section 2.2.35). The protein 
concentrations of the extracts were estimated by Bio-Rad 
assay (section 2.2.16). Receptor concentrations were 
calculated in f mol/mg protein and expressed as percentages of 
the control value (taken as 100%).
The ER results for ZR-75-1 cells are shown in table A.
The ER results for MCF-7 cells are shown in table B.
TABLE 5.3
Comparison of the effects of E 2 and HSV-2 on 
total ER levels in ZR-75-1 and MCF-7 cells
A. ZR-75-1
Treatment of 
ZR-75-1 cells
[ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 284 0.88 323 100
e 2 31 0.90 34 11
HSV-2 263 1.10 239 74
HSV-2 + E 2 35 1.40 25 8
B. MCF-7
Treatment of 
MCF-7 cells
[ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 313 0.22 1423 100
e 2 37 0.25 148 10
HSV-2 486 0.70 694 50
HSV-2 + E 2 188 0.76 247 20
5.3.3 Conclusions
1. Treatment of cells with E 2 and/or infection with HSV-2 results
in a reduction of total ER levels to 10% of the control level.
2. The Ea-induced stimulation of PR is reduced by HSV-2 infection.
3. HSV-2 infection alone results in a reduction of total PR levels.
5.3.4 Discussion
It is possible that the reduction in ER levels seen in response to E 2 
and/or HSV infection is due to interference of these agents with the 
[3H]-steroid exchange assay. For example, the presence of E 2 in the 
medium of the cells before harvesting may be competing with [3H]-E2 
for ER binding. HSV may also be interfering with the exchange of 
[3H]-E2 and endogenous E 2 . To investigate this further, immunological 
and biochemical methods of assaying ER were compared in the following 
experiment (section 5.4).
U t  EFFECT OF E 2 AND HSV ON ER LEVELS MEASURED BY
IMMUNOLOGICAL AND BIOCHEMICAL METHODS
T-^.I Introduction
To test if the presence of exogenous E 2 in the medium of cells and/or 
the presence of HSV was interfering with the [3H]-steroid exchange 
assay, ER levels were measured by the DCC exchange assay and by the 
Abbott EIA method using a monoclonal antibody to the ER. The 
antibody should recognize both filled and available receptor.
1 ^ 2  Method
Cells were treated with E 2 and/or HSV as previously described (5.2.1).
Cells were disrupted by sonication and the cytosol split into aliquots
C°r the DCC assay, the EIA assay and the Bio-Rad protein assay.
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5.4.3 Results
The results of experiments done in ZR-75-1 and MCF-7 cells are shown in 
tables 5.A and 5.5 respectively. In all cases, E 2 and HSV-2 caused a 
reduction in ER levels. However, in the case of E 2 treatment, the 
loss of ER, measured by the EIA method (approximately 10 - 20 % - 
see tables 5.4A and 5.5A), was less than when ER levels were measured 
by the DCC assay (60% in ZR-75-1 cells, table 5.4B; 90% in MCF-7 cells, 
table 5.5B). In MCF-7 cells (table 5.5), the fall in ER levels 
induced by HSV-2 was 80% when assayed by either method. However, the 
results in ZR-75-1 cells (table 5.4) show a 95% fall in ER level 
measured by the EIA assay and a 70% fall measured by the DCC assay.
The results of a further experiment, including the effect of HSV-1 ±  E 2> 
HSV-2 + E 2 or E 2 alone on ER levels are shown in table 5.6. As found 
in previous experiments, cells treated with E 2, HSV-2, HSV-2 + E 2 all - 
resulted in a reduction of ER levels when measured by the DCC assay.
Table 5.6 extends these findings to include HSV-1 and HSV-1 + E 2 in the 
ability to reduce ER levels. In this experiment, E 2 was given for 6h, 
the same length of time as virus infection.
The results presented in table 5.6 confirm the results of table 5.5 
and table 5.4 that the ER levels assayed by the EIA method are higher 
than by the DCC assay. In this particular experiment (table 5.6), 
no reduction of ER levels after E 2 treatment was seen with the EIA 
method but a 70% reduction was seen by the DCC method. The marked 
reduction in ER levels, induced by HSV-1 or HSV-2 was observed using 
either the DCC assay or the EIA assay. In both assays there was a 
greater reduction of ER when both HSV (-1 or -2) and E 2 were present 
together than with either agent alone. In a previous experiment 
(table 5.1A), E 2, HSV-2 or E 2 + HSV-2 all gave comparable reductions 
in ER levels.
Ir/Lrii Conclusions
E 2 and/or HSV (-1 or -2) reduce the level of ER in ZR-75-1
and MCF-7 cells.
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TABLE 5.4
Effect of E? or HSV-2 on ER levels in ZR-75-1 cells
assayed by immunological and biochemical methods
Growth and pretreatment of ZR-75-1 cells is described in 
section 5.2.1. Cells were treated as follows (as described in 
secion 5.2.1):
Control maintained as controls in DMEM + 2% HIDCC-FCS 
E 2 treated with 10~®M E 2 for 48h
HSV-2 maintained as controls for 42h, then infected with
HSV-2 (10 pfu/cell) for6h.
Cells were harvested and assayed for ER by the enzyme immuno­
assay (EIA), (section 2.2.37) and by the dextran-coated 
charcoal (DCC) [3H]-steroid exchange assay (section 2.2.36). 
The protein concentrations of the extracts were estimated by 
Bio-Rad assay as described in section 2.2.16. The ER 
concentrations were calculated in f mol/mg protein and 
expressed as percentages of the control value (taken as 100%).
The results of the EIA assay are shown in table A.
The results of the DCC assay are shown in table B.
TABLE 5.4
Effect of E2 or HSV-2 on ER levels in ZR-75-1 cells
assayed by immunological and biochemical methods
A. EIA Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as % 
of control
Control 117 0.88 133 100
e 2 88 0.76 116 87
HSV-2 10.5 1.52 7 5
B. DCC Results
Treatment [ER] 
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as % 
of control
Control 58 0.88 66 100
E2 21 0.76 28 42
HSV-2 30 1.52 20 30
TABLE 5.5
Effect of E2 or HSV-2 on ER levels in MCF-7 cells
assayed by immunological and biochemical methods
A. EIA Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 495 1.47 337 100
E2 212 0.83 255 76
HSV-2 61 0.91 66 20
B. DCC Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 394 1.47 268 100
e 2 23 0.83 28 10
HSV-2 46 0.91 51 19
Growth and treatment of MCF-7 cells, assay of ER and calculation 
of results were exactly as described in the legend to table 5.4.
TABLE 5.6
Effect of HSV-1 or HSV-2 infection, alone or in combination with
E2 on ER levels in MCF-7 cells assayed by immunological and
biochemical methods
Growth and pretreatment of cells is described in section 5.2.1. 
Cells were treated as follows:
Control maintained as controls in DMEM + 2% HIDCC-FCS
E 2 treated with 10~^M E? for 6h
HSV-1 infected with HSV-1 (10 pfu/cell) for 6h
HSV-2 infected with HSV-2 (10 pfu/cell) for 6h
HSV-1 infected with HSV-1 (10 pfu/cell) for 6h
+ E 2 in the presence of 10~^M E 2
HSV-2 infected with HSV-2 (10 pfu/cell) for 6h
+ E 2 in the presence of 10~^M E 2
Cells were harvested and assayed for ER by the enzyme immuno­
assay (EIA) and by the dextran-coated charcoal (DCC) [ H]- 
steroid exchange assay (sections 2.2.37 and 2.2.36 respectively) 
The protein concentrations of the extracts were estimated by 
Bio-Rad assay (section 2.2.16). The ER concentrations are 
calculated in f mol/mg protein and expressed as percentages of 
the control value (taken as 100%).
The results of the EIA assay are shown in table A. 
The results of the DCC assay are shown in table B.
TABLE 5.6
Effect of HSV-1 or HSV-2 infection, alone or in combination with E? on
ER levels in MCF-7 cells assayed by immunological and biochemical methods
A. EIA Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 40 0.36 111 100
e 2 84 0.75 112 100
HSV-1 58 0.82 71 64
HSV-2 52 1.03 50 45
HSV-1 + E 2 43 1.13 38 34
HSV-2 + E 2 47 1.22 39 35
B. DCC Results
Treatment [ER]
fmol/ml
[protein] 
mg/ml
[ER]
fmol/mg
[ER] as 
% of control
Control 23 0. 36 64 100
Ea 17 0.75 23 36
HSV-1 13 0.82 16 25
HSV-2 2 1.03 2 3
HSV-1 + E. 7 1.13 6 9
HSV-2 + E 2 - 1.22 - -
2. ER levels measured by the EIA method are generally higher than 
ER levels measured by the DCC assay.
3. The reduction in ER levels induced by E 2 is less when measured
by the EIA method compared to the DCC method.
4. The reduction in ER levels induced by virus is either the same
or less by the EIA method compared to the DCC method.
5. The presence of E 2 together with HSV, in some cases, results in
a greater reduction in ER levels than with either E 2 or HSV alone.
6. The ER content of MCF-7 cells is greater than that of ZR-75-1 cells.
5.4.5 Discussion
The results and conclusions from the comparison of immunological and 
biochemical methods for quantitating the level of ER after E 2 treatment 
and/or HSV infection suggest that E 2 and possibly also HSV interfere 
with the [3H]-steroid exchange assay used here.
As discussed in section 5.3.4, it is possible that an excess of 
unlabelled E 2 is present in the E 2-stimulated cytosol which may 
compete with exogenous [3H]-E2 in the exchange assay for receptor 
binding, thus reducing the amount of detectable ER bound to E 2.
HSV may interfere with the exchange assay by modifying or complexing 
with the receptor so that the receptor is less able to bind [ H]-E2.
In one case (table 5.4), a higher percentage level of ER after 
HSV-2 infection was seen with the DCC assay than with the EIA assay. 
However, the results of other experiments (tables 5.5, 5.6) do not 
confirm this result.
In each case, the level of ER after E 2 treatment, measured by the EJA 
assay was greater than by the DCC assay whereas with HSV infection, the 
levels of ER were the same or different. Therefore HSV and E 2 do not 
affect the ER in the same way.
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The fact that higher levels of ER are detected (even in control cells) 
by the EIA method compared to the DCC method can be explained by the 
fact that the EIA method measures both "filled" and "unfilled" 
receptor and possibly also cross-reacts with antigens other than ER, 
whereas the DCC assay measures only "unfilled" receptor. MCF-7 cells 
show a higher endogenous ER level than ZR-75-1 cells by both assays, 
therefore this result is not due to the fact that the Abbott antibody 
was raised against the MCF-7 ER.
Interference with the exchange assay by E 2 or HSV does not fully account 
for the reduction in ER levels. The loss of receptor able to bind 
steroid after E 2 treatment has been termed "processing" and has been 
extensively studied in MCF-7 cells (reviewed by Kassis and Gorski, 1983; 
see also section A1.4). Horwitz and McGuire (1978c, 1980) described a 
70% loss in competable nuclear receptor within 3 - 5 h of E 2 stimulation 
of MCF-7 cells, not explained by a concomitant rise in cytoplasmic 
receptor. Induction of PR accompanies loss of ER (Horwitz and McGuire, 
1978a) although further studies have shown no direct correlation of PR 
induction with ER loss (Strobl et a l ., 1984). Antioestrogens allow 
accumulation of nuclear receptor complexes but inhibit processing 
(Horwitz and McGuire, 1978c). It is thought that processing of the 
ER is intimately associated with the mechanism of action of the ER 
complex in the nucleus (Kassis and Gorski, 1983).
The reduction in total ER levels induced by E 2 and/or HSV may be 
explained by processing of the receptor. Processed ER may still be 
detected by the EIA monoclonal antibody. Processing in MCF-7 cells 
involves both physical and kinetic modifications of the receptor, 
resulting in a less exchangeable form of the receptor (Kassid et a l . , 
1984). HSV and E 2 may cause similar or different modifications to the 
receptor. In support of the second possibility, the combination of 
E 2 and HSV sometimes results in a greater reduction in ER levels than 
with E 2 or HSV alone (tables 5.2A and 5.6 ). Moreover, E 2 induces 
the synthesis of PR whereas HSV reduces the level of PR and inhibits 
the E 2-induced synthesis of PR (tables 5.IB and 5.2B). Thus E 2 and HSV 
have different mechanisms of action. HSV may modify the PR in some way 
to make it less able to bind steroid.
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5.5 IN VITRO TRANSLATION OF mRNA AND ANALYSIS BY SDS 
POLYACRYLAMIDE GEL ELECTROPHORESIS
5.5.1 Introduction
In view of the results of sections 5.3 and 5.4 showing a decrease in 
the level of the ER protein after E 2 stimulation and HSV-1 or HSV-2 
infection, assayed by biochemical and immunological methods, it was 
decided to test the level of ER by a completely different method.
Total cytoplasmic RNA was extracted from E 2 stimulated and virus 
infected cells, translated in vitro using the rabbit reticulocyte 
lysate system and the resultant polypeptides analysed by SDS-PAGE.
5.5.2 Method
The method for RNA extraction is described in section 2.2.28.2.
The method for in vitro translation is described in section 2.2.29.
1 yg total, cytoplasmic RNA was translated in vitro and the amount of 
[35g]-methionine incorporated into each sample was taken as a measure of 
the relative amount of protein synthesized in each case. Equal amounts 
of total protein (50 000 cpm/sample) were denatured in IX "boiling mix" 
(section 2.2.24) in a boiling water bath for 3 min, cooled on ice and 
loaded onto a 7% single concentration SDS polyacrylamide gel as 
described in section 2.2.24.
5.5.3 Results
Fig. 5.1 shows the results of SDS-PAGE analysis of in vitro translated 
RNA from ZR-75-1 cells infected with HSV-2 for 0 - 14 h or stimulated 
with 10~8M E? for 6h and 12h. The accumulation of HSV-2 viral poly­
peptides [e.g. the major capsid protein (157K), the large subunit of 
ribonucleotide reductase (136K), the glycoprotein B (118K), the 65K 
DNA binding protein/virion trans-inducing factor (Vmw 65), 
the small subunit of ribonucleotide reductase (37.8 K ) ] can be clearly 
seen. The cellular actin band is also clearly visible (43K). In no case 
(i.e. control, E 2 stimulated or HSV-2 infected extracts) was any band
126
FIG. 5.1 IN VITRO TRANSLATION OF mRNA FROM ZR-75-1 CELLS AND
ANALYSIS OF TRANSLATED PROTEINS BY SDS-PAGE 
The experiment was carried out as described in section 5.5.2.
The numbers below the figure refer to the following conditions:
1. in vitro translation mix with no RNA added
2. cells maintained as controls in DMEM + 2% HIDCC
3. - 9. cells infected with HSV-2 for 0, 2, 4, 6, 8, 12 and 14 h
10. cells treated with 10“^M E 2 for 6h
11. cells treated with 10_^M E 2 for 12h
Samples 1 . - 3 .  and samples 4. - 11. were run on separate gels at the 
same time.
The position of the following proteins on the gel (reading top to 
bottom) are marked by dashed lines:
major capsid protein (157K)
large subunit of ribonucleotide reductase (136K) 
glycoprotein B (118K)
65Kd b p  / Vmw 65
actin (43K)
small subunit of ribonucleotide reductase (37.8K)
=3*3
c o r r e s p o n d i n g  to the ER protein of around 68K mol. w t . seen. Similar 
experiments were carried out with most of the MCF-7 RNA samples which 
showed elevated levels of the ER message on Northern blots (section 6).
In no case was the ER protein band observed, either when the in vitro
translated proteins were subjected to SDS-PAGE or when immunoprecipitated
with the same anti-ER monoclonal antibody (H222) as was used in the EIA 
assays (section 5.4).
(SDS-PAGE and immunoprecipitation experiments were kindly carried out 
by Dr. J. Macnab).
5.5.4 Conclusion
RNA, extracted from ZR-75-1 or MCF-7 cells and translated in vitro 
fails to show evidence of the ER protein as judged by SDS-PAGE and 
immunoprecipitation of the translated proteins.
5.5.5 Discussion
The failure to translate the ER message in vitro by the method described 
here is not peculiar to the ER. Results of Dr. J. Macnab (personal 
communication) have shown that in vitro translation of RNA from HSV 
infected and HSV transformed rat embryo cells does not result in the 
detection of the cellular 90K and 40K proteins shown, by SDS-PAGE and 
immunoprecipitation analysis, to be present in protein extracts from 
the same cells (Macnab et a l . , 1985). A possible explanation is that 
the proteins undergo post-translational modification (e.g. glycosylation 
or phosphorylation) so that the final form of the protein is different 
from the newly translated protein. Moreover, the antibody used in 
immunoprecipitation reactions may not recognize both forms of the 
same protein. This is especially possible in the case of the ER 
monoclonal antibody, raised against a single epitope. If post- 
translational modification occurs with the ER then the antibody probably 
recognizes the modified form , rather than the newly synthesized form 
of the receptor. Walter et a l . (1985) used a combination of four ER
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monoclonal antibodies and hybrid-selected ER mRNA for in vitro 
translation and immunoprecipitation of the ER protein. A protein of 
approximately 65 000 mol. w t . was observed. The difference between 
the results of Walter et a l . (1985) and the results described above 
may be due to the low abundance of the ER message in our system 
and the fact that only one monoclonal antibody was used.
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6. EFFECT OF HSV INFECTION ON ER mRNA LEVELS
6.1 INTRODUCTION
HSV infection increases the expression of a cellular gene at the level 
of transcription (Kemp et a l .,1986) as well as the expression of 
certain cellular polypeptides (as described in section Bl.7.2).
During the course of the present study on the interaction of steroid 
hormones and HSV, the ER cDNA was cloned and sequenced (Walter et a l ., 
1985; Green et a l . , 1986). The availability of an ER cDNA clone 
made it possible to study the effect of HSV infection on the ER at the 
level of transcription.
6.2 PROBES USED TO DETECT THE ER MESSAGE
6.2.1 Oligonucleotide Probes
Synthetic oligonucleotides were synthesized on a Biosearch 8600 DNA 
synthesizer by Dr. J. McLauchlan, Institute of Virology, Glasgow. 
Labelling of oligonucleotide probes is described in section 2.2.27.
Oligonucleotide 1
Prior to the availability of a cDNA clone and the complete ER mRNA 
sequence, an oligonucleotide representing the cDNA sequence of one of 
the A0R8 clones, described by Walter et a l . (1985), was synthesized 
and used as a probe for the ER message. Once the ER mRNA sequence 
was published (Green et a l ., 1986), the ER mRNA sequence corresponding 
to the synthetic oligonucleotide was identified as nucleotides +1810 to 
+1844 in the putative steroid binding domain of the ER. The sequence 
of oligonucleotide 1 is shown below:
3 '-ATG TCG TAC TTC ACG TTC TTG CAC CAC GCG GAG ATA-5'
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Oligonucleotide 2
Once the ER mRNA sequence was published (Green et a l . , 1986), a longer 
oligonucleotide (57 bases) representing the cDNA strand of the ER mRNA 
sequence between nucleotides +258 and +315 in the N-terminal domain of 
the ER was synthesized. The N-terminal domain is the least conserved 
among steroid receptors (Green and Chambon, 1986). The use of a 
longer oligonucleotide from the region least homologous to other steroid 
receptors as a probe should minimise the risk of non-specific hybridiz- 
tion. The sequence of oligonucleotide 2 is shown below:
3' -CGT AGA CCC TAC CGG GAT GAC GTA GTA TAG GTT CCC TTG CTC GAC CTC 
GGG GAC T T G - 5 '
6.2.2 cDNA Probe - 0R3
The plasmid, pOR3 (fig. 6.1) containing the 1.3 kb 0R3 cDNA insert 
(described by Green et a l . , 1986) cloned into the EcoRl site of pBR322 
was obtained from Professor Pierre Chambon. Purified, nick-translated 
0R3 DNA (section 2.2.26) was used to probe total mRNA in slot-blots 
and size fractionated mRNA in Northern blots.
6.3 SLOT-BLOTS WITH CRUDE CELL EXTRACTS
6.3.1 Introduction
Attempts were made initially to develop a method for looking at ER. 
levels in small numbers of ZR-75-1 or MCF-7 cells with a view to 
examining the effect of HSV infection on ER mRNA levels in primary 
cultures of cervical cells.
6.3.2 Method
ZR-75-1 or MCF-7 cells were seeded in 50 mm diameter petri dishes at a 
density of 10^ cells per dish in DMEM + 10% FCS and allowed to adhere 
overnight. Cells were maintained in DMEM + 2% HIDCC-FCS for 2 days
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FIG. 6.1 PLASMID pOR3 CONTAINING cDNA INSERT OF ER
The plasmid pOR3 was kindly donated by Professor P. Chambon.
The 1.3 kb 0R3 cDNA fragment is cloned into the Eco R1 site of the 
vector pBR 322.
Below the diagram of the plasmid pOR3, the A0R3 clone is shown in 
relation to MCF-7 ER mRNA (reproduced from Green et a l . , 1986). The 
MCF-7 ER mRNA is represented by a solid line beginning at nucleotide 
+1 (the cap site) and ending at nucleotide +6322. The open reading 
frame is denoted as a box beginning at nucleotide +2018. The region 
which contains the nucleotide sequence coding for the epitope (in the 
DNA - binding domain) recognized by the ER monoclonal antibody H226 
(Greene et a l ♦, 1984) is shown as a hatched box. The A0R3 clone 
(which reacts with the H226 antibody) is represented as an arrowed line.
23
3
FIG. 6.1 PLASMID pOR3 CONTAINING cDNA INSERT OF ER
Eco R1 Eco R1
pBR 322
+ +
00
o
CO
H 22 6
A 0 R 3
500bp
+ 
6
3
2
2
to reduce endogenous steroid levels to a minimum. Cells were then 
maintained as controls, treated with E 2 or infected with HSV-1 or HSV-2.
Crude cellular extracts were prepared by lysing the cells with the 
detergent NP AO and spinning down the nuclei and cell debris (2.2.28.1). 
Equal volumes of cell extract prepared from equal numbers of cells were 
denatured in formamide/formaldehyde/lOX SSC at 65°C for 5 min, then 
transferred to nitrocellulose membrane via a Shleicher & Schuell slot- 
blot apparatus (section 2.2.30.1). The membrane was baked at 80°C 
for 2h prior to hybridization with [y-32P]-ATP-labelled oligonucleotide 
1 or nick-translated 0R3 cDNA (sections 2.2.30.2 and 2.2.30.3).
6.3.3 Results
Oligonucleotide 1 probing of a slot-blot of crude cytosol extracts from 
MCF-7 cells treated with either 1 0 ~ %  E 2 or lCT^M E 2 for 24h and 48h and 
infected with HSV-1 or HSV-2 (5 pfu/cell and 10 pfu/cell) for 8h is shown 
in fig 6.2. Results of densitometric analysis are shown in table 6.1.
The results show a 2- to 3- fold stimulation of the ER message by 
physiological (10~^M, 10~®M) concentrations of E 2 given for 24h or 48h. 
Infection of cells with HSV-1 (5 or 10 pfu/cell) resulted in a 2-fold 
stimulation of the ER message. In cells infected with HSV-2 there 
was a 2- to 4- fold increase in ER mRNA levels depending on the m.o.i.
6.3.4 Conclusions
Preliminary analysis of the effect of HSV on ER mRNA levels, using 
crude cell extracts on slot-blots indicates that HSV infection stimulates 
the level of ER mRNA within infected cells to a level similar to that 
obtained in uninfected cells treated with physiological concentrations 
of E 2.
6.3.5 Discussion
Although the method used in these experiments was useful for preliminary 
analysis of ER mRNA levels, it was not considered satisfactory for
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FIG. 6. SLOT-BLOT OF CRUDE CELL EXTRACTS FROM MCF-7 CELLS TREATED 
±  E 2 or HSV-2, PROBED WITH [y-32Pl-ATP-LABELLED OLIGO- 
NUCLEOTIDE 1
The experiment was carried out as described in the legend to 
table 6.1.
c o n t r o l
1 0 ' 9 M e 2 
t 1 0 - 9IV! E2
1 0 ~ 8 Mf E2 
1 0 * ® M  e 2 
5 pf u / c e  11 
1 0 pf u /ce  II
5 p fu /c e l l  
1 0 P f u /c  e 11
2 4  h 
4 8  h
2 4  h
4 8  h
H S V - 2
HSV- 2
HS V- 2
HSV- 2
TABLE 6.1
Slot-blot analysis of ER mRNA levels in MCF-7 crude cell extrart-g
Growth and pretreatment of cells is described in section 6.3.2. 
Cells were treated as fellows:
Control maintained as controls in DMEM + 2% HIDCC-FCS
E 2 treated with 10“%  or 10“%  E? for 24h or 48h
HSV infected with HSV-1 or HSV-2 ( 5 or 10 pfu/cell)
for 8h
Crude cell extracts were prepared as described in section 2.2.28.1., 
transferred to nitrocellulose membrane via a slot-blot apparatus 
and hybridized with [y-32P]-ATP-labelled ER oligonucleotide 1 
as described in section 2.2.30.
The autoradiograph was scanned by a Hoefer Scientific GS 300 
scanning densitometer and the density of each band was converted 
to an "area under the curve" using the IBM version of the GS300 
data system on an Amstrad PC 1512. The results are recorded in 
table 6.1 and expressed as percentages of the control (taken as 
100%).
TABLE 6.1
Slot-blot analysis of ER mRNA levels in MCF-7 crude cell extracts
Treatment "Area under 
the Curve"
Area Sample 
Area Control
ER mRNA
as % of Control
Control 28722 1.0 100
10“9M E 2 24h 55305 1.9 190
-9
10 M E 2 48h 81686 2.8 280
10_8M E 2 24h 69372 2.4 240
10“8M E 2 48h 72056 2.5 250
HSV-1 5pfu/cell 48848 1.7 170
HSV-1 lOpfu/cell 56553 2.0 200
HSV-2 5pfu/cell 58789 2.1 210
HSV-2 lOpfu/cell 115482 4.0 400
further comparative experiments for the following reasons:
(a) Although the cell debris and nuclei were spun down after cell 
lysis, there was the possibility of DNA leaking out of the nuclei 
into the cytosol thus contaminating the RNA in the cell extract.
(b) Comparison of mRNA levels was based on the assumption that equal 
numbers of cells were equally efficiently lysed and yielded 
comparable amounts of RNA. It was also assumed that each sample 
was equally efficiently transferred to the nitrocellulose 
membrane. In fact, in some cases, the presence of protein in the 
cell extract tended to block the slots on the slot-blot apparatus 
leading to uneven or incomplete transfer of the sample.
Since the observed differences in ER mRNA levels were relatively small, 
it was necessary to have a more sensitive and reliable system for 
analysing these differences and particularly for relating these specif­
ically to the ER message. More refined methods were developed for 
ZR-75-1 and MCF-7 cells (see next section).
The original reason for using slot-blots to look at RNA levels was that
only small numbers of cells were required thus making it a potentially 
useful system for studying RNA levels in primary cervical cells. 
However, difficulties were encountered in culturing cervical cells 
(described in section 3.3.3). In addition, the method just described 
for analysing RNA from crude cell extracts was not satisfactory for 
detailed comparative analysis of RNA levels in cells treated in various 
ways (for the reasons outlined above). Thus the idea of looking at
RNA levels in primary cells was not pursued.
6.4 SLOT-BLOTS WITH PURIFIED RNA
6.4.1 Method
The above method for analysing RNA levels in crude cell extracts was 
refined as follows:
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(a) Cells were grown and maintained in 80 c m 2 flasks of cells rather
than in 50 mm petri dishes so that RNA could be extracted and
purified from the greater number of cells.
(b) Cells were lysed in an NP 40 containing buffer, cell debris
and nuclei were spun down and the cytosol added to a urea/SDS
containing buffer to denature the proteins. RNA was purified 
by three phenol/chloroform extractions followed by ethanol 
precipitation (section 2.2.28.2).
(c) RNA was quantitated spectrophotometrically (section 2.2.13).
(d) To check for DNA contamination and the integrity of the RNA,
1 pig of each sample was electrophoresed on a 1% agarose mini-gel 
containing ethidium bromide (section 2.2.19). Bands corresponding 
to 28S, 18S and smaller RNA's were visualized under UV-light
and photographed (fig. 6.3). The samples were free of DNA.
(e) 5 - 10 pig denatured RNA was transferred to nitrocellulose 
membrane via the slot-blot apparatus.
(f) The blots were probed either with purified, nick-translated 
0R3 cDNA or by [y - 32P]-labelled oligonucleotide 2 rather than 
the shorter oligonucleotide 1 to minimize any risk of non­
specific hybridization. Probes were labelled to a specific 
activity of at least 1 x 10® cpm/ug-
(g) Stringent washing conditions for the 0R3 cDNA probe were as out­
lined by Professor Piere Chambon when he sent us the probe 
(section 2.2.30.3). Washing conditions for the oligonucleotide 
probe 2 were as oulined in section 2.2.30.2.
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FIG. 6.3 MINI-GEL AGAROSE GEL ELECTROPHORESIS OF MCF-7 RNA SAMPLES
—  28S
—  18S
—  small R N A 's
Total cytoplasmic RNA was extracted from MCF-7 cells as described in 
section 2.2'.28.2. The integrity of the RNA was checked by running a 
small amount ( 1 — 2 fig) of each sample on a 1% agarose mini—gel as 
described in section 2.2.19. The photograph, shown above, shows 
distinct bands of 28S and 18S ribosomal RNA and of the smaller RNA 
species.
6.4.2 Results
6.4.2.1 Stimulation of ER mRNA by E 2
Fig. 6.4 and table 6.2 show the results of a time-course of stimulation 
of ER mRNA by 10 E? in ZR-75-1 cells. The level of ER mRNA rose 
gradually to approximately 3X the control level by 12h, then dropped 
between 12h and 20h before rising again to 5X the control level by 
24h. Fig. 6.5 and table 6.3 show that treatment of MCF-7 cells with 
10-®M E 2 for 24h resulted in a 60% increase in ER mRNA.
In all subsequent experiments involving E 2 stimulation, cells were 
given 10~^M E 2 for 24h.
6.4.2.2 Stimulation of ER mRNA by HSV-2
In ZR-75-1 cells infected with HSV-2 for 0 - 12 h (fig. 6.6 and table
6.4) there was a gradual increase in ER mRNA levels starting within 2h
of infection and rising to 4.5X the control level by 12h post-infection.
In MCF-7 cells infected with HSV-2 for 6 - 8 h there was a 12- to 15- 
fold stimulation in ER mRNA levels (fig. 6.7 and table 6.5). However, 
difficulty was experienced in repeating this level of HSV-2 stimulation 
for unknown reasons.
Cytopathic effect appeared more quickly in MCF-7 cells infected with 
HSV-1 or HSV-2 than in ZR-75-1 cells infected with HSV-1 or HSV-2. 
Therefore MCF-7 cells were infected for 6 - 8 h by which time the cells 
started to detach from their plastic substrate. ZR-75-1 cells could 
be infected for up to 12h before the cells started to detach from their 
substrate.
6.4.3 Conclusions
1. Purified cytoplasmic RNA was easily quantitated spectrophoto-
metrically and tranferred quickly and efficiently to nitrocellulose
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FIG. 6.4 SFOT-BFOT OF TOTAF CYTOPFASMIC RNA FROM ZR-75-1 CEFFS
TREATED WITH 1Q~8M E 2 FOR 0 - 24 h, PROBED WITH 
[''PI-LABELLED, NICK-TRANSEATED OR3 cDNA
The experiment was carried out as described in the legend to
table 6.2.
Z R - 7 5 - 1  
S t i m u l a t i o n  by 10-8M  E 2
0 hours 12 hours
TABLE 6.2
—8
Time-course of stimulation of ER mRNA by 10 M Ez IN ZR-75-1 cells
Time of Stimulation 
with 10“®M E 2 (h)
"Area under 
The Curve"
Area Sample 
Area Control
ERmRNA as % 
of Control
0 21521 1.0 100
2 20499 1.0 100
4 35755 1.7 170
8 52562 2.4 240
12 58804 2.7 270
16 33007 1.5 150
20 26597 1.2 120
24 104588 ' 4.9 490
Cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then maintained 
in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the experiment. 
The medium was replaced by DMEM + 2% HIDCC-FCS supplemented with 10~^M 
E2 for 0 - 24 h. Cytoplasmic RNA was extracted as described in section
2.2.28.2. 10 ug RNA was transferred to nitrocellulose membrane via a
slot-blot apparatus and hybridized with [32P]-labelled (nick-translated) 
0R3 cDNA probe as described in section 2.2.30. The autoradiograph was 
analysed and results were calculated as described in the legend to fig. 
6 .1.
FIG. 6. SLOT-BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS 
TREATED ±  10~8M E 2 FOR 24h, PROBED WITH [32P]-LABELLED 
(NICK-TRANSLATED) OR3 cDNA
The experiment was carried out as described in the legend to
table 6.3.
TABLE 6 .3
—8
Stimulation of ER mRNA. levels in MCF-7 cells treated with 10 M Ez
Time of Stimulation "Area under Area Sample ER mRNA as %
with 10_8M E 2 (h) the Curve" Area Control of Control
0 8488 1.0 100
24 13660 1.6 160
Cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then maintained 
in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the experiment. 
The medium was replaced by DMEM + 2% HIDCC-FCS supplemented with 
10-8M E 2 on one flask of cells for 24h. A second flask of cells was 
maintained for 24h in DMEM + 2% HIDCC-FCS with no hormone supplement 
to act as a control. Cytoplasmic RNA was extracted as described in 
section 2.2.28.2. 10 ug RNA was transferred to nitrocellulose membrane
and hybridized with [32P]-labelled (nick-translated) 0R3 cDNA probe as 
described in section 2.2.30. The autoradiograph was analysed and 
results were calculated as described in the legend to table 6.1.
FIG. 6. SLOT-BLOT OF TOTAL CYTOPLASMIC RNA FROM ZR-75- 
INFECTED WITH HSV-2 FOR 0 - 12 h, PROBED WITH 
[y - 3 2 P 1-ATP-LABELLED ER OLIGONUCLEOTIDE 2
CELLS
The experiment was carried out as described in the legend to
table 6.4.
ZR-75-1
HSV-2 
hours p.a
8
12
TABLE 6.4
Time-course of HSV-2 stimulation of ER mRNA in ZR-75-1 cells
Time of Infection 
with HSV-2 (h)
"Area under 
the Curve"
Area Sample 
Area Control
ER mRNA as 
% of Control
0 1077 1.0 100
2 1837 1.7 170
4 1753 1.6 160
6 2577 2.4 240
8 4045 3.8 380
12 4881 4.5 450
Cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then maintained 
in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the experiment, 
and throughout the course of virus infection. Cells were infected 
with HSV-2 (10 pfu/cell) for 0 - 12 h. Cytoplasmic RNA was extracted 
as described in section 2.2.28.2. 10 yg RNA was transferred to
nitrocellulose membrane via a slot-blot apparatus and hybridized with 
[y-3 P]-ATP-labelled oligonucleotide 2 as described in section 2.2.30. 
The autoradiograph was analysed and results were calculated as described 
in the legend to table 6.1.
FIG. 6.7 SLOT-BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS
INFECTED WITH HSV-2 FOR 0, 6 or 8h, PROBED WITH 
[y-32Pl-ATP-LABELLED ER OLIGONUCLEOTIDE 2
The experiment was carried out as described in the legend to
table 6.5.
MC F - 7
HSV-2
0 h ours p.a. 
6 
8
Stimulation of ER mRNA levels in HSV-2 infected MCF-7 cells
Treatment "Area under 
the curve"
Area Sample 
Area Control
Control 412 1
HSV-2 6h 5125 12
HSV-2 8h 6314 15
The experiment was carried out exactly as described in the legend 
to table 6.A except that cells were infected with HSV-2 (10 pfu/cell) 
for 6h or 8h or maintained as a control.
membrane via the slot-blot apparatus.
2. Both E 2 and HSV-2 stimulated the level of ER mRNA to similar
extents but over different time intervals, suggesting different 
mechanisms of action.
6.4.4 Discussion
6.4.4.1 Discussion of Results
The results of slot-blot analysis using purified RNA and either the 
0R3 cDNA or oligonucleotide 2 as probes confirmed the results obtained 
with crude cell extracts and the oligonucleotide 1 probe. Both E 2 and 
HSV-2 were able to stimulate the level of ER mRNA in ZR-75-1 and MCF-7 
cells. The high level (12- to 15- fold) of stimulation of ER mRNA 
induced by HSV-2 infection in MCF-7 cells (fig. 6.7 and table 6.5) 
was not repeatable in later experiments. However, the fact that 
experiments with crude cell extracts and purified RNA from MCF-7 cells 
both showed stimulation of ER mRNA by HSV-2 indicated that these cells 
were suitable for doing further experiments.
E2 stimulation of the ER mRNA in MCF-7 cells was greater (2- to 3- 
fold stimulation) in the slot-blot done with crude cell extracts (fig.
6.2, table 6.1) than with the slot-blot using purified RNA (60% increase), 
(fig. 6.5, table 6.3). Later experiments in MCF-7 cells using Northern 
blot analysis (fig. 6.10, table 6.6) showed a 50% increase in ER mRNA 
in response to E 2 stimulation. Possible reasons for a higher level of 
stimulation in slot-blots compared to Northern blots are discussed 
in section 6.6.4.
Slot-blots with purified RNA from ZR-75-1 cells showed a gradual increase 
in ER mRNA levels in response to HSV-2 infection (fig. 6.6 and table 6.4), 
reaching a level 4.5X greater than the control value by 12h post-infection. 
Stimulation of ER mRNA by E 2 was also gradual (fig. 6.4, table 6.2) with 
maximum levels 5X above the control level after 24h of stimulation.
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In the cells used in these experiments, the response to E 2 appeared to 
be cyclical. The level of ER mRNA increased gradually during the first 
12h of E 2 stimulation (2.7-fold) then dropped during the next 8h of E 2 
stimulation (down to 1.2-fold) before rising again,reaching 5-fold 
stimulation by 24h of E 2 treatment. This cyclical effect on the ER 
mRNA level may be linked to the time of cell division, the time of 
commitment to DNA synthesis presumably being 12h. Commitment to DNA 
synthesis in the rat uterus occurs within 12h of E 2 stimulation although 
maximum levels of DNA synthesis are not reached until 24h (Leake et a l ., 1975).
Although infection with HSV-2 and stimulation by E 2 gave similar 
maximum levels of stimulation of ER mRNA, the time-courses were 
different suggesting that E 2 and HSV act in different ways. The 
possible mechanisms by which E 2 and HSV affect the level of ER mRNA 
in the cell are discussed in section 6.6.4.
The reason why cytopathic effect appeared more quickly in MCF-7 cells 
compared to ZR-75-1 cells infected with HSV-1 or HSV-2 is not clear.
However, this observation suggests that there are differences between 
MCF-7 cells and ZR-75-1 cells even although they were derived from 
similar sources (Soule et a l ., 1973, Engel et a l ., 1978).
6.4.4.2 Discussion of the Advantages and Disadvantages of Slot-Blots
Slot-blots using purified RNA and a specific radiolabelled probe are 
a quick and easy way of comparing levels of expression of a particular 
mRNA in a number of different samples at the same time. They are also 
useful for analysing small quantities ( 1 - 1 0  pig) of RNA. The quantity 
of RNA required depends on the relative abundance of the required 
message, the specificity of the probe sequence and the specific activity 
of the probe.
Under the experimental conditions used by Walter et a l . (1985), ER mRNA 
accounted for approximately 0.003% of the total MCF-7 mRNA population.
The exact proportion of ER mRNA relative to the total RNA population 
varies with the stage in the cell cycle. In the system presently being
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discussed, 5 - 10 pig total RNA and a probe of specific activity of at 
least 1 x 108 cpm/yg were required to give a strong hybridization 
signal within 1 - 3  days of exposure to X-ray film. The nick-translated 
0R3 fragment and the [y-32P]-labelled oligonucleotide 2 both gave good 
hybridization signals. However, a shorter exposure time (overnight) to 
X-ray film was required for blots probed with the oligonucleotide 
c o m p a r e d  to blots probed with the cDNA fragment ( 2 - 3  days).
The disadvantage of using slot-blots is the inability to check the 
intact nature of the mRNA and that the probe is hybridizing to a single, 
specific message of the correct size. Northern blots with molecular 
weight markers are required to check these factors.
6.5 NORTHERN BLOT ANALYSIS OF RNA
6.5.1 Standardization of mRNA Levels and Calculation of Results
RNA was extracted, purified and quantitated as described in sections
2.2.28.2 and 2.2.13. 25 ug denatured RNA was electrophoresed on a 1.2%
denaturing formaldehyde/MOPS/agarose gel along with RNA molecular weight 
markers and transferred to Hybond-N membrane as described in sections
2.2.31.1 and 2.2.31.2. The RNA marker track was stained in ethidium 
bromide and the migration of the bands visualized under UV-light 
(section 2.2.31.1), (fig* 6.8).
In the slot-blots described in the preceeding section (6.4), RNA was 
quantitated spectrophotometrically only. It was assumed that the amount 
of mRNA present in each sample was proportional to the amount of total 
RNA measured spectrophotometrically. It is advisable, when looking at 
small differences in mRNA expression, to take as a standard the level 
of expression of a cellular mRNA which is unlikely to change under the 
experimental conditions. The actin message is a popular choice for a 
standard message.
As discussed in section Bl.7.1, variable results have been obtained on
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FIG. 6.8 DENATURING GEL ELECTROPHORESIS OF RNA 
MOLECULAR WEIGHT MARKERS
—  9.5
—  7.5
—  4.4,
—  2.4
—  1.4
—  0.3
6 ug RNA molecular weight markers (i.e. 1 Ug of each RNA component) 
was denatured in formaldehyde/formamide/MOPS at 65°C for 5 min before 
loading onto a 1.2% denaturing agarose gel (as described in section
2.2.31.1) along with test RNA samples. After electrophoresis, the 
marker track was cut off and stained in a solution of 0.5 Ug/ml 
ethidium bromide overnight. The gel was then destained in distilled 
water for lh, visualised under short-wave UV light and photographed.
The size of each RNA component is shown.
the effect of HSV-1 and HSV-2 infection on cellular mRNA levels depend­
ing on the cell type and virus strain used. Although certain strains 
of HSV-2 cause a "shutoff" of cellular mRNA (including actin mRNA) 
expression (Shek and Bachenheimer, 1985; Bastow et a l ., 1986), HSV-2 
strain HG 52 (the strain used in the present study) has no effect on 
cellular mRNA expression (Bastow et a l ., 1986). Although Shek and 
Bachenheimer (1985) found that HSV-1, strain 17 syn+ shut off actin 
mRNA expression, there is no evidence in the system described here for 
this effect in MCF-7 cells with the possible exception of the HSV-1 
mutant, tsK (see later results, this section).
There is no evidence for a change in actin mRNA expression in response 
to E 2. Thus for the following experiments, actin mRNA was chosen as 
the standard message against which the level of ER message was compared 
under various experimental conditions.
To enable multiple probing of a single transfer, the reprobable Hybond-N 
membrane was used. Blots were first probed for the ER message, then 
the probe was washed off and the blots reprobed for the actin message 
(section 2.2.31.6). Each ER mRNA and actin mRNA band was scanned by a 
Hoefer Scientific GS300 scanning densitometer and converted to an "area 
under the curve" using the IBM version of the GS350 data system on an 
Amstrad PC 1512. An example of densitometric traces for ER mRNA and actin 
mRNA is shown in fig. 6.12(b). The relative amounts of ER mRNA, 
corrected with respect to the level of expression of actin mRNA, were 
calculated and compared.
6.5.2 Optimization of Hybridization Signals
Hybridization conditions were exactly as described in the Hybond 
manual and in section 2.2.31.3. Washing conditions were developed to 
give specific bands corresponding to the actin or ER messages and are 
described in section 2.2.31.4 and 2.2.31.5.
Optimum signals were obtained with high specific activity probes. The
1.2 kb actin fragment (donated in plasmid form by Dr. D. Leader, Dept, 
of Biochemistry, Glasgow and shown in fig. 6.9) was purified from its
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FIG. 6.9 DESCRIPTION OF ACTIN cDNA PROBE
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Physical map of recombinant bacteriophage A mA19 isolated from a 
mouse genomic library and containing the nucleotide sequence of an 
actin - like pseudogene (MyA-ipl) with an expected 85% identity to 
the human y (non-muscle) actin sequence.
The Xba 1 fragment was cloned into the pUC 13 vector.
vector sequences by restriction enzyme digestion with Xba J_ and electro­
phoresis on low melting point agarose (section 2.2.21) and was labelled 
in the agarose with [ P]-dCTP by the oligolabelling method (section
2.2.26.2)✓ Probes of specific activity 6 x 108 cpm/yg were routinely 
obtained, resulting in strong hybridization signals after an overnight 
exposure to X-ray film. For some unknown reason, 0R3 cDNA purified 
from vector sequences on a low melting point agarose gel and oligo- 
labelled in the same way as actin cDNA, did not hybridize successfully 
to the ER message. Probably the base composition of the DNA reflects 
the efficiency of the oligolabelling technique.
0R3 cDNA, purified from its vector on normal agarose (2.2.20) was nick- 
translated (2.2.26.1).to a specific activity in the range 5 x 10^ to 
1 x 108 cpm/yg. Probes of specific activity 1 x 108 cpm/yg gave a 
good hybridization signal after 2 - 3  days exposure to X-ray film. 
However, probes of lower specific activity resulted in a poorer signal 
and blots required a longer exposure time. To overcome this problem, 
the oligonucleotide 2 was used as it was easily labelled and consis­
tently gave strong hybridization signals with the 6.2 kb ER mRNA.
All of the blots shown in the remainder of this section were probed 
with [y-32P]-labelled ER oligonucleotide 2 first, then with [ 32P]-dCTP 
oligolabelled actin cDNA.
6.5.3 Cells
RNA from MCF-7 cells generally gave stronger hybridization signals 
than RNA fearm ZR-75-1 cells, therefore the experiments described in 
the remainder of this section were all done in MCF-7 cells.
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6.6 EFFECT OF HSV INFECTION ALONE OR IN COMBINATION WITH E? OR 
CYCLOHEXIMIDE ON ER mRNA LEVELS IN MCF-7 CELLS
6.6.1 Methods
MCF-7 cells were maintained in DMEM + 2% HIDCC-FCS for 2 days prior to 
the start of the experiment. Cells were then treated as follows:
Control
E? alone
Given fresh medium without any supplements. 
Harvested with the other cells at the end of the 
experiment.
 Q
Given fresh medium containing 10 °M Ea.
Harvested 24h later.
HSV alone
HSV + E 2
HSV +
Cycloheximide
tsK alone
Given fresh medium without any supplements for 16h. 
Cells were then infected at a m.o.i. of 10 pfu/cell 
at 37°C and harvested 8h later.
Q
Given fresh medium supplemented with 10 M Ea 
for 16h. Cells were then infected at a m.o.i. of 
10 pfu/cell at 37°C in the continued presence of 
10~8M E 2 and harvested 8h later.
Given fresh medium without any supplements for 16h. 
Cells were then treated with 50 pig/ml cycloheximide 
for 30 min prior to infecting with virus at a m.o.i. 
of 10 pfu/cell for 8h in the continued presence of 
cycloheximide.
Given fresh medium without any supplements for 16h. 
Cells were then infected at a m.o.i. of 10 pfu/cell 
for 8h at 38.5°C.
140
tsK + E, Same protocol as for HSV + E 2- except that 
infection was with tsK at 38.5°C.
Cycloheximide
tsK + Same protocol as for HSV + cycloheximide except 
that infection with tsK was at 38.5°C.
6.6.2 Results
6.6.2.1 HSV-1 Infection ± E 2 or ± Cycloheximide
The results of infecting MCF-7 cells with HSV-1 in the presence and 
absence of E 2 or cycloheximide in two separate experiments are shown 
in figs. 6.10, 6.11 and tables 6.6, 6.7. The time-course of HSV-1 
stimulation of the ER mRNA is shown in fig. 6.12 and table 6.8.
In the first experiment (fig. 6.10 and table 6.6), in cells infected 
with HSV-1 alone, the level of cytoplasmic ER mRNA rose by approximately 
250% compared to the level in control, uninfected cells. In cells 
treated with E 2 alone, a 50% increase in ER mRNA was observed. Infection 
with HSV-1 in the presence of E 2 resulted in a 370% increase in ER mRNA 
which was a greater stimulation than with either HSV-1 or E 2 alone.
The presence of cycloheximide during HSV-1 infection inhibited the 
virus induced increase in ER mRNA levels and caused the level of ER 
mRNA to fall to 60% of the control level.
In the second experiment (fig. 6.11 and table 6.7), HSV-1 infection 
resulted in a smaller (100%) increase in ER mRNA than in the first 
experiment. In this case, infection in the presence of E 2 gave only 
a slightly greater degree of stimulation (117%) of the ER mRNA than 
with HSV-1 alone (100% increase). In a similar way to the first 
experiment, the presence of cycloheximide before and during HSV-1 
infection caused the level of ER mRNA to fall to 50% of the control 
level.
The increase in ER mRNA induced by HSV-1 infection was gradual (fig. 6.12
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FIG. 6. NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS 
INFECTED WITH HSV-1 ALONE, OR IN COMBINATION WITH E ?
OR CYCLOHEXIMIDE (CH), PROBED FOR ER mRNA AND ACTIN mRNA
The experiment was carried out as described in the legend to
table 6.6.
HSV-1 HSV-1
c
04
LU>
e2 CH
TABLE 6.6
Effect of HSV-1 infection alone, or in combination with
E2 or cycloheximide, on ER mRNA levels in MCF-7 cells
MCF-7 cells, grown in DMEM + 10% FCS in 80 c m 2 flasks, were 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start 
of the experiment. Cells were treated with 10~^M E 2 alone for 
24h or infected with HSV-1 (10 pfu/cell for 8h) alone or in 
combination with 10“^M E 2 or 50 yg/ml cycloheximide (CH) as 
described in section 6.6.1.
Cytoplasmic RNA was extracted as described in section 2.2.28.2. 
25 pig RNA was subjected to Northern blot analysis, hybridized 
first with [y - 32P]-ATP-labelled ER oligonucleotide 2, then with 
[32P]-dCTP-labelled actin cDNA as described in section 2.2.31. 
The autoradiograph was scanned by a Hoefer Scientific GS 300 
scanning densitometer and, using conventional programming, the 
densities of the bands were converted to "areas under the curve" 
by an Amstrad PC 1512. The areas were taken as a measure of the 
relative abundance of the corresponding ER or actin m R N A ’s.
The value for ER mRNA was divided by the value for actin mRNA 
(standard mRNA), corrected with respect to (wrt) the control 
value and expressed as a percentage of the control value 
(taken as 100%).
TABLE 6.6
EFFECT OF HSV-1 INFECTION ALONE OR IN COMBINATION WITH 
E, OR CYCLOHEXIMIDE ON ERmRNA LEVELS IN MCF-7 CELLS
Treatment ER
(Area)
Actin
(Area)
ER
Actin
Corrected ER 
(wrt control)
ERmRNA as % 
of control
Control 1343 1003 1.34 1.00 100
HSV-1 4508 947 4.76 3.57 357
HSV-1 + E 2 4022 642 6.26 4.70 470
e 2 2534 1258 2.01 1.51 151
HSV-1 + CH 4179 4893 0.85 0.64 64
FIG. 6.11 NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS
INFECTED WITH HSV-1, HSV-2 OR tsK ALONE, OR IN COMBINATION 
WITH E 2 OR CYCLOHEXIMIDE (CH), PROBED FOR ER mRNA AND 
ACTIN mRNA
The experiment was carried out as described in the legend to
table 6.7.
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TABLE 6.7
Effect cf HSV-1, HSV-2 or tsK infection alone.or in  --  “------------------     f-----
ccofpination with E 2 or cycloheximide.in MCF-7 cells
Treatment ER
(Area)
Actin
(Area)
ER
Actin
Corrected ER 
wrt Control
ER mRNA as 
% of Control
Control 4015 2580 1.56 1.00 100
tsK 5300 944 5.61 3.61 361
tsK + E 2 4472 462 9.68 6.22 622
HSV-1 5297 1660 3.19 2.05 205
HSV-1 + E. 5767 1708 3.38 2.17 217
HSV-1 + CH 3107 4090 0.76 0.49 49
HSV-2 4299 2082 2.07 1.33 133
HSV-2 + E 2 4920 1718 2.86 1.84 184
HSV-2 + CH 4304 3038 1.42 0.91 91
MCF-7 cells, grown in 80 c m 2 flasks in DMEM + 10% FCS, were maintained 
in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the experiment. 
Cells were infected with tsK at 38.5°C or with HSV-1 or HSV-2 at 37°C 
(10 pfu/cell for 8h in each case) alone, or in combination with E 2 
(10_^M for 24h) or cycloheximide (50 Ug/ml given for 30 min prior to 
and throughout the course of virus infection) as described in section
6.6.1. Cytoplasmic RNA was extracted, analysed and the results 
calculated exactly as described in the legend to table 6.6.
FIG. 6.12 (A)
NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS INFECTED WITH 
HSV-2 (0 - 6 h), HSV-1 (0 - 8 h) OR tsK (8h), PROBED FOR ER mRNA 
AND ACTIN mRNA
The experiment was carried out as described in the legend to 
table 6.8.
The numbers at the bottom of the figure refer to the time (h) of 
infection.
The corresponding densitometer traces are shown in fig. 6.12 (B).
H S V - 2 H S V - 1
0 2 4 6 2 4 6 8 8
FTfi. 6.12 (B) DENSITOMETRIC TRACES CORRESPONDING TO ER mRNA AND
ACTIN mRNA BANDS OF NORTHERN BLOT SHOWN IN FIG. 6.12 (A)
ER mRNA
.W iiliuu
tsKHSV-1HSV-2
Actin mRNA
tsKHSV-1HSV-2
TABLE 6.8
Time-course of ER mRNA stimulation by HSV-1 and HSV-2
Treatment ER
(Area)
Actin
(Area)
ER
Actin
Corrected ER 
wrt Control
ER mRNA as 
% of Control
Control 2A09 3590 0.67 1.0 100
HSV-2 2h 157A 1982 0.79 1.18 118
HSV-2 Ah 2128 2811 0.76 1.13 113
HSV-2 6h 2070 2A32 0.85 1.27 127
HSV-1 2h 2116 2650 0.80 1.19 119
HSV-1 Ah 27A2 2765 0.99 1.A8 1A8
HSV-1 6h A9A1 3730 1.32 1.97 197
HSV-1 8h A6A0 3A0A 1.36 2.03 203
tsK 8h A719 
_ ________
2133 2.21 3.29 329
MCF-7 cells, grown in 80 c m 2 flasks in DMEM + 10% FCS and maintained 
in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the experiment, 
were infected with HSV-2 (10 pfu/cell) for 0 - 6 h at 37°C, HSV-1 
(10 pfu/cell) for 0 - 8 h at 37°C or tsK (10 pfu/cell) for 8h at 38.5°C 
or maintained as controls, as described in section 6.6.1.
Cytoplasmic RNA was extracted, analysed and the results calculated as 
described in the legend to table 6.6.
and table 6.8), starting within 2h of infection (20% increase) and 
reaching a maximum level by 6 - 8 h post-infection (100% increase, 
a similar level of stimulation as was found in the second experiment 
(fig. 6.11, table,,6.7)
6.6.2.2 HSV-2 Infection ± Ea or ± Cycloheximide
The results of infecting MCF-7 cells with HSV-2 in the presence and 
absence of E 2 or cycloheximide in a single experiment are shown in 
fig. 6.11 and table 6.7. The time-course of the effect of HSV-2 
infection on ER mRNA levels is shown in fig. 6.12 and table 6.8.
HSV-2 infection resulted in a 30% increase in ER mRNA levels by 6 - 8 h 
post-infection (in the two experiments shown in figs. 6.11, 6.12 and 
tables 6.7, 6.8). The rise in ER mRNA levels induced by HSV-2 started 
within 2h of infection (20% increase) and reached 30% stimulation by 
6h post-infection (fig. 6.12, table 6.7). At 6h the cells started to 
detach from their substrate, so that no further time-point was tested. 
Cells infected with HSV-1 did not detach from their substrate until 
after 12h of infection. The reason for this difference between HSV-1 
and HSV-2 infections is unknown but may reflect the greater instability 
of the ER mRNA and lesser degree of stimulation seen in HSV-2 infected 
cells compared to HSV-1 infected cells.
Infection with HSV-2 in the presence of E 2 (fig. 6.11, table 6.7) 
resulted in a 50% greater increase in ER mRNA levels than with HSV-2 
alone. Cycloheximide inhibited the HSV-2 response and the level of 
ER mRNA fell to 90% of the control value (fig. 6.11, table 6.7).
6.6.2.3 tsK Infection ± E 2
The results of two separate experiments on the effect of tsK infection 
on the level of ER mRNA are shown in figs. 6.11, 6.12 and tables 6.7, 
6.8). The effect of the combination of E 2 and tsK in a single experiment 
is shown in fig. 6.11 and table 6.7.
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FIG. 6.13 NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS
TREATED WITH E? OR INFECTED WITH tsK ±  E?, PROBED FOR 
ER mRNA AND ACTIN mRNA - DEPRESSION OF THE ACTIN MESSAGE 
BY tsK
MCF-7 cells, grown in 80 c m 2 flasks in DMEM + 10% FCS, were 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start of 
the experiment. Cells were then treated as follows:
Control maintained as controls in DMEM + 2% HIDCC-FCS
Ea treated with 10~^M E? for 24h
tsK infected with tsK at 38.5°C for 8h
tsK + E 2 treated with 10“®M E 2 for 16h, then infected with tsK at
38.5°C for 8h in the continued presence of 10-^M E 2.
Cytoplasmic RNA was extracted and blotted as described in the legend 
to table 6.6. Densitometric analysis was not carried out due to the 
weakness of the actin bands.
The results of both experiments on the effect of tsK infection on the 
level of ER mRNA showed approximately 250% increase in ER mRNA.
Infection in the presence of E 2 resulted in a further 260% increase 
in ER mRNA levels (fig. 6.11, table 6.7).
It is possible that the level of tsK stimulation of ER mRNA calculated 
in table 6.7 is artifactually high as the actin message is depressed in 
this experiment. Although such a depression of actin message in response 
to tsK infection was not always seen (e.g. fig. 6.12, table 6.8), one 
experiment (fig. 6.13) showed a very significant depression of the actin 
message in response to tsK infection.
6.6.2.A Stimulation of ER mRNA by E 2 or tsK in the
Absence of Phenol Red
Cells were grown in DMEM + 10% FCS until about 70% confluent and were 
maintained in Biggar's medium (containing no phenol red) + 2% HIDCC-FCS 
for 48h prior to the start of the experiment and throughout the course 
of E 2 stimulation (10~®M, 24h) or tsK infection (10 pfu/cell,8h, 38.5°C).
The results of a single experiment are shown in fig. 6.14 and table 6.9.
E 2 stimulation resulted in a 60% increase in ER mRNA levels and infect­
ion with tsK resulted in a 150% rise in ER mRNA levels. No effect of 
tsK on the level of actin mRNA was observed in this case.
6.6.3 Conclusions
1. Infection of MCF-7 cells by HSV-1 results in a gradual rise in
ER mRNA levels starting within 2h of infection and, by 8h, reaching
maximum levels in the range 100 - 250% (over 3 experiments).
2. Infection of MCF-7 cells by HSV-2 results in a gradual increase 
in ER mRNA levels starting within 2h of infection and reaching 
maximum levels of 30% above the control level by 6h post-infection.
The significance of a 30% stimulation is unknown but the low value may 
reflect early detachment of the infected cells from their substrate.
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FIG. 6.14 NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS
TREATED WITH E? OR INFECTED WITH tsK IN THE ABSENCE OF 
PHENOL RED, PROBED FOR ER mRNA AND ACTIN mRNA
The experiment was carried out as described in the legend to 
table 6.9.
c  E 2 tsK
TABLE 6.9
Stimulation of ER mRNA by E2 and tsK in the absence of phenol red
Treatment ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of Control
Control 1655 2710 0.61 100
10_8M E 2,24h 3655 3644 1.00 164
tsK,8h 3591 2335 1.54 252
MCF-7 cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then 
maintained in Biggar's medium (containing no phenol red) + 2% HIDCC- 
FCS for 2 days prior to the start of the experiment and throughout 
the course of E 2 stimulation (10“^M E 2 for 24h) and tsK infection 
(10 pfu/cell for 8h at 38.5°C). RNA was extracted, analysed and 
the results calculated as described in the legend to table 6.6.
3. Infection of MCF-7 cells with _tsK at 38.5°C for 8h results in 
approximately 250% stimulation of ER mRNA. In some cases, tsK 
depresses the actin message.
4. The stimulation of ER mRNA levels by HSV - 1 , HSV-2 or tsK can be 
further stimulated in the presence of E a .
5. Infection by HSV-1 or HSV-2 in the presence of cycloheximide 
results in a decrease in the level of ER mRNA to below the 
control value.
6. Stimulation of ER mRNA by Ea or virus in the absence of phenol 
red is of a similar level as is found in the presence of phenol 
r e d .
6.6.4 Discussion
6.6.4.1 Discussion of Assay Method
The results obtained with slot-blots and crude cell extracts or purified 
RNA (section 6.3 and 6.4) on the effect of HSV infection on cellular 
ER mRNA levels were confirmed by Northern blot analysis. However, the 
levels of response varied. The increase in ER mRNA induced by Ea or 
HSV-2 in the slot-blot experiments were generally higher than those 
found in Northern blots. In the case of HSV-2 infection, this may be 
due to the fact that a new stock of virus required to be used for the 
Northern blot experiments.
It is well known that cultured cells can vary in their response to 
various inducing agents such as E a . It may be that the cells were 
responding better to Ea in earlier experiments e.g. in terms of growth 
rate and macromolecular synthesis. Cells can vary in their behaviour 
according to the passage number. However, it may be that the differences 
in response levels were due to the inherent differences in the two 
systems used to analyse the RNA. Northern blot analysis ensures
144
that the precise messages are being detected. In the system described 
here, actin mRNA was taken as a standard message. This was not the 
case for the slot-blots, therefore it was not possible to correlate 
increases in ER mRNA with a standard mRNA. This may be one reason 
for the differing levels of response in Northern and slot-blots.
Another possibility is that densitometric scanning of broad bands such 
as those obtained with Northern blots is not as sensitive as scanning 
the finer, slct-blot bands. Finally, it may be that some non-specific 
hybridization was occurring in the slot-blots. With low stringency 
washing of the ER oligonucleotide or of the 0R3 cDNA probe (2X or IX 
SSPE at ambient temperature), two bands corresponding to 28S and 18S 
ribosomal RNA were seen on Northern blots (data not shown).
To test these possibilities, RNA from the same samples used for Northern 
blots should be used for slot-blots on reprobable Hybond membrane and 
hybridized with the ER and actin probes under the same hybridization 
conditions as for the Northern blots.
6.6.4.2 Discussion of Northern Blot Results
The observation that HSV infection in the presence of E 2 results in a 
greater accumulation of ER mRNA than with either inducing agent alone 
(figs. 6.10, 6.11 and tables 6.6, 6.7) suggests that the virus and 
hormone are acting via different pathways. Accumulation of ER mRNA 
may result from activation of transcription of the ER gene or from 
stabilization of the message. E 2 induces synthesis of its own receptor 
(Hsueh et a l ., 1975, 1976; Kassis and Gorski, 1983) possibly by 
activation of transcription of the ER gene or by some post-transcript- 
ional control mechanism, perhaps involving stabilization of the ER 
message or control at the level of translation. By analogy with the 
control mechanisms worked out for other steroid regulated genes such 
as the control of MMTV gene expression by glucocorticoid hormones 
(section Al.7.1.1), it may be that the complex of E 2 with its receptor 
binds to particular sequences upstream of the ER gene resulting in 
activation of ER gene transcription. However, currently there is no 
published information on the 5'-flanking sequence of the human ER 
gene and it is not known if and how the ER gene is regulated at the 
transcriptional level.
Occasionally (e.g. fig. 6.11 and table 6.7), E 2 failed to augment the 
HSV-1 response. This may reflect the state of the cells or it may be 
that factors other than virus or E 2 are also involved in increasing 
the level of ER mRNA.
Despite the fact that a component present in commercial preparations of 
medium containing phenol red has been shown to be a weak oestrogen 
(Berthois et al., 1986; Rajendran et al.t 1987), the presence or 
absence of phenol red did not affect the level of response to E a 
(fig. 6.14; table 6.9). The level of response to tsK was less (150% 
increase) in the absence of phenol red than previous experiments 
done in the presence of phenol red (200 - 300% increase). However, 
this is unlikely to be due to the absence of phenol red as it would be 
expected that in the absence of the weak oestrogen, the response would 
be greater than in the presence of the weak oestrogen. It is more 
likely that the cells did not respond so well on that occasion to 
tsK infection. t
Induction of ER mRNA levels by virus was inhibited by cycloheximide 
(figs. 6.10, 6.11 and tables 6.6, 6.7). In fact, the level of ER mRNA 
fell to between 50% and 60% of the control level in cells infected with 
HSV-1 in the presence of cycloheximide (figs. 6.10, 6.11 and tables 
6.6 , 6.7). Cycloheximide was given for 30 min prior to virus infection 
and was present throughout the course of infection (as already described 
in section 6.6.1). These results suggest that viral and cellular proteins 
are important for the induction of ER mRNA levels. The situation may 
be analogous to the interaction of Vmw 65 with its target TAATGARAT 
sequence which occurs in association with cellular proteins (sections 
Bl.6.3 and 4.5). A viral protein could trans-activate the ER gene by 
interacting directly or indirectly (via a cellular factor) with 
regulatory sequences upstream of the ER mRNA start of transcription. 
Alternatively, the ER message may be stabilized by a viral and/or 
cellular protein.
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The mutant virus tsK, contains a ts_ lesion in IE gene 3 such that IE 
Vmw 175 is inactive and thus IE proteins, negatively regulated by 
Vmw 175, are overproduced and later classes of proteins are not 
synthesized at the non-permissive temperature of 38.5°C (Preston,
1979a, Watson and Clements, 1980). Infection with tsK at 38.5°C 
resulted in an increase of ER mRNA to at least a similar or greater 
level than with wild-type virus (figs. 6.11, 6.12 and tables 6.7, 6.8), 
suggesting that IE proteins are sufficient for the effect on ER mRNA 
levels or that the virion itself plays a role in stimulation of the ER 
message. However, it should also be noted that in certain experiments 
(e.g. figs. 6.11, 6.13 and table 6.7) the level of actin mRNA was 
depressed by tsK infection. This is especially true for the case of 
tsK + E 2 (fig. 6.11, track 3), which would account for the corresponding 
high level of stimulation of ER mRNA calculated using actin as the 
standard message. The actin bands in fig. 6.13 were too faint to trace 
on the densitometer. Thus although the actin message is a suitable 
standard for HSV-1, HSV-2 infection and E 2 stimulation, it is not ideal 
for tsK infection.
The mutant virus, t s K , synthesizes an abnormal form of the Vmw 175 
protein (Preston, 1979b) and is known to show some abnormal 
characteristics compared to wild-type virus. For example, induction 
of the heat shock response in tsK infected cells (Notarianni and Preston, 
1982) results from the production of abnormal forms of the Vmw 175 
protein (Russell et a l ., 1987) rather than the overproduction of IE 
proteins.
The variation in the level of depression of the actin message may 
result from possible variation in incubation temperature. The tsK 
virus is temperature sensitive and the mutant form of Vmw 175 is 
only synthesized at the non-permissive temperature of 38.5°C. As a 
communal incubator was used for the tsK experiments, it is possible 
that an inadvertant drop in temperature may have occurred if the 
incubator was opened during the course of the experiment.
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6.7 EFFECT OF HSV IE PROTEINS Vmw 175 AND Vmw 110 ON ER mRNA LEVELS
6.7.1 Introduction
As described in section Bl.6.4, the HSV IE proteins, Vmw 110 and Vmw 
175 are regulators of gene expression. Since the results of section 
6.6 suggest the involvement of a viral protein(s) in stimulation of ER 
mRNA levels, the ability of Vmw 175 and Vmw 110 to activate the level
of expression of the ER message was tested.
6.7.2 Plasmids used in Transfection Studies
The following plasmids were kindly supplied by Dr. R. Everett, Institute 
of Virology:
pill (Everett, 1987) encodes IE protein Vmw 110
pl75 (Everett, 1987) encodes IE protein Vmw 175
ptk-CAT (Everett, 1986) encodes the CAT gene under the control of
the HSV early promoter, tk.
In addition, the plasmid pAT (Twigg and Sheratt, 1980) was used to 
equalise the total amount of transfected DNA and as a control plasmid.
6.7.3 Method
Cells maintained in DMEM + 2% HIDCC-FCS were transfected with pl75 or 
pill or the control plasmid, pAT and harvested 48h later. The relative
level of ER mRNA in each case was compared.
As a positive control to show that the transfections were working, the 
same plasmids were cotransfected with the tk-CAT plasmid and the level 
of CAT activity was measured 48h later.
148
FIG. 6.15 CAT ASSAY OF CYTOSOL EXTRACTS FROM MCF-7 CELLS COTRANS­
FECTED WITH tk-CAT + p!75 / pill / p!75 + pill / pAT
The experiment was carried out as described in the legend to 
table 6.10.
The samples were spotted onto TLC paper at the origin (ori).
The positions of unconverted chloramphenicol (CAP), chloramphenicol 
acetylated at Cl (1-ac) and C3 (3-ac) after ascending chromatography 
and autoradiography are shown.
C A P
TABLE 6.10
Activation of the HSV tk promoter by Vmw 175 and Vmw 110
Transfected DNA % acetylation 
of [1AC]-CM
Ug protein/ 
assay
Acetylated 
[U C]-CM 
n moles/mg/h
tk-CAT + pAT 0 25 0
tk-CAT + pi75 46 25 151
tk-CAT + pill 1 25 3
tk-CAT + pl75 + pill 94 25 308
MCF-7 cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start of 
the experiment and throughout the course of transfection. Cells 
were cotransfected with 10 ug ptk-CAT together with 10 ug of pAT 
or pl75 or pill or with 5 ug pl75 + 5 ug pill. Plasmids are 
described in section 6.7.2. The methods for transfection, harvesting 
of cells, protein estimation and CAT assay are described in sections 
2.2.15 - 2.2.17. Results are expressed as n moles acetylated [ ^ C ] -  
chloramphenicol (CM)/mg protein /h.
FIG. 6.16 NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS
TRANSFECTED WITH pAT (CONTROL) OR p!75 or pill, PROBED 
FOR ER mRNA AND ACTIN mRNA.
(A) and (B) are two separate experiments.
The experiments were carried out as described in the legend to 
table 6.11.
p A T  p175 pill p A T p175 p111
TABLE 6.11
Effect of Vmw 175 and Vmw 110 on ER mRNA levels 
A.
Transfected DNA ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of Control
pAT alone 4025 6967 0.58 100
pAT + pi75 3840 5374 0.72 124
pAT + pill 4196 7255 0.58 100
B.
Transfected DNA ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of Control
pAT alone 2410 4592 0.52 100
pAT + pl75 2981 4363 0.68 131
pAT + pill 3288 5085 0.65 125
MCF-7 cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start of 
the experiment and throughout the course of transfection. Cells were 
transfected (as described in section 2.2.15) with 20 pig pAT (control) 
or 10 ptg pAT + 10 ug pl75 or with 10 ug pAT + 10 ug pill. Plasmids 
are described in section 6.7.2. Cytoplasmic RNA was extracted, 
analysed and the results calculated as described in the legend to 
table 6.6. The results of two separate experiments are shown in 
tables 6.11 A. and B.
6.7.A Results
The results of cotransfecting the IE gene plasmids with tk-CAT are 
shown in fig. 6.15 and table 6.10. The control plasmid, pAT did not
activate the tk-promoter. Plasmid pill induced a very low level of
CAT activity. Plasmid pl75 caused a significant activation of the 
tk-promoter. The combination of pl75 and pill together with tk-CAT 
resulted in a greater stimulation of CAT activity than with either 
pi75 or pill alone.
The results of two experiments on the effect of Vmw 175 or Vmw 110 
are shown in fig. 6.16 and table 6.11.
Vmw 175 caused a small (20 - 30%) increase in ER mRNA levels. The 
effect of Vmw 110 was variable as no stimulation of ER mRNA was seen 
in experiment (A) but a rise of 20% was seen in experiment (B). In
a single experiment, the combination of pl75 and pill did not
stimulate the level of ER mRNA (data not shown).
6.7.5 Conclusions
1. CAT expression from the tk-promoter is greatly enhanced in the 
presence of Vmw 175 and activated at a low level by Vmw 110.
2. The combination of Vmw 175 and Vmw 110 together results in a
greater stimulation of CAT expression from the tk-promoter than 
with either Vmw 175 or Vmw 110 alone.
3. Vmw 175 stimulates the level of ER mRNA only by a small amount
(20 - 30%), the significance of which is unknown.
4. The effect of Vmw 110 on the level of ER mRNA is variable in
these experiments.
5. The results of a limited experiment do not show a synergistic
effect of Vmw 175 and Vmw 110 in activating the level of ER mRNA.
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6.7.6 Discussion
It should be noted that the above conclusions are based on a limited 
number of experiments. Efficiency of transfection is known to vary 
among experiments (Dr. R. Everett, personal communication; Dr. J.
Macnab, personal communication; personal experience). Therefore, to 
make firm conclusions, several experiments showing consistent results 
are necessary. Due to the shortage of time, only a limited number of 
experiments were carried out but these are consistent with the 
interpretation that Vmw 175 and Vmw 110 do not account for the 100 -
200% increase in ER mRNA observed in HSV-1 infected cells.
The CAT results in MCF-7 cells (fig. 6.15, table 6.10) are similar to
those described for the effect of Vmw 175 or Vmw 110 on the HSV gD
or tk early promoters in HeLa cells (Everett, 1984, 1987; Gelman and 
Silverstein, 1985; 0'Hare and Hayward, 1985a; Quinlan and Knipe, 1985). 
These authors came to the conclusion that Vmw 110 and Vmw 175 were 
able to independently activate HSV early promoters but that the 
greatest stimulation occurred when both Vmw 175 and Vmw 110 were 
present together.
The results described here indicate that pill can activate the tk- 
promoter to a small extent while pl75 gives a large activation of 
promoter activity. The level of expression seen in the presence of 
Vmw 175 alone is increased 2-fold when pill is also present. Everett 
(1987) reported a 3- to 5- fold stimulation of CAT expression under 
the control of the HSV gD promoter in HeLa cells transfected with 
p175 or pill. The combination of pl75 and pill together gave a 20- 
fold greater stimulation than with either pill or pl75 alone. Thus 
the level of expression of the CAT gene is stimulated to varying 
degrees according to the type of promoter and/or the cell type used.
The level of stimulation of ER mRNA by Vmw 175 is not sufficient to 
account for the increase in ER mRNA induced by HSV-1 infection 
(section 6.6.2.1) although it is of a similar level to that found in
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response to HSV-2 infection (section 6.6.2.2). Whether or not a 
stimulation of 20 - 30% is significant is unknown.
It is known that virus infection is a more efficient way of introducing 
viral DNA into cells than transfection. Deletion mutants for HSV-1 Vmw 175 
(DeLuca et a l ., 1985), HSV-2 Vmw 175 (Smith and Schaffer, 1987a) and 
HSV-1 Vmw 110 (Stow and Stow, 1986; Sacks and Schaffer, 1987) could 
be used (with wild-type virus as control) to investigate the effect of 
HSV IE proteins on the levels of ER mRNA.
Clearly the results of the CAT assays (fig. 6.15 and table 6.10) and 
the RNA results (fig. 6.16 and table 6.11) are not comparable. It 
may be that the 5'-flanking sequences of the ER gene do not contain 
target sequences for HSV IE proteins. A target sequence for the 
binding of Vmw 175 in the HSV gD promoter has been identified (Faber 
and Wilcox, 1986). However, it is not known if this sequence is 
present in the regulatory sequences of the ER gene.
A more direct way of looking at the effect of IE proteins on expression 
of the ER gene would be to cotransfect pill and/or pl75 together with 
a plasmid containing the 5'-flanking sequences of the ER gene linked 
upstream of the CAT gene into ER negative cells. By this procedure,
CAT expression under the control of the ER promoter could be easily 
measured.
6.8 EFFECT OF THE HSV VIRION COMPONENT, Vmw 65, ON THE
EXPRESSION OF THE ER MESSAGE
6.8.1 Introduction
As previously described (section Bl.6.3), the HSV virion component,
Vmw 65 is a late protein which acts as a trans-inducing factor of HSV 
IE gene expression. Vmw 65 can also activate expression of heterolog­
ous genes in the presence of its target sequence, TAATGARAT (section Bl.6.3' 
Since ER mRNA levels in MCF-7 cells are stimulated by infection with
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HSV-1, HSV-2 and tsK (section 6.6), the possibility that Vmw 65 was 
involved in this stimulation was investigated.
6.8.2 Plasmids used in Transfection Studies
The following plasmids were kindly provided by Dr. C. Preston, Institute
of Virology and are represented diagramatically on the map of Vmw 65,
fig. 1.5:
pMCl, pBamf (Campbell et a l ., 1984) both encode wild-type Vmw 65
pBamfr:25 (pMC3) (Campbell et a l ., 1984) has the normal reading frame 
of the 1.9 kb mRNA for Vmw 65 disrupted by an 8 bp 
EcoRl linker insertion which inactivates the trans- 
inducing function in transfection studies.
was constructed by Dr. C. Preston (unpublished results)
and contains an 8 bp insertion at the second Sal 1_
site, which inactivates the trans-inducing function in 
transfection studies.
was constructed by C. Ace (unpublished results) and 
contains an in-frame 4-amino acid insertion sequence 
at position 173 of the Vmw 65 amino acid coding 
sequence determined by Dalrymple et a l .(1985). This 
insertion inactivates the trans-inducing function in 
transfection studies.
The plasmids pLW4 and pAT have already been described (sections 4.2.1 
and 6.7.2 respectively). The plasmid pAT was used as carrier DNA to 
make up the total amount of transfected DNA to 20 pig.
6.8.3 Method
Cells maintained in DMEM + 2% HIDCC-FCS were transfected with each of
pMC7
pMCl:ln8
152
the above plasmids encoding wild-type or mutant forms of Vmw 65 and 
harvested 48h later. The relative level of ER mRNA in each case was 
compared by Northern blot analysis. As a positive control that 
Vmw 65 was able to activate gene expression in the presence of its 
target sequence, the above Vmw 65 plasmids were also cotransfected 
together with pLW4 and the level of CAT activity measured 48h later.
6.8.4 Results
The results of two cotransfection experiments are shown in figs. 6.17A, 
6.17B and tables 6.12A, 6.12B. Cotransfection of pLW4 and pMCl 
resulted in an 8- or 9- fold stimulation of CAT activity. Cotransfect­
ion of pLW4 and pBamf resulted in a 12-fold stimulation of CAT activity. 
Thus Vmw 65 encoded by either pMCl or by pBamf was able to activate 
the TAATGARAT element present in pLW4. The ability of the mutated 
forms of Vmw 65, encoded by p M C 7 , pMCl:ln8 and pBamfr:25, to stimulate 
CAT expression via the TAATGARAT element was greatly reduced compared 
with the wild-type level of expression, giving a 2- to 4- fold increase 
in CAT activity.
Transfection results with Vmw 65 or mutated forms of Vmw 65 on ER mRNA 
levels are shown in figs. 6.18A, 6.18B and tables 6.13A, 6.13B. All of 
the plasmids tested resulted in 100 - 200 % increase in ER mRNA except 
for pBamf. However, in a repeat experiment with a fresh preparation of 
pBamf obtained from Dr. M. Campbell, there was a 120% increase in ER 
mRNA level (data not shown).
6.8.5 Conclusions
1. Plasmid encoded Vmw 65 stimulates CAT expression from pLW4 by 
8- to 12- fold.
2. Mutated forms of Vmw 65 stimulate CAT expression from pLW4 to a
reduced extent of 2- to 4-fold.
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FIG. 6.17 (A) and (B)
CAT ASSAYS OF CYTOSOL EXTRACTS FROM MCF-7 CELLS COTRANSFECTED WITH 
PLASMIDS ENCODING WILD-TYPE OR MUTANT Vmw 65 TOGETHER WITH pLW4.
Figures (A) and (B) are the results of two separate experiments.
The experiments were carried out as described in the legend to 
table 6.12.
Fig. 6.17 (A) is shown opposite.
Fig. 6.17 (B) is shown on the next page.
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TABLE 6.12
Effect of Vmw 65 or mutant Vmw 65 on the activation of TAATGARAT
MCF-7 cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start 
of the experiment and throughout the course of transfection. 
Plasmids used for transfection are described in section 6.8.2. 
Cells were transfected with (A) 10 Ug pLWA + 10 Ug (pAT or pMCl 
or pMC7) and (B) 10 ug pLWA + 10 ug (pAT or pMCl or pMCl:ln8 
or pBamf or pBamfr:25). The methods for transfection, harvesting 
of cells, protein estimation and CAT assay are described in 
sections 2.2.15 - 2.2.17.
Results are expressed as n moles acetylated [ ]-chloramphenicol 
(CM)/mg protein/h and divided by the control (pLW4 + pAT) value 
for comparative results.
TABLE 6.12
Effect of Vmw 65 or mutant Vmw 65 on the activation of TAATGARAT
A.
Transfected
DNA
% acetylation 
of [14C]-CM
Ug protein/ 
assay
Acetylated 
[U C]-CM 
n moles/mg/h
Fold
Difference 
wrt control
pLW4 + pAT 15 89 14 1
pLW4 + pMCl 99 73 111 8
pLW4 + pMC7 59 114 42 3
B.
Transfected
DNA
% acetylation 
of [1AC]-CM
Ug protein/ 
assay
Acetylated 
[U Cj-CM 
n moles/mg/h
Fold
Difference 
wrt control
pLW4 + pAT 7.4 50 12 1
pLW4 + pMCl 66 50 108 9
pLW4+pMCl:ln8 12 50 20 2
pLW4 + pBamf 88 50 144 12
pLW4+pBamfr25 31 50 50 4
FIG. 6.18 (A) and (B)
NORTHERN BLOTS OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS TRANSFECTED 
WITH PLASMIDS ENCODING WILD-TYPE OR MUTANT Vmw 65, PROBED FOR 
ER mRNA AND ACTIN mRNA
Figures (A) and (B) are the results of two separate experiments.
The experiments were carried out as described in the legend to table
6.13.
p A T  p M C 1  p M C 7
t
TABLE 6.13
Effect of Vmw 65 or mutant Vmw 65 on ER mRNA levels 
A.
Transfected DNA ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of Control
pAT alone 1485 3039 1.00 100
pAT + pMCl 2553 2381 2.19 219
pAT + pMC7 3309 2575 2.63 263
B.
Transfected DNA ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of control
pAT alone 4011 7768 0.52 100
pAT + pBamf 1524 3370 0.45 87
pAT + pBamfr:25 2675 2439 1.10 213
pAT + pMCl 3821 2740 1.40 270
pAT + p M C l : In 8 3341 3461 0.97 187
MCF-7 cells were grown and transfected with plasmid DNA exactly as 
described in the legend to table 6.12. Cytoplasmic RNA was extracted, 
analysed and the results calculated as described in the legend to table 
6.6.
3. Plasmids encoding either wild-type Vmw 65 or any mutated form of 
Vmw 65 all stimulate the level of ER mRNA by 100 - 200 %.
6.8.6 Discussion
In agreement with the results of Campbell et a l .(1984), Vmw 65 acts as 
a trans-inducing protein in MCF-7 cells in the presence of the 
TAATGARAT element. This ability is greatly reduced when mutations 
are introduced into the protein.
Both wild-type and mutated forms of Vmw 65 have the ability to stimulate 
the ER message. This result appears to contradict the result of the 
CAT assay. Several explanations are possible. It is possible that 
Vmw 65 is recognizing a sequence different from TAATGARAT, upstream of 
the ER gene resulting in activation of transcription of the ER gene 
and that the particular mutant proteins tested do not affect this 
function. Vmw 65 may be involved in stabilizing the ER message, a 
function which may not be affected by the particular mutations investi­
gated here. Whatever the reason, Vmw 65 is acting differently in 
stimulating CAT expression from pLW4 than in stimulating the level of 
ER mRNA in the cells. These functions may reside on different domains 
of the protein.
Although the mutant proteins studied here showed a reduced ability to 
activate CAT expression, this ability was not completely abolished. 
Either the function involved in .activating the TAATGARAT element was 
not totally inactivated by these mutations or some other domain of 
Vmw 65 has some trans-activating activity. This residual trans- 
activating activity may be activating the ER gene.
The level of stimulation of ER mRNA observed with Vmw 65 is comparable 
to that seen with HSV-1 infection. Moreover, as discussed in section 
6.6.4.2, the cycloheximide results suggest that viral and cellular 
proteins are involved in increasing the level of ER mRNA. As Vmw 65 
requires cellular proteins for its mechanism of action (Preston et a l .,
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in press), it is possible that cycloheximide inhibits the HSV-1 
activation of ER mRNA levels by inhibiting synthesis of Vmw 65 and the 
cellular protein(s) with which it interacts.
6.9 EFFECT OF CHEMICAL AND HEAT INDUCED STRESS ON THE
EXPRESSION OF THE ER MESSAGE
6.9.1 Introduction
HSV infection results in an elevation of the levels of certain cellular 
proteins, notably the heat shock proteins (Notarianni and Preston, 1982; 
La Thangue et a l ., 1984), which in the latter case occurs at the level 
of transcription (Patel et a l ., 1986), (see.also section Bl.7.2).
An experiment was carried out to determine if the virus induced elevat­
ion of ER mRNA levels was related to the heat shock response at the 
level of transcription.
6.9.2 Method
Cells were maintained in DMEM + 2% HIDCC-FCS for 48h prior to the start 
of the experiment. The cells were then given the following treatments:
Control Given fresh medium and harvested 4h later.
Sodium arsenate Given fresh medium supplemented by 0.1 mM NaArs and 
(NaArs) harvested 4h later.
Disulfiram Given fresh medium supplemented by 0.3 yM DS and
(DS) harvested 4h later.
Heat shock Given fresh medium and incubated for 4h at 44°C then
(HS) transferred to 37°C for 30 min before harvesting.
These conditions have been shown by Dr. J. Macnab to result in the 
expression of heat shock proteins (personal communication).
155
FIG. 6. NORTHERN BLOT OF TOTAL CYTOPLASMIC RNA FROM MCF-7 CELLS 
SUBJECTED TO HEAT OR CHEMICAL STRESS, PROBED FOR 
ER mRNA AND ACTIN mRNA
The experiment was carried out as described in the legend to table
6.14.
C DS Na HS 
Ars
TABLE 6.14
Effect of chemical and heat induced stress on ER mRNA levels
Treatment ER
(Area)
Actin
(Area)
ER
Actin
ER mRNA as 
% of Control
Control 7400 5111 1.45 100
NaArs 7299 4800 1.52 100
DS 8502 5905 1.44 100
HS 5609 2151 2.61 180
MCF-7 cells were grown in 80 c m 2 flasks in DMEM + 10% FCS, then 
maintained in DMEM + 2% HIDCC-FCS for 2 days prior to the start of the 
experiment and throughout the course of the experiment. Cells were 
maintained as controls, treated with 0.1 mM sodium arsenate (NaArs) 
for 4 h , treated with 0.3 yM disulfiram (DS) for 4h or incubated at 
44°C for 4h, then at 37°C for 30 min. Cytoplasmic RNA was extracted, 
analysed and the results calculated as described in the legend to 
table 6.6.
6.9.3 Results
The results are shown in fig. 6.19 and table 6.14.
Treatment of cells with NaArs or disulfiram resulted in no change in 
the level of ER mRNA compared to control cells. In this particular 
experiment, heat shock treatment resulted in an 80% stimulation of the 
ER message. However, this was not a repeatable result and may have 
reflected the physiological state of the cells.
6.9.4 Conclusion
General stress, as applied in these experiments, does not change the 
level of expression of the ER message.
6.10 OVERALL CONCLUSIONS ON THE EFFECT OF HSV INFECTION ON
ER mRNA LEVELS
Infection of MCF-7 cells by HSV-1 or by the mutant, t s K , at the non- 
permissive temperature, results in a 200 - 300 % increase in ER mRNA 
levels. Infection by HSV-2 results in a smaller increase (30%) in 
ER mRNA levels. The accumulation of ER mRNA is gradual, starting 
within 2h of infection and reaching maximum levels by 6 - 8 h post­
infection. Treatment with 10~^M Es for 24h results in a 50% rise 
in ER mRNA levels. With all three viruses, infection in the presence 
of 10-^M E 2 results in a higher level of ER mRNA than with either 
virus of E 2 alone. Cycloheximide results suggest the involvement of 
viral and cellular proteins. Transfection studies are consistent with 
the idea that Vmw 65 is involved in the virus mechanism of action.
The stimulation of ER mRNA levels is not linked to the stress response 
(with the exception of a single experiment which showed an increase in
ER message in response to elevated temperature).
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GENERAL CONCLUSIONS AND DISCUSSION
7. GENERAL CONCLUSIONS AND DISCUSSION
The aim of this thesis was to investigate the possible interaction of 
steroid hormones and HSV. The studies were based on the association of 
HSV with cervical cancer (section Cl.3), the role of hormones in the 
normal development and pathology of the cervix (section Cl.2) and the 
increased risk of developing CIN in women using the contraceptive pill 
(section Cl.1.3). Four aspects of steroid hormone /HSV interaction 
were studied:
(a) The effect of hormones on virus growth (section 3)
(b) The effect of hormones on virus gene expression (section 4)
(c) The effect of virus infection on steroid receptor levels (section 5
(d) The effect of virus infection on steroid mRNA levels (section 6)
The results are discussed in detail at the end of each set of 
experiments. The most important points will be emphasized in this 
final discussion.
The object of the experiments on the growth of HSV-2 in primary cells 
(section 3) was to mimic the in vivo situation as closely as possible, 
therefore primary cells, physiological concentrations of hormones and 
low multiplicity of infection were used. Neither oestrogen nor 
progesterone significantly affected HSV-2 titres in either primary 
cervical cells or in ZR-75-1 cells. As discussed in section 3.6, 
stromal cells may influence the response of epithelial cells to 
hormones or virus infection in v i v o , possibly by the secretion of 
growth factors (Cuhna et a l ., 1987) as has been shown for breast cells 
Schor et a l ., 1987). The effect of hormones and/or virus infection on 
stromal cells was not investigated.
The results of section 4 show that in transient, transfection assays, 
in MCF-7 or ZR-75-1 cells, neither oestrogen nor progesterone modulate 
expression of the CAT gene under the control of an HSV promoter and 
upstream activator sequence, TAATGARAT (which shows partial homology
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to the consensus binding site for chicken oviduct PR), even although 
both MCF-7 and ZR-75-1 cells contain cellular factors which specifi­
cally complex with TAATGARAT DNA in vitro. These results are 
discussed in detail in section 4.4.A and 4.5.6. Points to be noted 
are that (a) both the TAATGARAT sequence and chicken PR binding 
sequence are consensus sequences and only show partial homology with 
each other; (b) it is known, at least in the case of the TAATGARAT 
sequence (Bzik and Preston, 1986), that flanking sequences are 
important for full activation of transcription via the TAATGARAT 
element; (c) chicken and human cells contain different cellular 
factors which could affect binding of PR to its target sequence. 
Therefore, it is probable that the precise DNA core and flanking 
sequences, chromatin configuration and cellular factors involved in 
binding PR are specific and are not mimicked by the HSV IE activator 
sequence which is the target sequence for the virion trans-inducing 
factor, Vmw 65. As discussed in section Al.7.4, tissue specific 
transcription factors are important for regulation of steroid induc­
ible genes in the chicken oviduct.
The other possible reasons (discussed in section 4.4.4) for the 
failure of hormones to activate gene expresssion in the presence of 
the TAATGARAT element include the possibility that the concentration 
of PR in the cells was too low or was not at a constant level or that 
transfection efficiency was not high enough. It would be worthwhile 
repeating these experiments by cotransfection of the pLW plasmids 
with a plasmid encoding the PR under the control of a strong, inducible 
promoter to ensure high, constant levels of PR synthesis.
In the context of these experiments, it is interesting to note that 
Gloss et a l . (1987) found that the upstream regulatory region of 
HPV-16 genomic DNA contains a sequence element with a large degree of 
homology to known GRE's of glucocorticoid regulated genes, binds GR 
in vitro and is protected from DNase J_ cleavage and dimethylsulphate 
(DMS) methylation by GR. However, when HPV-16 RNA from CaSki cells 
(which contain and express endogenous HPV-16 genomes; Smotkin and 
Wettstein, 1986) treated with or without dexamethasone was quantitated
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on Northern blots, no difference was seen between control and 
dexamethasone treated cells. Moreover, when a positive control plasmid 
containing a known GRE linked to the CAT gene was transfected into 
CaSki cells with or without dexamethasone, no increase in CAT 
expression was observed in the presence of dexamethasone. The authors 
concluded that this may be due to a low endogenous level of GR in 
CaSki cells. It could also be due to incorrect flanking sequences or 
the wrong DNA configuration.
Section 5 describes biochemical and immunological analysis of detectable 
ER and PR levels in ZR-75-1 and MCF-7 cells in response to E 2 stimulat­
ion and/or HSV infection. Both HSV and E 2 caused a fall in ER levels 
to about 10% of the control value. E 2 caused the levels of PR to rise, 
thus indicating that the cells were responding as expected to E 2 .
HSV infection resulted in a reduction of PR levels, thus indicating 
that the mechanisms of action of E 2 and HSV are different. These 
results are discussed fully in sections 5.3.4 and 5.4.5. The reason 
for the drop in receptor levels may be due to modification of the 
receptor in a way which prevents ligand binding or recognition by the 
monoclonal antibody so that the receptor is no longer detectable by 
these means. The virus may bind the receptor so that it is no longer 
able to bind ligand and the epitope recognized by the antibody may be 
m asked.
Attempts to in vitro translate and immunoprecipitate the ER protein 
from total cellular RNA were unsuccessful (section 5.5). As discussed 
in section 5.5.5, this may be due to the low abundance of the ER 
message or the fact that only one monoclonal antibody to the ER was 
used (which is known to recognize the nuclear bound form of the receptor 
but may not recognize the newly synthesized receptor). In contrast, 
Walter et a l . (1985), using hybrid-selected ER mRNA and a combination 
of four monoclonal antibodies managed to in vitro translate and 
immunoprecipitate a protein of mol. wt. approximately 65 000.
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Section 6 describes the effects of E 2 stimulation, HSV infection and 
transfection of HSV regulatory proteins on ER mRNA levels. Overall 
conclusions are given section 6.10. Results are discussed in 
detail in sections 6.4.4, 6.7.6 and 6.8.6. The ability of E 2 or 
HSV to increase the cellular levels of the ER message seems to cont­
radict the results with the ER protein levels (section 5). However, 
if it is true that the reason for the fall in detectable ER levels 
is due to modification of the' receptor so that it Can no longer 
bind ligand and is no longer recognized by the antibody, then the 
problem lies in the assay methods used to detect the ER protein. 
Alternatively,■(a) there may be a post-transcriptional block such that 
the extra ER mRNA available is not translated into protein or (b) it is 
not the complete ER message that is being detected by the probe in 
hybridization experiments. A few examples of increased message levels 
without a corresponding increase in protein levels do exist, including 
the trans-acting protein, t a t , of the human immunodeficiency virus 
(HIV), (J. Nelson, personal communication). Expression of the tat 
message seems to alter expression of other genes in a way that is 
not yet understood. The tat message possibly binds to other messages 
resulting in stabilization of those messages.
The activation of a cellular message is an unusual consequence of 
HSV infection. Most macromolecular synthesis is turned off as a 
result of HSV infection (section Bl.7.1). There are two examples of 
transcriptional activation of cellular genes by HSV. One is a heat 
shock protein (Patel et a l ., 1986) and the other is of unknown function 
(Kemp et a l ., 1986). Certain cellular polypeptides are upregulated 
by HSV infection, including the heat shock proteins (Notarianni and 
Preston, 1982; La Thangue et a l ., 1984) and some polypeptides of 
unknown function in HSV-2 infected and HSV-2 transformed rodent cells 
(Macnab et a l ., 1985). Most other cellular gene and protein 
expression is turned off.
As previously discussed (sections Bl.7.1 and 6.5.1), there has been 
great variability in results of shutting off of cellular messages by
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HSV, depending on the virus strain and cell type used. It is important
to stress that the experiments described in section 6 were done in
breast epithelial cells, but not in cervical epithelial cells which 
are infected with HSV in vivo. There was no evidence for the switching 
off of actin message by HSV-1 or HSV-2 but tsK was capable of signifi­
cant depression of actin mRNA (section 6.6.2.3). As discussed in 
section 6.6.4.2, this effect of tsK may be due to the synthesis of an 
abnormal form of Vmw 175, also known to induce the heat shock response 
(Russell et a l ., 1987).
The effect of E 2 on the expression of the ER message showed a 
cyclical effect (section 6.4.2.1). This is probably linked to the 
cell cycle; The E 2 binding capacity of breast cancer cells varies 
with the cell cycle (Chua et a l ., 1986)., It is known that genes 
which are switched on early in the cell cycle are expressed at a 
much lower level at later stages in the cell- cycle and then more 
fully again after cell division (Wheatley, 1982).
The importance of cell type in testing the response of HSV IE-CAT
constructs to viral trans-acting proteins (Vmw 175, Vmw 110 and 
Vmw 65) has been demonstrated by Gelman and Silverstein (1987b).
They found that IE-CAT constructs showed a different basal level of 
transcription and differed in the level of their response to trans­
acting viral proteins in Vero (African green monkey kidney cells) 
and HeLa cells, even although the virus grows equally well in both 
cell lines. Therefore, it is important to consider both viral and 
cellular factors in studying regulation of transcription by virus.
The ability of HSV to increase the level of the ER message may have 
important consequences. The ER plays a central role in the mechanism 
of action of oestrogen. The biological responses of cells to -eestrogen 
are described in sections A1.5and A1.6. Overall, oestrogen promotes 
cell growth and division. The fact that HSV affects the level of the 
ER message may have implications in regulation of cell growth. In 
view of the association of HSV with CIN (section Cl.3) and one of the
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proposed mechanisms for transformation by HSV being activation of 
cellular genes (Macnab, 1987), it is very interesting to find that 
HSV increases the level of a cellular message of a protein directly 
involved in growth control. E 2 directly affects cell growth by 
changes in RNA, protein and DNA synthesis (section Al.^f) and indirectly 
by influencing the secretion of growth factors (section A1.6).
As described in section A1.8, the amino acid sequences of steroid 
and thyroid hormone receptors, vitamin D 3 receptor and retinoic acid 
receptor all share high homology with the v-erb A oncogene of AEV, 
especially in the putative DNA - binding domain. The v-erb A oncogene 
is not sufficient by itself to transform erythroblasts but potentiates 
the action of the v-erb B oncogene (section Al.8.4). Recent experi­
ments (Boucher et a l ., 1988), using oligopeptide antisera directed 
against specific domains of the v-erb A protein in immunoflorescence 
and immunoprecipitation studies on subfractionated cell extracts, 
have shown both cytoplasmic and nuclear localization of v-erb A. Both 
forms of the protein were able to bind DNA. A mutation within the
v-erb A coding region which inhibited DNA binding and nuclear 
■fci
localizai-ton, also inhibited the ability of the v-erb A protein to 
potentiate erythroid transformation, consistent with the model of 
v-erb A as a transcriptional regulator. Moreover, the mutation which 
inhibits nuclear localization of v-erb A occurs within a similar 
sequence and in a position equivalent to the site of the nuclear 
localization signal in the GR (Picard and Yamamoto, 1987). Deletion 
of the hormone - binding domain of the GR leads to a constitutively 
active receptor which does not bind hormone (Godowski et a l ., 1987). 
The v-erb A protein has lost the ability to bind hormone, in contrast 
to its cellular counterpart, c-erb A which is a high affinity thyroid 
hormone receptor (section Al.8.4). Sap et a l .(1986) have proposed 
that the v-erb A protein functions in oncogenesis as a constitutively 
"turned on" derivative of a hormone receptor and this view is supported 
by Boucher et a l . (1988). Presumably, v-erb A acts by modulating 
transcription of specific target genes within the nucleus of the trans­
formed erythroid cell.
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In view of the homology between v-erb A and steroid and retinoic acid 
receptors (retinoic acid affects cell differentiation) and the results 
of this thesis showing elevation of the levels of the ER message by 
HSV infection, it would be interesting to test the ability of HSV to 
activate the expression of other normal cellular genes and cellular 
oncogenes.
The oncogene, v- r a s ^ , when transfected into MCF-7 cells, is able to 
bypass the oestrogen dependence on growth of these cells as tumours 
in vivo ( Kasid et a l ., 1985) probably because the cells can now
secrete growth factors capable of supporting their own tumour growth 
in vivo ( Kasid et a l ., 1987). Human breast tumours sometimes lose
their hormone dependence and this may reflect a change to control by 
autonomous growth factors. Transfection of v-ras^ into MCF-7 cells 
also affects their ability to interact with and cross basement 
membrane components (Albini et a l ., 1986). The ability of tumour cells to 
cross basement membranes is an important step in the progression to 
malignancy.
The mechanism of action of oestrogen in cell or tumour growth seems to 
be linked indirectly with the secretion of growth factors either by the 
oestrogen target cell or by a neighbouring cell (section A1.6). Thus 
it would be interesting to look at the effect of HSV on growth factor 
mRNA levels.
In conclusion, the studies described in this thesis show no effect of 
steroid hormones on HSV growth or gene expression. However, HSV 
infection has an effect on steroid receptor and message levels. The 
stimulation of ER mRNA levels by HSV appears to be mediated by the 
HSV trans-inducing factor, Vmw 65. Transcriptional activation of 
cellular genes is an important mechanism of action of certain oncogenes.
In view of the association of HSV with cervical carcinoma, it is 
possible that HSV activates the expression of certain cellular genes 
involved in growth control, thus playing a role in the progression to 
abnormal cell growth.
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